<DOCUMENT>
<TYPE>EX-2.1
<SEQUENCE>2
<FILENAME>d53102exv2w1.htm
<DESCRIPTION>AGREEMENT AND PLAN OF MERGER
<TEXT>
<HTML>
<HEAD>
<TITLE>exv2w1</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><B>EXECUTION VERSION</B>
</DIV>


<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><B>Exhibit&nbsp;2.1</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>AGREEMENT AND PLAN OF MERGER</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>by and among</B>

</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>Odyssey HealthCare Holding Company,</B>

</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>OHC Investment, Inc.</B>

</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>and</B>

</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>VistaCare, Inc.</B>

</DIV>

<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>Dated as of January&nbsp;15, 2008</B>

</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>TABLE OF CONTENTS</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="8%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="85%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000">Page</TD>
    <TD>&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD colspan="5" align="left">ARTICLE I THE TENDER OFFER AND MERGER</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">2</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" nowrap>Section 1.1.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The Offer</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">2</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 1.2.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Company Action</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">4</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 1.3.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Top-Up Option</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">6</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 1.4.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Directors</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">7</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD colspan="5" align="left">ARTICLE II THE MERGER</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">8</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 2.1.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">The Merger</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">8</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 2.2.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Closing</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">8</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 2.3.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Effective Time</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">9</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 2.4.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Effects of the Merger</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">9</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 2.5.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Certificate of Incorporation and By-laws of the Surviving Corporation</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">9</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 2.6.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Directors</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">9</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 2.7.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Officers</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">9</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 2.8.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Merger Without Meeting of Stockholders</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">10</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD colspan="5" align="left">ARTICLE III CONVERSION OF SHARES; EXCHANGE OF CERTIFICATES</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">10</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 3.1.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Effect on Capital Stock</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">10</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 3.2.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Exchange of Certificates</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">11</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 3.3.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Treatment of Stock Options and Other Stock-Based Awards</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">14</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD colspan="5" align="left">ARTICLE IV REPRESENTATIONS AND WARRANTIES OF THE COMPANY</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">15</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 4.1.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Qualification, Organization, Subsidiaries, etc</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">15</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 4.2.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Capital Stock</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">16</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 4.3.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Subsidiaries; Investments</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">17</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 4.4.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Corporate Authority Relative to This Agreement; No Violation</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">17</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 4.5.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Reports and Financial Statements</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">19</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 4.6.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Compliance with Law; Permits</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">20</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 4.7.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Environmental Laws and Regulations</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">22</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 4.8.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Employee Benefit Plans</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">23</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 4.9.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Absence of Certain Changes or Events</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">24</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 4.10.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Investigations; Litigation</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">24</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 4.11.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Schedule 14D-9, Offer Documents; Proxy Statement; Other Information</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">25</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 4.12.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Other Approvals</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">25</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 4.13.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Tax Matters</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">26</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 4.14.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Labor Matters</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">28</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" nowrap>Section 4.15.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Intellectual Property</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">30</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="8%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="85%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000">Page</TD>
    <TD>&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" nowrap>Section 4.16.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">HIPAA</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">30</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 4.17.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Property</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">31</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 4.18.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Opinion of Financial Advisors</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">32</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 4.19.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Required Vote of the Company Stockholders</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">32</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 4.20.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Contracts</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">32</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 4.21.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Finders or Brokers</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">34</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 4.22.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Insurance</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">34</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 4.23.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Health Care Legal Matters</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">35</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 4.24.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Changes in Suppliers and Third-Party Payors</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">35</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 4.25.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Certain Relationships</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">35</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 4.26.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Rates and Reimbursement Policies</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">35</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 4.27.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">No Additional Representations</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">35</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD colspan="5" align="left">ARTICLE V REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">36</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 5.1.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Qualification, Organization, Subsidiaries, etc</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">36</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 5.2.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Corporate Authority Relative to This Agreement; No Violation</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">36</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 5.3.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Investigations; Litigation</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">37</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 5.4.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Proxy Statement; Schedule 14D-9; Other Information</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">37</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 5.5.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Aggregate Cash Consideration</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">38</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 5.6.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Parent Business</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">38</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 5.7.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Capitalization of Merger Sub</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">38</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 5.8.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">No Vote of Parent Stockholders</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">38</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 5.9.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Finders or Brokers</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">38</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 5.10.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Certain Arrangements</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">38</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 5.11.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">No Additional Representations</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">38</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD colspan="5" align="left">ARTICLE VI COVENANTS AND AGREEMENTS</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">39</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 6.1.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Conduct of Business by the Company and Parent</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">39</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 6.2.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Access</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">43</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 6.3.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Solicitation</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">44</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 6.4.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Filings; Other Actions</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">49</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 6.5.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Employee Matters</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">50</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 6.6.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Efforts</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">51</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 6.7.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Takeover Statute</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">53</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 6.8.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Public Announcements</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">54</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 6.9.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Indemnification and Insurance</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">54</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 6.10.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Control of Operations</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">56</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 6.11.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Disposition of Litigation</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">56</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 6.12.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Notification of Certain Matters</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">57</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 6.13.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Termination of Credit Agreement and Funded Indebtedness</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">57</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 6.14.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Company Rights Agreement</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">57</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 6.15.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Stock Exchange De-listing</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">58</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 6.16.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Transfer Taxes</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">58</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 6.17.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Rule 14d-10(d)</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">58</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="8%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="85%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000">Page</TD>
    <TD>&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" nowrap>Section 6.18.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Financing</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">58</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD colspan="5" align="left">ARTICLE VII CONDITIONS TO THE MERGER</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">58</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 7.1.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Conditions to Each Party's Obligation to Effect the Merger</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">58</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD colspan="5" align="left">ARTICLE VIII TERMINATION</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">59</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 8.1.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Termination or Abandonment</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">59</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 8.2.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Effect of Termination</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">61</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 8.3.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Termination Fees and Expense Reimbursement</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">61</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD colspan="5" align="left">ARTICLE IX MISCELLANEOUS</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">64</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 9.1.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">No Survival of Representations and Warranties</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">64</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 9.2.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Expenses</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">64</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 9.3.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Counterparts; Effectiveness</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">64</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 9.4.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Governing Law</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">65</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 9.5.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Jurisdiction; Enforcement</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">65</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 9.6.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">WAIVER OF JURY TRIAL</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">65</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 9.7.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Notices</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">66</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 9.8.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Assignment; Binding Effect</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">67</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 9.9.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Severability</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">67</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 9.10.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Entire Agreement; No Third-Party Beneficiaries</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">67</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 9.11.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Amendments; Waivers</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">67</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 9.12.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Headings</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">68</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 9.13.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Interpretation</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">68</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 9.14.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">No Recourse</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">68</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Section 9.15.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Definitions</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD align="right" valign="top">68</TD>
    <TD valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><U>Annexes</U>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Annex A &#151; Conditions to Offer<BR>
Annex B &#151; Form of Stockholder Agreement

</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;AGREEMENT AND PLAN OF MERGER, dated as of January&nbsp;15, 2008 (this &#147;<U>Agreement</U>&#148;), among
Odyssey HealthCare Holding Company, a Delaware corporation (&#147;<U>Parent</U>&#148;), OHC Investment,
Inc., a Delaware corporation and a direct wholly owned subsidiary of Parent (&#147;<U>Merger Sub</U>&#148;),
and VistaCare, Inc., a Delaware corporation (the &#147;<U>Company</U>&#148;).
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>W I T N E S S E T H:</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, on the terms and subject to the conditions set forth herein, including <U>Annex
A</U> hereto, Merger Sub has agreed to commence (within the meaning of Rule&nbsp;14d-2 under the
Exchange Act) an offer (the &#147;<U>Offer</U>&#148;) to purchase for cash all of the issued and outstanding
shares of the Company&#146;s Common Stock (as defined below), at a price of $8.60 per share, or any
higher price per share of Common Stock paid by Merger Sub pursuant to the terms of the Offer for
shares of Common Stock tendered pursuant to the Offer;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, the parties intend that Merger Sub be merged with and into the Company (the
&#147;<U>Merger</U>&#148;), with the Company surviving the Merger as a wholly owned subsidiary of Parent;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, the board of directors of the Company (the &#147;<U>Board of Directors</U>&#148;), acting upon
the recommendation of a special committee of independent directors of the Company (the &#147;<U>Special
Committee</U>&#148;), has (i)&nbsp;determined that the terms of the Offer, the Merger and the other
transactions contemplated by this Agreement are fair to and in the best interests of the Company
and its stockholders, and declared this Agreement advisable, (ii)&nbsp;approved the execution, delivery
and performance of this Agreement and (iii)&nbsp;determined to recommend that the Company&#146;s stockholders
accept the Offer and tender their Shares to Merger Sub pursuant thereto and, to the extent
applicable, to adopt this Agreement;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, the board of directors of each of Parent and Merger Sub have approved this Agreement
and declared it advisable for Parent and Merger Sub, respectively, to enter into this Agreement;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, Parent and Merger Sub are unwilling to enter into this Agreement (and effect the
transactions contemplated hereby) unless, contemporaneously with the execution and delivery hereof,
certain directors and executive officers of the Company enter into
Stockholder Agreements
substantially in the form of <U>Annex B</U> hereto (collectively, the &#147;<U>Stockholder
Agreements</U>&#148;) and, in order to induce Parent and Merger Sub to enter into this Agreement, such
Persons are executing and delivering the Stockholder Agreements to Parent and Merger Sub
concurrently herewith; and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, Parent, Merger Sub and the Company desire to make certain representations,
warranties, covenants and agreements specified herein in connection with this Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;NOW, THEREFORE, in consideration of the foregoing and the representations, warranties,
covenants and agreements contained herein, and intending to be legally bound hereby, Parent, Merger
Sub and the Company agree as follows:
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->1<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ARTICLE I</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 6pt"><B>THE TENDER OFFER AND MERGER</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;1.1. <U>The Offer</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Provided that this Agreement shall not have been terminated in accordance with <U>Article
VIII</U> and that none of the events set forth in <U>Annex A</U> hereto shall have occurred and be
continuing, within ten Business Days after the date hereof, Merger Sub shall, and Parent shall
cause Merger Sub (and the Company shall cooperate with Parent and Merger Sub) to, commence (within
the meaning of Rule&nbsp;14d-2 under the Exchange Act) an offer to purchase all outstanding shares of
Common Stock of the Company at the purchase price of $8.60 per share of Common Stock (such price,
or any higher price per share of Common Stock paid by Merger Sub pursuant to the terms of the
Offer, the &#147;<U>Per Share Amount</U>&#148;) and shall, upon commencement of the Offer but after
affording the Company reasonable opportunity to review and comment thereon, file a Tender Offer
Statement on Schedule&nbsp;TO (together with all amendments and supplements thereto, including the
exhibits thereto, the &#147;<U>Schedule&nbsp;TO</U>&#148;) and all other necessary documents with the Securities
and Exchange Commission (the &#147;<U>SEC</U>&#148;) and make all deliveries, mailings and telephonic
notices required by Rule&nbsp;14d-3 under the Exchange Act, in each case in connection with the Offer
(the &#147;<U>Offer Documents</U>&#148;), and shall use its reasonable best efforts to consummate the Offer,
subject to the terms and conditions thereof. Subject to the terms and conditions of this Agreement
and to the satisfaction or waiver of the conditions set forth in <U>Annex A</U> hereto (the
&#147;<U>Tender Offer Conditions</U>&#148;), Merger Sub shall, upon the expiration of the Offer, accept for
payment, and pay for (after giving effect to any required withholding Tax), all Shares validly
tendered pursuant to the Offer and not withdrawn on the Acceptance Date. The obligation of Merger
Sub to accept for payment and to pay for any Shares validly tendered shall be subject solely to the
satisfaction of the Tender Offer Conditions. The Per Share Amount shall be net to the seller in
cash, without interest, subject to reduction for any applicable withholding or stock transfer Taxes
payable by such seller. No Shares held by the Company or its Subsidiaries shall be tendered
pursuant to the Offer. For the avoidance of doubt, the parties hereto agree that Restricted Shares
may be tendered in the Offer and be acquired by Parent or Merger Sub pursuant to the Offer.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Parent on behalf of Merger Sub expressly reserves the right from time to time, subject to
<U>Sections&nbsp;1.1(c)</U> and <U>1.1(d)</U>, in its sole discretion, to waive any Tender Offer
Condition, to increase the Per Share Amount or to make any other changes in the terms and
conditions of the Offer, <U>provided</U> that, without the prior written consent of the Company,
Merger Sub shall not and Parent shall cause Merger Sub not to (i)&nbsp;decrease the Per Share Amount or
change the form of consideration payable in the Offer, (ii)&nbsp;decrease the number of Shares sought to
be purchased in the Offer, (iii)&nbsp;amend or waive satisfaction of the Minimum Condition (as defined
in <U>Annex A</U>), (iv)&nbsp;impose additional conditions to the Offer, (v)&nbsp;make any change in the
Offer that would require an extension or delay of the then current Expiration Date (other than an
increase in the Per Share Amount); <U>provided</U>, <U>however</U>, that this clause (v)&nbsp;shall
not limit the right of Parent and Merger Sub to extend the Expiration Date as required or permitted
by <U>Section&nbsp;1.1(d)</U>, (vi)&nbsp;modify or amend the Tender Offer Conditions (other than to waive
such Tender Offer Conditions, other than the Minimum Condition), or (vii)&nbsp;modify or amend any
other term of the Offer, in the case of this clause (vii), in any manner (A)&nbsp;adverse to the holders
of Shares or (B)
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->2<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">that would reasonably be expected to result in, individually or in the aggregate, a Parent
Material Adverse Effect.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;No agreement or representation hereby is made or shall be made by Parent or Merger Sub
with respect to information supplied by the Company expressly for inclusion in, or with respect to
Company information derived from the Company&#146;s public SEC filings that is included or incorporated
by reference in, the Offer Documents. Parent, Merger Sub and the Company each agrees promptly to
correct any information provided by it for use in the Offer Documents if and to the extent that it
shall have become false or misleading in any material respect and Merger Sub shall, and Parent
further agrees to cause Merger Sub to, take all steps necessary to cause the Schedule&nbsp;TO, as so
corrected or supplemented, to be filed with the SEC and the Offer Documents, as so corrected or
supplemented, to be disseminated to holders of Shares, in each case as and to the extent required
by applicable Federal securities laws. The Company and its counsel shall be given a reasonable
opportunity to review and comment on any Offer Documents (including each amendment or supplement
thereto), and shall provide any comments thereon as promptly as practicable after receipt thereof,
before they are filed with the SEC. Merger Sub shall, and Parent agrees to cause Merger Sub to,
provide the Company with (in writing, if written), and to consult with the Company regarding, any
comments (written or oral) that may be received by Parent, Merger Sub or their counsel from the SEC
or its staff with respect to the Offer Documents as promptly as practicable after receipt thereof.
The Company and its counsel shall be given a reasonable opportunity to review any such written and
oral comments and proposed responses.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;The initial expiration date of the Offer shall be the twentieth business day (as such term
is defined in Rule&nbsp;14d-1(g)(3) under the Exchange Act, &#147;<U>Business Day</U>&#148;) following the
commencement of the Offer (determined using Rules&nbsp;14d-1(g)(3) and 14d-2 promulgated under the
Exchange Act) (such date, or such subsequent date to which the expiration of the Offer is extended
pursuant to and in accordance with the terms of this Agreement, the &#147;<U>Expiration Date</U>&#148;).
Merger Sub shall not and Parent agrees that it shall cause Merger Sub to not terminate or withdraw
the Offer other than in connection with the effective termination of this Agreement in accordance
with <U>Section&nbsp;8.1</U> hereof. Notwithstanding the foregoing, Merger Sub may, without Parent or
Merger Sub obtaining the consent of the Company, (i)&nbsp;extend the Expiration Date for any period
required by the rules and regulations of the SEC or the NASDAQ applicable to the Offer, including
in connection with an increase in the Per Share Amount, (ii)&nbsp;extend the Expiration Date if on any
then scheduled Expiration Date, any of the Tender Offer Conditions is not satisfied or waived by
Parent, for such periods for up to five (5)&nbsp;Business Days at a time (or such longer period as shall
be approved by the Company) as Merger Sub may deem reasonably necessary, but, except as provided in
<U>Section&nbsp;1.1(d)(iii)</U> or as required by the rules and regulations of the SEC or the NASDAQ
applicable to the Offer (including in connection with an increase in the Per Share Amount), in no
event may the Expiration Date be extended to a date later than the End Date, or (iii)&nbsp;extend the
Expiration Date beyond the End Date for up to a period not to exceed the period which ends on the
15th Business Day after the date that either (w)&nbsp;the Company shall have publicly announced the
receipt of a Company Acquisition Proposal in the event such announcement is made less than ten
Business Days prior to the End Date, (x)&nbsp;the Company publicly announces its reaffirmation of its
approval or recommendation of the Offer following the public announcement of the receipt of any
Company Acquisition Proposal in the event that such reaffirmation or announcement is made less than
ten Business Days prior to
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->3<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">the End Date, (y)&nbsp;the Board of Directors shall have withdrawn or adversely modified, made a
public statement or taken a public position inconsistent with the Recommendation at any time within
ten Business Days prior to the End Date or (z)&nbsp;any Notice of Superior Proposal is given by the
Company in accordance with <U>Section&nbsp;6.3(e)</U> if such notice is received by Parent less than
ten Business Days prior to the End Date. Except as expressly provided in this <U>Section
1.1(d)</U>, Parent shall not extend the Offer if all of the Tender Offer Conditions are satisfied
or waived and it is permitted under applicable Law to accept for payment and pay for validly
tendered Shares that are not validly withdrawn.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;In the event the Acceptance Date occurs but Merger Sub does not acquire a sufficient
number of Shares to enable a Short-Form&nbsp;Merger to occur pursuant to <U>Section&nbsp;2.8</U> hereof,
Merger Sub may (in its sole discretion), and Parent may (in its sole discretion) cause Merger Sub
to, provide a &#147;subsequent offering period&#148; for a number of days to be determined by Parent but not
less than three nor more than 20 Business Days in accordance with Rule&nbsp;14d-11 under the Exchange
Act.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;Promptly upon the satisfaction or waiver by Merger Sub of the Tender Offer Conditions in
accordance with <U>Section&nbsp;1.1(b)</U>, Merger Sub shall, and Parent shall cause Merger Sub to, (i)
as soon as practicable after the Expiration Date, accept for payment and pay for all Shares validly
tendered and not properly withdrawn pursuant to the Offer (the date of acceptance for payment, the
&#147;<U>Acceptance Date</U>&#148;), (ii)&nbsp;on the Acceptance Date, deposit with the depositary engaged by
Merger Sub in connection with the Offer, cash in U.S. dollars sufficient to pay the aggregate Per
Share Amount for all such accepted Shares and (iii)&nbsp;as soon as practicable following such deposit,
cause the depositary to pay for all Shares so accepted for payment. Parent shall provide or cause
to be provided to Merger Sub on a timely basis the funds necessary to purchase any Shares that
Merger Sub becomes obligated to purchase pursuant to the Offer.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;1.2. <U>Company Action</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;The Company hereby consents to the Offer and represents that the Board of Directors,
acting upon the recommendation of the Special Committee, at a duly called and held meeting, has
unanimously adopted resolutions: (i)&nbsp;determining that the terms of the Offer, the Merger and the
other transactions contemplated by this Agreement are fair to and in the best interests of the
Company and its stockholders, and declaring the Agreement advisable; (ii)&nbsp;approving the execution,
delivery and performance of this Agreement and the consummation of the transactions contemplated
hereby, including the Offer and the Merger; (iii)&nbsp;approving the Recommendation and resolving to
make the Recommendation to the stockholders of the Company; (iv)&nbsp;rendering the Rights and the
limitations on business combinations contained in Section&nbsp;203 of the General Corporation Law of the
State of Delaware (the &#147;<U>DGCL</U>&#148;) inapplicable to the Stockholder Agreements, the Offer, this
Agreement and the other transactions contemplated hereby, including the Merger; and (v)&nbsp;electing
that the Offer and the Merger, to the extent of the Board of Directors&#146; power and authority and to
the extent permitted by Law, not be subject to any &#147;moratorium,&#148; &#147;control share acquisition,&#148;
&#147;business combination,&#148; &#147;fair price&#148; or other form of anti-takeover laws and regulations
(collectively, &#147;<U>Takeover Laws</U>&#148;) of any jurisdiction that may purport to be applicable to
this Agreement (such actions by the Board of Directors described in the preceding clauses (i)
through (v), collectively, the &#147;<U>Board Actions</U>&#148;). The Company hereby consents to the
inclusion of the Recommendation in the Offer Documents.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->4<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;The Company shall file with the SEC, concurrently with the filing by Parent and Merger Sub
of the Schedule&nbsp;TO with respect to the Offer, a Tender Offer Solicitation/Recommendation Statement
on Schedule&nbsp;14D-9 (together with any amendments or supplements thereto, the &#147;<U>Schedule
14D-9</U>&#148;) that will comply in all material respects with the provisions of all applicable Federal
securities laws. The Company agrees to mail such Schedule&nbsp;14D-9 to the stockholders of the Company
along with the Offer Documents promptly after the commencement of the Offer. Subject to any
Recommendation Withdrawal in accordance with this Agreement, the Schedule&nbsp;14D-9 and the Offer
Documents shall contain the Recommendation. The Company agrees to promptly correct the Schedule
14D-9 if and to the extent that it shall become false or misleading in any material respect (and
each of Parent and Merger Sub, with respect to written information supplied by it, shall promptly
notify the Company of any required corrections of such information and cooperate with the Company
with respect to correcting such information) and to supplement the information contained in the
Schedule&nbsp;14D-9 to include any information that shall become necessary in order to make the
statements therein, in light of the circumstances under which they were made, not misleading, and
the Company shall cause the Schedule&nbsp;14D-9 as so corrected to be filed with the SEC and promptly
disseminated to the Company&#146;s stockholders to the extent required by applicable Federal securities
laws. Parent and its counsel shall be given a reasonable opportunity to review and comment on the
Schedule&nbsp;14D-9 before it is filed with the SEC. The Company shall give reasonable and good faith
consideration to any comments made by Parent and its counsel. The Company shall provide Parent and
Merger Sub (in writing, if written), and consult with Parent and Merger Sub regarding, any comments
the Company or its counsel may receive from the SEC or its staff with respect to the Schedule&nbsp;14D-9
promptly after receipt of such comments.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;In connection with the Offer, the Company shall promptly furnish, or cause its transfer
agent to furnish, Parent and Merger Sub with mailing labels, security position listings,
non-objecting beneficial owner lists and all reasonably available listings or computer files
containing the names and addresses of the record holders of the Common Stock as of the most recent
practicable date and shall furnish, or cause its transfer agent to furnish, Parent and Merger Sub
with such additional available information and assistance (including updated lists of stockholders
and their addresses, mailing labels and lists of security positions and non-objecting beneficial
owner lists as they become available) and such other assistance as Parent and Merger Sub or their
agents may reasonably request in communicating the Offer to the record and beneficial holders of
Common Stock. Subject to the requirements of applicable Law and stock exchange rules, and except
for such actions as are necessary to disseminate the Offer Documents and any other documents
necessary to consummate the Offer and the Merger prior to a termination in accordance with
<U>Section&nbsp;8.1</U>, Parent and Merger Sub shall hold in confidence the information contained in
such labels and lists, shall use such information only in connection with the Offer and the Merger
and, if this Agreement is terminated for any reason, shall deliver promptly to the Company all
copies of such information then in their possession or control. In connection with the Offer, the
Company shall furnish Parent with such information (which will be treated and held in confidence by
Parent) and assistance as Parent or its officers, employees, accountants, counsel and other
representatives may reasonably request in connection with the preparation of the Offer and Offer
Documents and communicating the Offer to the record and beneficial holders of shares of Common
Stock.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->5<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;1.3. <U>Top-Up Option</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <U>Grant of Top-Up Option</U>. The Company hereby grants to Parent and Merger Sub an
irrevocable option (the &#147;<U>Top-Up Option</U>&#148;) to purchase, at a price per share equal to the Per
Share Amount (the &#147;<U>Per Common Share Price</U>&#148;), a number of newly issued shares of Class&nbsp;A
Common Stock (the &#147;<U>Top-Up Option Shares</U>&#148;) that, when added to the number of shares of Class
A Common Stock owned, directly or indirectly, by Parent or Merger Sub at the time of exercise of
the Top-Up Option, constitutes one share of Class&nbsp;A Common Stock more than 90% of the number of
shares of Class&nbsp;A Common Stock that will be outstanding immediately after the issuance of the
Top-Up Option Shares. The Top-Up Option may be exercised at any time on or after any Expiration
Date hereunder and on or prior to the fifth Business Day after the later to occur of the Expiration
Date or the expiration date of any subsequent offering period; <U>provided</U>, <U>however</U>,
that the obligation of the Company to deliver Top-Up Option Shares upon the exercise of the Top-Up
Option is subject to the conditions that (A)&nbsp;no provision of any applicable Law shall prohibit the
exercise of the Top-Up Option or the delivery of the Top-Up Option Shares in respect of such
exercise, (B)&nbsp;the issuance of Top-Up Option Shares pursuant to the Top-Up Option would not require
approval by the Company&#146;s stockholders under applicable Law or regulation (including NASDAQ rules
and regulations), (C)&nbsp;upon exercise of the Top-Up Option, the number of shares of Class&nbsp;A Common
Stock owned, directly or indirectly, by Parent or Merger Sub constitutes one share of Class&nbsp;A
Common Stock more than 90% of the number of shares of Class&nbsp;A Common Stock that will be outstanding
immediately after the issuance of the Top-Up Option Shares, (D)&nbsp;the number of Top-Up Option Shares
issued pursuant to the Top-Up Option shall in no event exceed the number of authorized and unissued
shares of Class&nbsp;A Common Stock not otherwise reserved for issuance for outstanding Company Stock
Options or other obligations of the Company, (E)&nbsp;Merger Sub has accepted for payment and paid for
all Shares validly tendered in the Offer and not validly withdrawn, and (F)&nbsp;the number of shares
tendered in the Offer and not validly withdrawn shall be not less than 70% of the number of shares
of Class&nbsp;A Common Stock outstanding immediately prior to the exercise of the Top Up Option. The
parties shall cooperate to ensure that the issuance of the Top-Up Option Shares is accomplished
consistent with all applicable Laws, including compliance with an applicable exemption from
registration of the Top-Up Option Shares under the Securities Act.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <U>Exercise of Top-Up Option</U>. Upon the exercise of the Top-Up Option in accordance
with <U>Section&nbsp;1.3(a)</U>, Merger Sub shall so notify the Company and shall set forth in such
notice (i)&nbsp;the number of shares of Class&nbsp;A Common Stock expected to be owned, directly or
indirectly, by Parent or Merger Sub immediately preceding the purchase of the Top-Up Option Shares
and (ii)&nbsp;a place and time for the closing of the purchase of the Top-Up Option Shares. The Company
shall, as soon as practicable following receipt of such notice, notify Merger Sub of the number of
shares of Class&nbsp;A Common Stock then outstanding and the number of Top-Up Option Shares. At the
closing of the purchase of the Top-Up Option Shares, Merger Sub shall pay the Company the aggregate
price required to be paid for the Top-Up Option Shares pursuant to this <U>Section&nbsp;1.3</U>, and
the Company shall cause to be issued to Merger Sub a certificate representing the Top-Up Option
Shares. The aggregate purchase price payable for the Top-Up Shares may be paid, at the election of
Merger Sub or Parent, by Merger Sub by executing and delivering to the Company a promissory note
having a principal amount equal to the balance of the aggregate purchase price for the Top-Up
Option Shares. Any such promissory note shall bear interest at the rate of interest per annum
equal to 3%, shall mature on the first anniversary of
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->6<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">the date of execution and delivery of such promissory note and may be prepaid without premium
or penalty.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) <U>Adjustment upon Changes in Capitalization</U>. In the event of any change in the
number of shares of outstanding Common Stock by reason of any stock dividend, stock split,
recapitalization, combination, exchange of shares, merger, consolidation, reorganization or the
like or any other change in the corporate or capital structure of the Company that would have the
effect of diluting Merger Sub&#146;s rights under the Top-Up Option, the number of Top-Up Option Shares
and the Per Common Share Price shall be adjusted appropriately so as to restore Merger Sub to its
rights hereunder with respect to the Top-Up Option; <U>provided</U>, <U>however</U>, that nothing
in this <U>Section&nbsp;1.3</U> shall be construed as permitting the Company to take any action or
enter into any transaction otherwise prohibited by this Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;1.4. <U>Directors</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Subject to compliance with applicable Law, promptly upon the payment by Parent or Merger
Sub for all Shares tendered pursuant to the Offer which represent at least a majority of the
outstanding shares of Common Stock, and from time to time thereafter, as shares of Common Stock are
acquired by Parent or Merger Sub, Parent shall be entitled to designate such number of directors,
rounded up to the next whole number, on the Board of Directors as will give Parent representation
on the Board of Directors equal to at least that number of directors which equals the product of
(i)&nbsp;the total number of directors on the Board of Directors (giving effect to the directors
appointed or elected pursuant to this sentence and including current directors serving as officers
of the Company), multiplied by (ii)&nbsp;the percentage (the &#147;<U>Board Percentage</U>&#148;) that the
aggregate number of shares of Common Stock beneficially owned by Merger Sub, Parent or any of their
affiliates (including for purposes of this <U>Section&nbsp;1.4</U> such shares of Common Stock as are
accepted for payment pursuant to the Offer) bears to the aggregate number of shares of Common Stock
outstanding; <U>provided</U>, <U>however</U>, that Parent shall be entitled to designate at least
a majority of the directors on the Board of Directors (as long as Parent, Merger Sub and their
affiliates own a majority of the outstanding shares of Common Stock); <U>provided</U>,
<U>further</U>, that following the time directors designated by Parent are elected or appointed to
the Board of Directors and prior to the Effective Time the Board of Directors shall always have at
least three directors who are directors on the date hereof and who are neither officers of the
Company nor designees, affiliates or associates (within the meaning of the Federal securities laws)
of Parent (one or more of such directors, the &#147;<U>Independent Directors</U>&#148;); <U>provided</U>
<U>further</U>, that if there are in office fewer than three Independent Directors, the Board of
Directors shall take all actions necessary to cause a person or, if there are two vacancies, two
persons designated by the remaining Independent Director(s) to fill such vacancy(ies) who shall be
neither an officer of the Company nor a designee, affiliate or associate of Parent, and each such
person(s) shall be deemed to be an Independent Director for purposes of this Agreement, or, if no
Independent Directors remain, the other directors shall designate three persons to fill the
vacancies who shall be neither an officer of the Company nor a designee, affiliate or associate of
Parent, and each such person shall be deemed to be an Independent Director for purposes of this
Agreement. At each such time, the Company shall, subject to any limitations imposed by applicable
Law or NASDAQ rules, also cause (x)&nbsp;each committee of the Board of Directors, (y)&nbsp;if requested by
Parent, the board of directors of each of the Company&#146;s Subsidiaries and (z)&nbsp;if requested by
Parent, each committee of such board of directors of each of the Company&#146;s
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->7<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Subsidiaries to include persons designated by Parent constituting the Board Percentage of each
such committee or board as Parent&#146;s designees constitute on the Board of Directors. The Company
shall, upon request by Parent, subject to the Company&#146;s Certificate of Incorporation, promptly
increase the size of the Board of Directors or exercise its reasonable best efforts to secure the
resignations of such number of directors as necessary to enable Parent&#146;s designees to be elected to
the Board of Directors in accordance with the terms of this <U>Section&nbsp;1.4(a)</U> and shall cause
Parent&#146;s designees to be so elected. The Company shall promptly amend, or cause to be amended, its
by-laws, if necessary, to increase the size of the Board of Directors if such increase is required
to satisfy the Board Percentage pursuant to this <U>Section&nbsp;1.4</U>. The Company shall promptly
take, at the Company&#146;s expense, any lawful action necessary to effect any such election, including
mailing to its stockholders the information required by Section 14(f) of the Exchange Act and Rule
14f-1 promulgated thereunder (<U>provided</U> that Parent has provided the information described
in the following sentence), unless such information has previously been provided to the Company&#146;s
stockholders in the Schedule&nbsp;14D-9. Parent shall supply to the Company in writing and be solely
responsible for any information with respect to itself and its nominees, directors and affiliates
required by Section 14(f) of the Exchange Act and Rule&nbsp;14f-1 thereunder.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Notwithstanding anything in this Agreement to the contrary, following the time directors
designated by Parent are elected or appointed to the Board of Directors and prior to the Effective
Time, the affirmative vote of a majority of the Independent Directors shall be required to (i)
authorize any agreement between the Company and any of its Subsidiaries, on the one hand, and
Parent, Merger Sub and any of their affiliates (other than the Company and any of its
Subsidiaries), on the other hand, (ii)&nbsp;amend or terminate this Agreement on behalf of the Company,
(iii)&nbsp;exercise or waive any of the Company&#146;s rights or remedies hereunder, (iv)&nbsp;extend the time for
performance of Parent&#146;s or Merger Sub&#146;s obligations hereunder or (v)&nbsp;take any other action by the
Company in connection with this Agreement or the transactions contemplated hereby required to be
taken by the Board of Directors. The Independent Directors shall have the authority to retain such
counsel (which may include current counsel to the Company) and other advisors at the expense of the
Company as determined appropriate by the Independent Directors and shall have the authority to
institute any action on behalf of the Company to enforce the performance of this Agreement.
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ARTICLE II</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>THE MERGER</B>

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;2.1. <U>The Merger</U>. On the terms and subject to the conditions set forth in this
Agreement, and in accordance with the DGCL, at the Effective Time, Merger Sub will merge with and
into the Company, whereupon the separate corporate existence of Merger Sub will cease, and the
Company will continue its corporate existence under Delaware law as the surviving corporation in
the Merger (the &#147;<U>Surviving Corporation</U>&#148;) and a wholly owned subsidiary of Parent.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;2.2. <U>Closing</U>. Unless this Agreement shall have been terminated and the
transactions herein contemplated shall have been abandoned pursuant to <U>Article&nbsp;VIII</U>, the
closing of the Merger (the &#147;<U>Closing</U>&#148;) shall take place at the offices of Squire, Sanders &#038;
Dempsey
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->8<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">L.L.P., Two Renaissance Square, 40 North Central Avenue, Suite&nbsp;2700, Phoenix, Arizona 85004
at 10:00&nbsp;a.m., local time, on a date (the &#147;<U>Closing Date</U>&#148;) which shall be the second
Business Day after the satisfaction or waiver (to the extent permitted by applicable Law) of the
conditions set forth in <U>Article&nbsp;VII</U> (other than those conditions that by their nature are
to be satisfied by actions to be taken at the Closing, but subject to the satisfaction or waiver of
such conditions), or at such other place, date and time as the Company and Parent may agree in
writing; <U>provided</U>, <U>however</U>, that if, as of or immediately following the Acceptance
Date, the expiration of any subsequent offering period pursuant to <U>Section&nbsp;1.1(d)</U>, or the
exercise of the Top-Up Option, a Short Form&nbsp;Merger is available pursuant to <U>Section&nbsp;2.8</U> and
Section&nbsp;253 of the DGCL, the Closing shall, subject to the satisfaction or waiver of the conditions
set forth in <U>Section&nbsp;7.1</U>, occur no later than the Business Day immediately following the
Acceptance Date, the expiration of such subsequent offering period, or the purchase of the Top-Up
Option Shares, as applicable.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;2.3. <U>Effective Time</U>. Subject to the provisions of this Agreement, at the
Closing, the Company will cause a certificate of merger (the &#147;<U>Certificate of Merger</U>&#148;) to be
executed, acknowledged and filed with the Secretary of State of the State of Delaware in accordance
with Section&nbsp;251 of the DGCL (or to the extent provided in <U>Section&nbsp;2.8</U> hereof, Section&nbsp;253
of the DGCL). The Merger will become effective at such time as the Certificate of Merger has been
duly filed with the Secretary of State of the State of Delaware or at such later date or time as
may be agreed by the Company and Merger Sub in writing and specified in the Certificate of Merger
in accordance with the DGCL (the effective time of the Merger being hereinafter referred to as the
&#147;<U>Effective Time</U>&#148;).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;2.4. <U>Effects of the Merger</U>. The Merger shall have the effects set forth in
this Agreement and the applicable provisions of the DGCL.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;2.5. <U>Certificate of Incorporation and By-laws of the Surviving Corporation</U>.
At the Effective Time, (a)&nbsp;the certificate of incorporation of the Surviving Corporation shall be
amended to read in its entirety as the certificate of incorporation of Merger Sub read immediately
prior to the Effective Time, except that the name of the Surviving Corporation shall be VistaCare,
Inc. and the provision in the certificate of incorporation of Merger Sub naming its incorporator
shall be omitted, and (b)&nbsp;the by-laws of the Surviving Corporation shall be amended so as to read
in their entirety as the by-laws of Merger Sub as in effect immediately prior to the Effective
Time, until thereafter amended in accordance with applicable Law, except that the references to
Merger Sub&#146;s name shall be replaced by references to VistaCare, Inc.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;2.6. <U>Directors</U>. Subject to applicable Law, the directors of Merger Sub
immediately prior to the Effective Time shall be the initial directors of the Surviving Corporation
and shall hold office until their respective successors are duly elected and qualified, or their
earlier death, resignation or removal.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;2.7. <U>Officers</U>. The officers of Merger Sub immediately prior to the Effective
Time shall be the initial officers of the Surviving Corporation and shall hold office until their
respective successors are duly elected and qualified, or their earlier death, resignation or
removal.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->9<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;2.8. <U>Merger Without Meeting of Stockholders</U>. Notwithstanding anything in this
Agreement to the contrary, but subject to <U>Article&nbsp;VII</U>, if, following the Offer and any
subsequent offering period, and the exercise, if any, of the Top-Up Option, Parent or any direct or
indirect Subsidiary of Parent shall own at least 90% of the outstanding Shares, pursuant to the
Offer, exercise of the Top-Up Option or otherwise, the parties hereto shall, subject to <U>Article
VII</U> hereof, take all necessary and appropriate action to cause the Merger to become effective
as soon as practicable after the satisfaction of such threshold, without a meeting of stockholders
of the Company, in accordance with Section&nbsp;253 of the DGCL (such Merger, a &#147;<U>Short-Form
Merger</U>&#148;).
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ARTICLE III</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>CONVERSION OF SHARES; EXCHANGE OF CERTIFICATES</B>

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;3.1. <U>Effect on Capital Stock</U>. At the Effective Time, by virtue of the Merger
and without any action on the part of the Company, Merger Sub or the holders of any securities of
the Company or Merger Sub:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <U>Conversion of Common Stock</U>. Each share of Class&nbsp;A Common Stock (such shares,
together, unless the context clearly otherwise requires, with the associated Rights, collectively,
the &#147;<U>Common Stock</U>&#148;, and each, a &#147;<U>Share</U>&#148;) issued and outstanding immediately prior
to the Effective Time, other than Cancelled Shares pursuant to <U>Section&nbsp;3.1(b)</U> and other
than Dissenting Shares, shall be converted automatically into and shall thereafter represent the
right to receive in cash an amount equal to the Per Share Amount (the &#147;<U>Merger
Consideration</U>&#148;), payable to the holder thereof in cash, without any interest thereon, upon
surrender and exchange of the Certificate representing such Share pursuant to the terms hereof.
All Shares that have been converted into the right to receive the Merger Consideration as provided
in this <U>Section&nbsp;3.1</U> shall be automatically cancelled and shall cease to exist, and the
holders of Certificates which immediately prior to the Effective Time represented such Shares shall
cease to have any rights with respect to such Shares other than the right to receive the Merger
Consideration.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <U>Parent and Merger Sub-Owned Shares</U>. Each Share that is owned, directly or
indirectly, by Parent or Merger Sub immediately prior to the Effective Time or held by the Company
or its Subsidiaries immediately prior to the Effective Time (in each case, other than any such
Shares held on behalf of Third Parties) (the &#147;<U>Cancelled Shares</U>&#148;) shall by virtue of the
Merger and without any action on the part of the holder thereof, be cancelled and retired and shall
cease to exist, and no consideration shall be delivered in exchange for such cancellation and
retirement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) <U>Conversion of Merger Sub Common Stock</U>. Each share of common stock, par value
$0.01 per share, of Merger Sub issued and outstanding immediately prior to the Effective Time shall
be converted into and become one validly issued, fully paid and nonassessable share of common
stock, par value $0.01 per share, of the Surviving Corporation with the same rights, powers and
privileges as the shares so converted and shall constitute the only outstanding shares of capital
stock of the Surviving Corporation. From and after the Effective Time, all certificates
representing the common stock of Merger Sub shall be deemed for all purposes to represent the
number of shares of common stock of the Surviving Corporation into which they were converted in
accordance with the immediately preceding sentence.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->10<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) <U>Dissenters&#146; Rights</U>. Any provision of this Agreement to the contrary
notwithstanding, if required by the DGCL (but only to the extent required thereby), Shares that are
issued and outstanding immediately prior to the Effective Time (other than Cancelled Shares) and
that are held by holders of such Shares who have not voted in favor of the adoption of this
Agreement or consented thereto in writing and who are entitled to demand and who have properly
exercised appraisal rights with respect thereto in accordance with, and who have complied with,
Section&nbsp;262 of the DGCL (the &#147;<U>Dissenting Shares</U>&#148;) will not be converted into the right to
receive the Merger Consideration, but instead holders of such Dissenting Shares will be entitled to
receive payment of the appraised value of such Dissenting Shares in accordance with the provisions
of Section&nbsp;262 of the DGCL unless and until any such holder fails to perfect or effectively
withdraws or loses its rights to appraisal and payment under the DGCL. If, after the Effective
Time, any holder of Dissenting Shares fails to perfect or effectively withdraws or loses such
right, such Dissenting Shares will thereupon be treated as if they had been converted into and have
become exchangeable for, at the Effective Time, the right to receive the Merger Consideration,
without any interest thereon, and the Surviving Corporation shall remain liable for payment of the
Merger Consideration for such Shares. At the Effective Time, any holder of Dissenting Shares shall
cease to have any rights with respect thereto, except the rights provided in Section&nbsp;262 of the
DGCL and as provided in the previous sentence. The Company will give Parent (i)&nbsp;prompt written
notice of any demands received by the Company for appraisals of Shares, attempted withdrawals of
such demands and any other instruments served pursuant to the DGCL and received by the Company
relating to stockholders&#146; rights of appraisal and (ii)&nbsp;the opportunity to participate in all
negotiations and proceedings with respect to such notices and demands. The Company shall not,
except with the prior written consent of Parent, voluntarily make any payment with respect to any
demands for appraisal or settle, or offer or agree to settle, any such demands.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) <U>Adjustments</U>. If at any time during the period between the date of this Agreement
and the Effective Time, any change in the outstanding shares of capital stock of the Company, or
securities convertible or exchangeable into or exercisable for shares of capital stock, shall occur
as a result of any reclassification, recapitalization, stock split (including a reverse stock
split) or subdivision or combination, exchange or readjustment of shares, or any stock dividend or
stock distribution with a record date during such period, merger or other similar transaction, the
Merger Consideration shall be equitably adjusted to reflect such change; <U>provided</U> that
nothing herein shall be construed to permit the Company to take any action with respect to its
securities that is prohibited by the terms of this Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;3.2. <U>Exchange of Certificates</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <U>Paying Agent</U>. At or prior to the Effective Time, Parent shall deposit, or shall
cause to be deposited, with a U.S. bank or trust company that shall be appointed by Parent, and is
reasonably acceptable to the Company to act as a paying agent hereunder (the &#147;<U>Paying
Agent</U>&#148;), in trust for the benefit of holders of the Shares cash in U.S. dollars sufficient to
pay the aggregate Merger Consideration in exchange for all of the Shares outstanding immediately
prior to the Effective Time (other than the Cancelled Shares), payable upon due surrender of the
certificates that immediately prior to the Effective Time represented Shares
(&#147;<U>Certificates</U>&#148;) (or effective affidavits of loss in lieu thereof) or noncertificated
Shares represented by book-entry (&#147;<U>Book-Entry Shares</U>&#148;) pursuant to the provisions of this
<U>Article&nbsp;III</U> (such cash being hereinafter
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->11<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">referred to as the &#147;<U>Exchange Fund</U>&#148;). The Paying Agent shall invest the Exchange Fund
as directed by Parent or the Surviving Corporation, as the case may be, on a daily basis. Any
interest and other income resulting from such investments shall be paid to the Surviving
Corporation or Parent, as Parent directs. To the extent that there are losses with respect to such
investments, or the Exchange Fund diminishes for other reasons below the level required to make
prompt payments of the Merger Consideration payable pursuant to this <U>Section&nbsp;3.2</U>, Parent
and the Surviving Corporation shall promptly replace or restore the portion of the Exchange Fund
lost through investments or other events so as to ensure that the Exchange Fund is, at all times,
maintained at a level sufficient to make such payments.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <U>Payment Procedures</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;As soon as reasonably practicable after the Effective Time and in any event not later than
the fifth Business Day following the Closing Date, the Paying Agent shall mail, to each holder of
record of Shares whose Shares were converted into the Merger Consideration pursuant to <U>Section
3.1</U>, (A)&nbsp;a letter of transmittal (which shall specify that delivery shall be effected, and risk
of loss and title to Certificates shall pass, only upon proper delivery of the Certificates (or
effective affidavits of loss in lieu thereof pursuant to <U>Section&nbsp;3.2(f)</U>) to the Paying
Agent or, in the case of Book-Entry Shares, upon adherence to the procedures set forth in the
letter of transmittal, and (B)&nbsp;instructions for use in effecting the surrender of Certificates (or
effective affidavits of loss in lieu thereof) or Book-Entry Shares in exchange for the Merger
Consideration.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;Upon surrender of Certificates (or effective affidavits of loss in lieu thereof pursuant
to <U>Section&nbsp;3.2(f)</U>) or Book-Entry Shares to the Paying Agent together with such letter of
transmittal, duly completed and validly executed in accordance with the instructions thereto, and
such other documents as may customarily be required by the Paying Agent, the holder of such
Certificates or Book-Entry Shares shall be entitled to receive in exchange therefor a check in an
amount equal to the product of (x)&nbsp;the number of Shares formerly represented by such holder&#146;s
properly surrendered Certificates (or effective affidavits of loss in lieu thereof pursuant to
<U>Section&nbsp;3.2(f)</U>) or Book-Entry Shares and (y)&nbsp;the Merger Consideration, and the Certificate
so surrendered shall forthwith be canceled. No interest will be paid or accrued on any amount
payable upon due surrender of Certificates (or effective affidavits of loss in lieu thereof
pursuant to <U>Section&nbsp;3.2(f)</U>) or Book-Entry Shares. In the event of a transfer of ownership
of Shares that is not registered in the transfer records of the Company, a check for any cash to be
paid upon due surrender of the Certificate may be paid to such a transferee if the Certificate
formerly representing such Shares is presented to the Paying Agent, properly endorsed or otherwise
in proper form for transfer and accompanied by all documents required to evidence and effect such
transfer and to evidence, to the satisfaction of the Surviving Corporation, that any applicable
stock transfer Taxes have been paid or are not applicable. Until surrendered as contemplated by
this <U>Section&nbsp;3.2</U>, each Certificate and Book-Entry Share shall be deemed after the Effective
Time to represent only the right to receive the Merger Consideration.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)&nbsp;All cash paid upon surrender of Certificates or Book-Entry Shares in accordance with the
terms hereof shall be deemed to have been issued in full satisfaction of all rights pertaining to
the Shares represented thereby. From and after the Effective Time, the
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->12<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">holders of Certificates or Book-Entry Shares shall cease to have any rights with respect to
Shares, except as otherwise provided herein or by applicable Law.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv)&nbsp;Parent, Merger Sub, the Surviving Corporation and the Paying Agent shall be entitled to
deduct and withhold from the consideration otherwise payable under this Agreement (whether pursuant
to the Offer, the Merger or otherwise) to any holder of Shares (including, for the avoidance of
doubt, Restricted Shares) or holder of Company Stock Options, such amounts as are required to be
withheld or deducted under the Internal Revenue Code of 1986, as amended (the &#147;<U>Code</U>&#148;), the
rules and regulations promulgated thereunder, or any provision of U.S. state or local Tax Law with
respect to the making of such payment. To the extent that amounts are so withheld or deducted and
paid over to the applicable Governmental Entity, such withheld or deducted amounts shall be treated
for all purposes of this Agreement as having been paid to the holder of the Shares or holder of the
Company Stock Options, in respect of which such deduction and withholding were made.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) <U>Closing of Transfer Books</U>. At the Effective Time, the stock transfer books of the
Company shall be closed, and there shall be no further registration of transfers on the stock
transfer books of the Surviving Corporation or by book-entry of the Shares, other than transfers
that occurred before the Effective Time. If, after the Effective Time, Certificates or Book-Entry
Shares are presented to the Surviving Corporation or Parent for any reason, they shall be cancelled
and exchanged for a check in the proper amount pursuant to this <U>Article&nbsp;III</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) <U>Termination of Exchange Fund</U>. Any portion of the Exchange Fund (including the
proceeds of any investments thereof) that remains undistributed to the former holders of Shares for
180&nbsp;days after the Effective Time shall be delivered to the Surviving Corporation upon demand, and
any former holders of Shares who have not surrendered their Shares in accordance with this
<U>Section&nbsp;3.2</U> and the instructions set forth in the letter of transmittal mailed to such
holder after the Effective Time shall thereafter look only to the Surviving Corporation for payment
of their claim for the Merger Consideration, without any interest thereon, upon due surrender of
their Shares.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) <U>No Liability</U>. Anything herein to the contrary notwithstanding, none of the
Company, Parent, Merger Sub, the Surviving Corporation, the Paying Agent or any other Person shall
be liable to any former holder of Shares for any amount properly delivered to a public official
pursuant to any applicable abandoned property, escheat or similar Law.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) <U>Lost Certificates</U>. In the case of any Certificate claimed to have been lost,
stolen or destroyed, upon the making of an affidavit of that fact by the Person claiming such
Certificate to be lost, stolen or destroyed and, if required by the Surviving Corporation, the
posting by such Person of a bond in such customary amount as the Surviving Corporation may direct,
as indemnity against any claim that may be made against it with respect to such Certificate, the
Paying Agent will issue in exchange for such lost, stolen or destroyed Certificate a check in the
amount of the number of Shares represented by such lost, stolen or destroyed Certificate multiplied
by the Merger Consideration.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->13<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;3.3. <U>Treatment of Stock Options and Other Stock-Based Awards</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Each option, prior to the Effective Time, to purchase Common Stock (collectively, the
&#147;<U>Company Stock Options</U>&#148;) granted under any equity based compensation plan (including the
Company&#146;s employee stock purchase plans) of the Company (the &#147;<U>Company Stock Plans</U>&#148;),
whether vested or unvested, that is outstanding immediately prior to the Effective Time will at the
Effective Time be cancelled and the holder of such Company Stock Option will, in full settlement of
such Company Stock Option, receive from the Surviving Corporation an amount (subject to any
applicable withholding Tax) in cash equal to the product of (x)&nbsp;the excess, if any, of the Merger
Consideration over the exercise price per Share of such Company Stock Option, multiplied by (y)&nbsp;the
total number of Shares subject to such Company Stock Option (the aggregate amount of such cash
hereinafter referred to as the &#147;<U>Option Consideration</U>&#148;). In the case of any Company Stock
Option that does not explicitly provide for the cash out of such stock option as contemplated by
this <U>Section&nbsp;3.3(a)</U>, the Company shall obtain, prior to the Acceptance Date, a waiver and
release from the holders of all such Company Stock Options, except as provided below in this
<U>Section&nbsp;3.3(a),</U> in exchange for the Option Consideration; in any case where the Option
Consideration is zero or negative, the Company shall offer the stock option holder an amount of
cash (the &#147;<U>Stock Option Cash Out Consideration</U>&#148;) as determined by the Company and the
applicable stock option holder as necessary to obtain the waiver and release as contemplated herein
and the Company shall pay to such holders the Stock Option Cash Out Consideration prior to the
Acceptance Date; <U>provided</U>, <U>however</U>, that any Stock Option Cash Out Consideration
must be approved by Parent in writing prior to any payment thereof. Notwithstanding the foregoing,
the Company has frozen the VistaCare, Inc. Employee Stock Purchase Plan (&#147;<U>ESPP</U>&#148;), effective
December&nbsp;31, 2007, and any amounts not utilized to purchase Common Stock shall be distributed prior
to the Effective Time.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Each award of restricted Common Stock granted under the Company Stock Plans, together with
the associated Rights (the &#147;<U>Restricted Shares</U>&#148;), that is issued and outstanding immediately
prior to the Acceptance Date shall vest in full immediately prior to the Acceptance Date and either
(i)&nbsp;to the limited extent such Restricted Shares are tendered by the beneficial owner of such
Restricted Shares in the Offer and accepted by the Merger Sub, the beneficial owner of such
Restricted Shares will be entitled to the Per Share Amount for such Restricted Shares payable
pursuant to <U>Section&nbsp;1.1(f)</U>, or (ii)&nbsp;to the extent such Restricted Shares are not tendered
by the beneficial owner in the Offer and only to the extent such payment is not duplicative of the
payment described in <U>Section&nbsp;3.3(b)(i)</U>, such Restricted Shares shall be converted into the
right to receive the Merger Consideration pursuant to <U>Section&nbsp;3.1(a)</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;The surrender of a Company Stock Option to the Company in exchange for the Option
Consideration shall be deemed a release of any and all rights the holder had or may have had in
respect of such Company Stock Option. Prior to the expiration of the Offer, the Company shall use
its reasonable best efforts to take all action necessary (including causing the Board of Directors
(or any committees thereof) to take such actions as are allowed by the Company Stock Plans or any
option or award agreements) to effectuate the actions contemplated by this <U>Section&nbsp;3.3</U> and
to ensure that, following the Effective Time, no Person other than Parent and its Subsidiaries
shall have any right (i)&nbsp;to acquire equity securities of the Company, the Surviving Corporation or
any Subsidiary thereof or (ii)&nbsp;to receive any payment in respect of any
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->14<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">equity based compensatory award or warrant other than with respect to the payment of the
Option Consideration as provided in this <U>Section&nbsp;3.3</U>.
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ARTICLE IV</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>REPRESENTATIONS AND WARRANTIES OF THE COMPANY</B>

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except (i)&nbsp;as disclosed in the Designated SEC Reports with respect to information that, on its
face, is readily apparent that it relates to the representations and warranties contained in this
<U>Article&nbsp;IV</U> or (ii)&nbsp;as disclosed in the disclosure schedule delivered by the Company to
Parent immediately prior to the execution of this Agreement (the &#147;<U>Company Disclosure
Letter</U>&#148;, it being agreed that disclosure of any item in any section of the Company Disclosure
Letter shall also be deemed disclosure with respect to any other section of this <U>Article&nbsp;IV</U>
to which the relevance of such item is readily apparent on its face as responsive to such other
section), the Company represents and warrants to Parent and Merger Sub as set forth in this
<U>Article&nbsp;IV</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.1. <U>Qualification, Organization, Subsidiaries, etc</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Each of the Company and its Subsidiaries is a legal entity duly organized, validly
existing and in good standing under the Laws of its respective jurisdiction of organization. Each
of the Company and its Subsidiaries has all requisite corporate or similar power and authority to
own, lease and operate its properties and assets and to carry on its business as presently
conducted, except where the failure to have such power or authority has not had and would not have,
individually or in the aggregate, a Company Material Adverse Effect.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Each of the Company and its Subsidiaries is qualified to do business and is in good
standing as a foreign corporation in each jurisdiction where the ownership, leasing or operation of
its assets or properties or conduct of its business requires such qualification, except where the
failure to be so qualified or in good standing has not had and would not have, individually or in
the aggregate, a Company Material Adverse Effect.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;As used in this Agreement, any reference to any fact, circumstance, event, change, effect
or occurrence having a &#147;<U>Company Material Adverse Effect</U>&#148; means any fact, condition,
circumstance, event, change, effect or occurrence that has or would be reasonably likely to have a
material adverse effect on the business, operations, results of operation, assets or financial
condition of the Company and its Subsidiaries, taken as a whole, but, in any case, shall not
include (subject to the provisos set forth below) facts, conditions, circumstances, events,
changes, effects or occurrences (i)&nbsp;generally affecting the industries in which the Company and its
Subsidiaries operate (including general pricing or changes in the Medicare hospice base payment
rates), or the economy or the financial or securities markets in the United States or elsewhere in
the world (including any regulatory and political conditions or developments, or any outbreak or
escalation of hostilities, declared or undeclared acts of war or terrorism); <U>provided,</U> that
such facts, conditions, circumstances, events, changes, effects or occurrences do not have a
materially disproportionate effect (relative to comparable industry participants) on the Company
and its Subsidiaries, taken as a whole; or (ii)&nbsp;resulting from the announcement of (A)&nbsp;the proposal
of the Offer and Merger or (B)&nbsp;this Agreement and the transactions contemplated hereby;
<U>provided</U>, that (1)&nbsp;the filing of any litigation related to this Agreement or the
transactions
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->15<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">contemplated hereby brought by any shareholder of the Company shall not, in and of itself,
constitute a Company Material Adverse Effect, but the foregoing shall not prevent an assertion that
any underlying facts, circumstances, conditions and events of such litigation and the nature,
outcome, effects or result of such litigation had, or would be reasonably likely to have, a Company
Material Adverse Effect and (2)&nbsp;the Company&#146;s receipt of any notice or charge from a Governmental
Entity asserting any material violation of Law shall not, in and of itself, constitute a Company
Material Adverse Effect, but the foregoing shall not prevent an assertion that any underlying
violation of Law, any underlying facts, circumstances or conditions regarding any such violation of
Law or any Liability of the Company or any of its Subsidiaries with respect thereto had, or would
be reasonably likely to have, a Company Material Adverse Effect; and <U>provided</U>
<U>further</U>, that any failure to meet internal or published projections, forecasts or revenue
or earning predictions for any period shall not, in and of itself, constitute a Company Material
Adverse Effect, but such failure shall not prevent an assertion that any underlying cause of such
failure has independently caused, or would be reasonably likely to cause, a Company Material
Adverse Effect.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.2. <U>Capital Stock</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;The authorized share capital of the Company consists of 33,000,000 Shares, 200,000 shares
of Class&nbsp;B Common Stock, $0.01 par value per share (&#147;<U>Class&nbsp;B Common Stock</U>&#148;), and 2,000,000
shares of Preferred Stock, $0.01 par value per share (&#147;<U>Preferred Stock</U>&#148;). As of January
14, 2008, there were (i) 16,885,958 Shares issued and outstanding, (ii) zero shares of Class&nbsp;A
Common Stock were held by the Company in treasury, and (iii)&nbsp;Company Stock Options granted under
the 1998 Stock Option Plan and 2002 Non-Employee Director Stock Option Plan, collectively, to
purchase an aggregate of 1,514,393 shares of Class&nbsp;A Common Stock (the &#147;<U>Options Reserved
Shares</U>&#148;), issued and outstanding, 400,776 of which have an exercise price to purchase a share of Class A
Common Stock equal to $8.60 or less. As of the date hereof, no additional shares may be issued
under the ESPP, as the ESPP was frozen on December&nbsp;31, 2007. In addition, Restricted Shares may be
granted in an amount not to exceed 3,000 shares in aggregate in accordance with <U>Section
6.1(b)(ii)</U>; such amounts are not included in the amounts set forth in the second sentence of
this paragraph for purposes of <U>Section&nbsp;8.1(k)</U>. As of the date of this Agreement, the total
amount withheld during the option period under the ESPP beginning July&nbsp;1, 2007, to purchase Class&nbsp;A
Common Stock did not exceed the amount set forth on <U>Section&nbsp;4.2(a)</U> of the Company
Disclosure Letter. There are no shares of Class&nbsp;B Common Stock or Preferred Stock outstanding.
All outstanding Shares are duly authorized, validly issued, fully paid and non-assessable, and are
not subject to and were not issued in violation of any preemptive or similar right, purchase
option, call or right of first refusal or similar right. Except as set forth in <U>Sections
4.2(a)</U> and <U>4.3(a)</U>, there are not issued or outstanding any other equity securities of
the Company or any stock appreciation, profit participation, &#147;phantom stock&#148; or other similar plans
or awards with respect to the Company or any of its Subsidiaries.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;As of the date hereof, (i)&nbsp;except for the Options Reserved Shares, the Company does not
have any shares of its capital stock reserved for issuance pursuant to any securities of the
Company that are convertible into or exercisable or exchangeable for shares of capital stock of or
other voting securities or equity interests of the Company, including option awards issued pursuant
to an equity compensation plan, and (ii)&nbsp;except as set forth in the Rights Agreement, dated as of
August&nbsp;18, 2004, as amended to the date hereof, between the Company and Equiserve Trust Company,
N.A., as Rights Agent (the &#147;<U>Rights Agreement</U>&#148;) and except for
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->16<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Company Stock Options granted under the 1998 Stock Option Plan and 2002 Non-Employee Director
Stock Option Plan, there are no outstanding subscriptions, options, warrants, calls, convertible
securities or other similar rights, agreements or commitments relating to the issuance of capital
stock to which the Company or any of the Company&#146;s Subsidiaries is a party obligating the Company
or any of the Company&#146;s Subsidiaries to (A)&nbsp;issue, transfer or sell any shares of capital stock or
other equity interests of the Company or any Subsidiary of the Company or securities convertible
into or exercisable or exchangeable for such shares or equity interests, (B)&nbsp;grant, extend or enter
into any such subscription, option, warrant, call, convertible securities or other similar right,
agreement or arrangement, (C)&nbsp;redeem or otherwise acquire any such shares of capital stock or other
equity interests, or (D)&nbsp;provide an amount of funds to, or make any investment (in the form of a
loan, capital contribution or otherwise) in, any Subsidiary.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Neither the Company nor any of its Subsidiaries has outstanding bonds, debentures, notes
or other securities, the holders of which have the right to vote (or which are convertible into or
exercisable for securities having the right to vote) with the stockholders of the Company on any
matter.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;There are no stockholder agreements, voting trusts or other agreements or understandings
to which the Company or any of its Subsidiaries is a party with respect to the voting of the
capital stock or other equity interest of the Company or any of its Subsidiaries.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.3. <U>Subsidiaries; Investments</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <U>Section&nbsp;4.3(a)</U> of the Company Disclosure Letter lists each Subsidiary of the
Company and/or one or more of its Subsidiaries and the Company and/or its Subsidiaries that own
such Subsidiary. Except as set forth in <U>Section&nbsp;4.3(a)</U> of the Company Disclosure Letter,
each Subsidiary of the Company set forth in <U>Section&nbsp;4.3(a)</U> of the Company Disclosure Letter
is wholly owned by the Company or a wholly owned Subsidiary of the Company. All equity interests
(including partnership interests and limited liability company interests) of the Company&#146;s
Subsidiaries held by the Company or any other Subsidiary of the Company have been duly and validly
authorized and are validly issued, fully paid and non-assessable and were not issued in violation
of any preemptive or similar rights, purchase options, calls or rights of first refusal or similar
rights. Each Subsidiary owned by the Company and/or one or more of its Subsidiaries is owned free
and clear of any Lien (except for Liens under the Credit Agreement).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;None of the Company or any of its Subsidiaries owns any Minority Investment.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.4. <U>Corporate Authority Relative to This Agreement; No Violation</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;The Company has the requisite corporate power and authority to enter into this Agreement
and, subject to receipt of the Company Stockholder Approval if applicable with respect to the
Merger, to consummate the transactions contemplated hereby. The Board of Directors, acting upon
the recommendation of the Special Committee, at a duly called and held meeting, has unanimously
adopted resolutions (i)&nbsp;determining that the terms of the Offer, the Merger and the other
transactions contemplated by this Agreement are fair to and in the best interests of the Company
and its stockholders, and declaring this Agreement advisable, (ii)
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->17<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">approving the execution, delivery and performance of this Agreement and the consummation of
the transactions contemplated hereby, including the Offer and the Merger, (iii)&nbsp;resolving to
recommend that the stockholders of the Company accept the Offer, tender their Shares to Merger Sub
pursuant to the Offer and, if applicable, approve and adopt this Agreement and the Merger (the
&#147;<U>Recommendation</U>&#148;), and (iv)&nbsp;resolving to make the Recommendation to the stockholders of the
Company and directing, that, to the extent required by the DGCL, this Agreement and the Merger be
submitted for consideration of the stockholders of the Company at the Company Meeting. The Board
of Directors has consented to the inclusion of the Board Actions (including, without limitation,
the Recommendation) in the Schedule&nbsp;14D-9 and the Offer Documents. Except for the Company
Stockholder Approval if applicable with respect to the Merger, no other corporate proceedings on
the part of the Company are necessary to authorize the consummation of the transactions
contemplated hereby. This Agreement has been duly and validly executed and delivered by the
Company and, assuming this Agreement constitutes the valid and binding agreement of Parent and
Merger Sub, constitutes the valid and binding agreement of the Company, enforceable against the
Company in accordance with its terms, subject to (A)&nbsp;applicable bankruptcy, insolvency,
reorganization, moratorium or other similar Laws, now or hereafter in effect, relating to
creditors&#146; rights generally and (B)&nbsp;general principles of equity (regardless of whether
enforceability is considered in a proceeding at law or in equity) (collectively, the
&#147;<U>Enforceability Exceptions</U>&#148;).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;The execution, delivery and performance by the Company of this Agreement and the
consummation of the Merger by the Company do not and will not require any consent, approval,
authorization or permit of, action by, filing with or notification to any federal, state, local or
foreign governmental or regulatory agency, commission, court, body, entity or authority (each, a
&#147;<U>Governmental Entity</U>&#148;), other than (i)&nbsp;the filing of the Certificate of Merger with the
Secretary of State of the State of Delaware in accordance with the DGCL, (ii)&nbsp;compliance with the
applicable requirements of the Exchange Act, including the filing of the Schedule&nbsp;14D-9 in
connection with the Offer and the Proxy Statement, if applicable, in connection with the Company
Stockholder Approval, (iii)&nbsp;compliance with the rules and regulations of NASDAQ, (iv)&nbsp;compliance
with the HSR Act and (v)&nbsp;compliance with any applicable foreign or state securities or blue sky
laws (collectively, clauses (i)&nbsp;through (v), the &#147;<U>Specified Approvals</U>&#148;), and other than any
consent, approval, authorization, permit, action, filing or notification the failure of which to
make or obtain would not (A)&nbsp;have, individually or in the aggregate, a Company Material Adverse
Effect or (B)&nbsp;prevent or materially delay the consummation of the Offer or the Merger.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Assuming compliance with the matters referenced in <U>Section&nbsp;4.4(b)</U>, receipt of the
Specified Approvals and the receipt of the Company Stockholder Approval if applicable with respect
to the Merger, the execution, delivery and performance by the Company of this Agreement, the
consummation by Merger Sub of the Offer and the consummation by the Company of the Merger and the
other transactions contemplated hereby do not and will not (i)&nbsp;contravene or conflict with the
organizational or governing documents of the Company or any of its Subsidiaries or (ii)&nbsp;contravene
or conflict with or constitute a material violation of any provision of any Law binding upon or
applicable to the Company or any of its Subsidiaries or any of their respective properties or
assets, other than any such contravention or conflict that has not had and would not have,
individually or in the aggregate, a Company Material Adverse Effect.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->18<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.5. <U>Reports and Financial Statements</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;The Company has filed or furnished all forms, documents, statements, registration
statements and reports required to be filed or furnished prior to the date hereof by it with the
SEC since September&nbsp;30, 2004 (the forms, documents, statements, registration statements and reports
filed with the SEC since September&nbsp;30, 2004 and those filed with the SEC subsequent to the date of
this Agreement, if any, including any amendments thereto, the &#147;<U>Company SEC Documents</U>&#148;).
None of the Company SEC Documents so filed or that will be filed subsequent to the date of this
Agreement contained or will contain, as the case may be, any untrue statement of a material fact or
omitted to state any material fact required to be stated therein or necessary in order to make the
statements therein, in the light of the circumstances under which they were made, not misleading.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Each of the audited consolidated financial statements and unaudited consolidated interim
financial statements of the Company included in the Company SEC Documents were prepared in
conformity with GAAP throughout the periods involved, and each fairly presents, in all material
respects, the consolidated financial position of the Company and its consolidated Subsidiaries in
accordance with GAAP as of the dates thereof and their consolidated results of operations and
changes in financial position for the periods then ended (subject to normal year-end adjustments
and the absence of notes that may be required by GAAP in the case of any unaudited interim
financial statements). The management of the Company has implemented and maintains disclosure
controls and procedures (as defined in Rule&nbsp;13a-15(e) of the Exchange Act) to ensure that material
information relating to the Company, including its consolidated Subsidiaries, is made known to the
chief executive officer and the chief financial officer of the Company by other employees within
those entities. The Company&#146;s principal executive officer and principal financial officer have
disclosed, based on their most recent evaluation of internal control over financial reporting, to
the Company&#146;s auditors and the audit committee of the Board of Directors (or persons performing the
equivalent functions): (i)&nbsp;all significant deficiencies and material weaknesses within their
knowledge in the design or operation of internal control over financial reporting which are
reasonably likely to adversely affect the Company&#146;s ability to record, process, summarize and
report financial information; and (ii)&nbsp;any fraud that involves management or other employees who
have a significant role in the Company&#146;s internal control over financial reporting. The Company&#146;s
principal executive officer and principal financial officer have made, with respect to the Company
SEC Documents, all certifications required by the Sarbanes-Oxley Act. The Company has delivered to
Parent a summary of any disclosure made by the management of the Company to the Company&#146;s
independent auditors and the audit committee of the Board of Directors since January&nbsp;1, 2003
referred to in such certificates. The Company has not identified any material weaknesses in the
design or operation of its internal control over financial reporting except as disclosed in the
Company SEC Documents filed prior to the date hereof. Neither the Company nor any of the Company
Subsidiaries has outstanding, or has arranged any outstanding, &#147;extensions of credit&#148; to directors
or executive officers of the Company within the meaning of Section&nbsp;402 of the Sarbanes-Oxley Act.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;There are no liabilities or obligations of the Company or any of its Subsidiaries, of any
kind whatsoever, whether accrued, contingent, absolute, determined, determinable or otherwise,
other than: (i)&nbsp;liabilities or obligations (A)&nbsp;disclosed or provided for
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->19<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">in the Company Balance Sheet or (B)&nbsp;not required by GAAP to be disclosed or provided for in a
consolidated balance sheet of the Company and its Subsidiaries (or the notes thereto) and that were
incurred in the ordinary course of business consistent with past practice or would not reasonably
be expected to have, individually or in the aggregate, a Company Material Adverse Effect; (ii)
liabilities or obligations incurred after September&nbsp;30, 2007 in the ordinary course of business
consistent with past practice; and (iii)&nbsp;liabilities or obligations under this Agreement or
incurred in connection with the transactions contemplated hereby.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;Neither the Company nor any of its Subsidiaries is a party to, or has a legally binding
commitment to enter into, any joint venture, off balance sheet partnership or any similar Contract
(including any Contract relating to any transaction or relationship between or among the Company or
any of its Subsidiaries, on the one hand, and any unconsolidated affiliate, including any
structured finance, special purpose or limited purpose entity or Person, on the other hand, or any
&#147;off balance sheet arrangements&#148; (as defined in Item 303(a) of Regulation&nbsp;S-K under the Exchange
Act)).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;As of the date hereof, the total aggregate amount of indebtedness for borrowed money
(which shall include principal, interest and any fees associated therewith) owed by the Company and
its Subsidiaries is approximately $103,005. Neither the Company nor any of its Subsidiaries is in default, and
no waiver of default is currently in effect, in the payment of any principal or interest on any
indebtedness of the Company or any of its Subsidiaries and no breach or violation of any term or
other event or condition exists with respect to any indebtedness of the Company or any of its
Subsidiaries that would permit (or that with notice or lapse of time, or both, would permit) one or
more persons to cause such indebtedness to become due and payable before its stated maturity or
before its regularly scheduled dates of payment. Neither the Company nor any of its Subsidiaries
is required to provide any letters of credit, bonds or other financial security arrangements in
connection with any transactions with its suppliers or customers.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.6. <U>Compliance with Law; Permits</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;The Company, each of the Company&#146;s Subsidiaries and each Hospice are in compliance with
and are not in default under or in violation of any applicable Law (including the Foreign Corrupt
Practices Act of 1977, but excluding for purposes of this sentence, the Sarbanes-Oxley Act), except
where such non-compliance, default or violation would not have, individually or in the aggregate, a
Company Material Adverse Effect. Anything contained in this <U>Section&nbsp;4.6(a)</U> to the contrary
notwithstanding, no representation or warranty shall be deemed to be made in this <U>Section
4.6(a)</U> in respect of the matters referenced in <U>Sections&nbsp;4.7</U>, <U>4.8,</U> <U>4.14</U>,
<U>4.23</U> and <U>4.26</U>. The Company and, to the Company&#146;s knowledge, each of its officers
and directors are in compliance with, and have complied in all material respects with, all
applicable provisions of the Sarbanes-Oxley Act as it relates to the Company. The Company is in
compliance in all material respects with the applicable listing and corporate governance rules and
regulations of the NASDAQ.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;The Company, the Company&#146;s Subsidiaries and each Hospice are in possession of all
franchises, grants, authorizations, licenses, permits, easements, variances, exceptions, consents,
certificates, approvals and orders of any Governmental Entity necessary for
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->20<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">the Company and the Company&#146;s Subsidiaries to own, lease and operate their properties and
assets and to furnish Hospice Services (the &#147;<U>Company Permits</U>&#148;), except where the failure to
have any of the Company Permits would not have, individually or in the aggregate, a Company
Material Adverse Effect.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;The Company has not received any notice or charge from any Governmental Entity asserting
any material violation of Law or any material Liability with respect thereto.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;All of the Company&#146;s Hospices are certified for participation and reimbursement under
Titles XVIII and XIX of the Social Security Act (the &#147;<U>Medicare and Medicaid Programs</U>&#148; and
collectively, the &#147;<U>Governmental Programs</U>&#148;). All of the Company&#146;s Hospices currently
participate in the Governmental Programs pursuant to provider agreements (the &#147;<U>Provider
Agreements</U>&#148;). Since September&nbsp;30, 2004, no Hospice has been denied participation in or
terminated from participation in the Governmental Programs.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) <U>Section&nbsp;4.6(e)</U> of the Company Disclosure Letter contains a correct and complete
list of all the Company Permits (including the name of the issuing Governmental Entity and the
expiration date) and all provider numbers and Provider Agreements under all Governmental Programs
that are held by the Company and/or any of its Subsidiaries for the conduct of the Business. True
and complete copies of all such Company Permits and provider numbers have been made available to
Parent.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;The Company is not in breach, conflict or violation of, or default under, and there is no
pending Action or Order with respect to, any of the items listed in <U>Section&nbsp;4.6(e)</U> of the
Company Disclosure Letter, except for any such breach, conflict, violation, default, Action or
Order that, individually or in the aggregate, has not had and would not have, individually or in
the aggregate, a Company Material Adverse Effect. The Company has not received any notice, written
or otherwise, of any action under consideration, pending or recommended by any federal or state
Governmental Entity having jurisdiction over the Business either to revoke, withdraw or suspend any
Company Permit or to terminate or modify the participation of the Company or any of its
Subsidiaries or Hospices in any Governmental Program. To the Company&#146;s knowledge, no event has
occurred that, with or without notice or the passage of time, (i)&nbsp;would constitute a breach,
conflict or violation of, or default under, or would constitute grounds for an Action or Order with
respect to, any of the items listed in <U>Section&nbsp;4.6(e)</U> of the Company Disclosure Letter,
except for any such breach, conflict, violation, default, Action or Order that, individually or in
the aggregate, has not had and would not have, individually or in the aggregate, a Company Material
Adverse Effect, or (ii)&nbsp;would constitute a basis to revoke, withdraw or suspend any Company Permit
or to terminate or modify the participation of the Company or any of its Subsidiaries or Hospices
in any Government Program. Since September&nbsp;30, 2006, there has been no decision by the Company or
its Subsidiaries not to renew any provider number, Provider Agreement or material third-party payor
agreement relating to the Business.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;Except as set forth on <U>Section&nbsp;4.6(g)</U> of the Company Disclosure Letter, the
Company and its Subsidiaries have timely filed all claims, except for claims that have not been
timely filed in the ordinary course of business and which have been adequately reserved for on the
Company&#146;s financial statements, and reports required to be filed by the Company and its
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->21<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Subsidiaries prior to the date hereof with respect to the Governmental Programs and all fiscal
intermediaries. All such claims, except for claims that have not been timely filed in the ordinary
course of business and which have been adequately reserved for on the Company&#146;s financial
statements, and reports are complete and accurate in all material respects and have been prepared
in material compliance with all applicable Laws governing reimbursement and payment claims.
<U>Section&nbsp;4.6(g)</U> of the Company Disclosure Letter sets forth a correct and complete list of
all additional document or development requests made by Governmental Programs to which the Company
or any of its Subsidiaries has not responded and all denials of claims currently being appealed by
the Company or any of its Subsidiaries. True and complete copies of all such claims and reports
filed for the most recent cost reporting year of each Hospice have been made available to Parent.
The Company has paid or caused to be paid all known and undisputed refunds, overpayments, discounts
or adjustments which have become due pursuant to such claims and reports. To the Company&#146;s
knowledge, the Company has not claimed or received reimbursements from Governmental Programs in
excess of the amounts permitted by applicable Law, and, has no Liability under any Governmental
Program, other than any refund, overpayment, discount or adjustment that occurs in the ordinary
course of business consistent with past practice. To the knowledge of the Company, except as
disclosed in <U>Section&nbsp;4.6(g)</U> of the Company Disclosure Letter, there are no pending appeals,
adjustments, challenges, litigation or notices of intent to audit and, no audits or inquiries with
respect to such prior claims or reports, except for such appeals or individual claim denials that
occur in the ordinary course of business consistent with past practice or that, individually or in
the aggregate, have not had and would not reasonably be expected to have a Company Material Adverse
Effect. Except for reports that are not yet due, there are no reports required to be filed by the
Company or any of its Subsidiaries in order to be paid under any Governmental Program for services
rendered.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.7. <U>Environmental Laws and Regulations</U>. Except as has not had or would not
have, individually or in the aggregate, a Company Material Adverse Effect, (i)&nbsp;the Company and its
Subsidiaries have conducted their respective businesses in compliance with all applicable
Environmental Laws (as hereinafter defined), (ii)&nbsp;there has been no release of any Hazardous
Substance by the Company or any of its Subsidiaries in any manner that could reasonably be expected
to give rise to any remedial obligation or corrective action requirement under applicable
Environmental Laws or any Lease, (iii)&nbsp;neither the Company nor any of its Subsidiaries has received
any written notices, demand letters or written requests for information from any Governmental
Entity alleging that the Company or any of its Subsidiaries is in violation of, or liable under,
any Environmental Law or from any landlord under any Lease alleging that the Company or any of its
Subsidiaries is in violation of, or liable under, any Lease, (iv)&nbsp;no Hazardous Substance has been
disposed of, released or transported in violation of any applicable Environmental Law, or in a
manner giving rise to any liability under Environmental Law or any Lease, from any properties while
owned or operated by the Company or any of its Subsidiaries, (v)&nbsp;neither the Company, any of its
Subsidiaries nor any of their respective properties are subject to any material liabilities
relating to any suit, settlement, court order, administrative order, regulatory requirement,
judgment or written claim asserted or arising under any Environmental Law or any agreement relating
to environmental liabilities and (vi)&nbsp;to the knowledge of the Company, neither the Company nor any
of its Subsidiaries has ever manufactured asbestos-containing materials.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->22<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;As used herein, &#147;<U>Environmental Law</U>&#148; means any Law relating to (i)&nbsp;the protection,
preservation or restoration of the environment (including air, water vapor, surface water,
groundwater, drinking water supply, surface land, subsurface land, plant and animal life or any
other natural resource), or (ii)&nbsp;the exposure to, or the use, storage, recycling, treatment,
generation, transportation, processing, handling, labeling, production, release or disposal of
Hazardous Substances, in each case as in effect at the date hereof.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;As used herein, &#147;<U>Hazardous Substance</U>&#148; means any substance listed, defined,
designated or classified as hazardous, toxic, radioactive or dangerous under any Environmental Law.
Hazardous Substance includes any substance to which exposure is regulated by any Governmental
Entity or any Environmental Law including any toxic waste, pollutant, contaminant, hazardous
substance, toxic substance, hazardous waste, special waste, medical waste, industrial substance or
petroleum or any derivative or byproduct thereof, radon, radioactive material, asbestos or asbestos
containing material, urea formaldehyde, foam insulation or polychlorinated biphenyls.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;The generality of any other representations and warranties in this Agreement
notwithstanding, this <U>Section&nbsp;4.7</U> shall be deemed to contain the only representations and
warranties in this Agreement with respect to Environmental Law, Hazardous Substances and any other
environmental matter.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.8. <U>Employee Benefit Plans</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <U>Section&nbsp;4.8(a)</U> of the Company Disclosure Letter lists all &#147;multiemployer plans&#148;
within the meaning of Section&nbsp;4001(a)(3) of the Employee Retirement Income Security Act of 1974, as
amended (&#147;<U>ERISA</U>&#148;), (each such plan a &#147;<U>Multiemployer Plan</U>&#148;) to which the Company or
its Subsidiaries contributes, Company Benefit Plans that are employee welfare plans within the
meaning of Section&nbsp;3(1) of <U>ERISA</U>, any employee pension benefit plan within the meaning of
Section&nbsp;3(2) of ERISA and all other Company Benefit Plans (whether or not such plan is subject to
ERISA). &#147;<U>Company Benefit Plans</U>&#148; means all compensation and/or benefit plans, programs,
policies, agreements or other arrangements, including any employee welfare plan within the meaning
of Section&nbsp;3(1) of ERISA, any employee pension benefit plan within the meaning of Section&nbsp;3(2) of
ERISA (whether or not such plan is subject to ERISA), and any bonus, incentive, deferred
compensation, vacation, stock purchase, stock option, severance, retention, employment, change of
control or fringe benefit plan, program, agreement or arrangement (other than any Multiemployer
Plan and any other plan, program or arrangement maintained by an entity other than the Company or
any of its Subsidiaries pursuant to any collective bargaining agreements), in each case that is
sponsored, maintained or contributed to by the Company or any of its ERISA Affiliates for the
benefit of current or former employees, directors or consultants of the Company or its ERISA
Affiliates. <U>Section&nbsp;4.8(a)</U> of the Company Disclosure Letter separately lists each Company
Benefit Plan that is a bonus, severance, employment, change in control, deferred compensation or
similar agreement that constitutes any unfunded promise to pay any amount that will not be fully
paid prior to the Closing Date and further lists the amount potentially payable pursuant to each
arrangement. It is agreed and understood that no representation or warranty is made in respect of
ERISA matters in any Section of this Agreement other than this <U>Section&nbsp;4.8</U>. Complete
copies of all Company Benefit Plans and any material ancillary documents have been made available
in the Company&#146;s online
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->23<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">data site to Parent. &#147;<U>ERISA Affiliate</U>&#148; means, with respect to any entity, trade or
business, any other entity, trade or business that is a member of a group described in Section
414(b), (c), (m)&nbsp;or (o)&nbsp;of the Code or Section&nbsp;4001(b)(1) of ERISA that includes the first entity,
trade or business, or that is a member of the same &#147;controlled group&#148; as the first entity, trade or
business pursuant to Section&nbsp;4001(a)(14) of ERISA.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) (i)&nbsp;Each Company Benefit Plan has been maintained and administered in compliance in all
material respects with its terms and with applicable Law, including but not limited to, ERISA and
the Code to the extent applicable thereto; (ii)&nbsp;each of the Company Benefit Plans intended to be
&#147;qualified&#148; within the meaning of Section 401(a) of the Code has received a favorable determination
letter from the IRS or is entitled to rely upon a favorable opinion issued by the IRS, and, to the
knowledge of the Company, there are no existing circumstances or any events that have occurred that
could reasonably be expected to adversely affect the qualified status of any such plan; (iii)&nbsp;no
Company Benefit Plan (other than a Multiemployer Plan) is subject to Title IV of ERISA; (iv)&nbsp;no
Company Benefit Plan provides retiree medical or other welfare benefits, other than coverage
mandated by applicable Law; (v)&nbsp;no material liability under Title IV of ERISA has been incurred by
the Company, its Subsidiaries or any ERISA Affiliate of the Company that has not been satisfied in
full; (vi)&nbsp;all material contributions or other amounts payable by the Company, its Subsidiaries or
any ERISA Affiliate as of the date hereof with respect to each Company Benefit Plan in respect of
current or prior plan years have been paid or accrued in accordance with GAAP (other than with
respect to amounts not yet due); (vii)&nbsp;no payments made or to be made pursuant to any Company
Benefit Plan as a result of the transactions contemplated in this Agreement will result in the
nondeductibility of any payment pursuant to Section&nbsp;280G of the Code; (viii)&nbsp;there are no actions,
suits or claims (other than routine claims for benefits) pending or to the knowledge of the Company
threatened with respect to any Company Benefit Plan; and (ix)&nbsp;to the knowledge of the Company there
are no matters pending (other than determination letter requests) with respect to any Company
Benefit Plan before any Governmental Entity.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Each Company Benefit Plan that is a &#147;nonqualified deferred compensation plan&#148; (as defined
in Section&nbsp;409A(d)(1) of the Code) has been operated since January&nbsp;1, 2007 in good faith compliance
with Section&nbsp;409A of the Code and the final regulations thereunder or, as appropriate, the proposed
regulations thereunder and other applicable IRS guidance.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.9. <U>Absence of Certain Changes or Events</U>. Since September&nbsp;30, 2006 through
the date of this Agreement, except as otherwise expressly contemplated or required by this
Agreement, (a)&nbsp;the businesses of the Company and its Subsidiaries have been conducted, in all
material respects, in the ordinary course of business consistent with past practice, (b)&nbsp;there have
not been any facts, conditions, circumstances, events, changes, effects or occurrences that have
had or would reasonably be expected to have, individually or in the aggregate, a Company Material
Adverse Effect, and (c)&nbsp;there has not been any action or event, nor any authorization, commitment
or agreement by the Company or any of its Subsidiaries with respect to any action or event, that if
taken or if it occurred after the date hereof would be prohibited by <U>Section&nbsp;6.1(b)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.10. <U>Investigations; Litigation</U>. There is no (a)&nbsp;investigation, litigation,
action, suit, claim, demand, arbitration, mediation or proceeding or inquiry, whether civil,
criminal or
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->24<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">administrative (each a &#147;<U>Claim</U>&#148;) pending, or to the knowledge of the Company,
threatened, by or before any Governmental Entity or arbitral authority with respect to the Company
or any of its Subsidiaries or (b)&nbsp;Claim pending, or to the knowledge of the Company, threatened, by
any Person against or affecting the Company or any of its Subsidiaries, or any of their respective
properties at Law or in equity, and to the Company&#146;s knowledge, and there are no Orders against the
Company or any of its Subsidiaries, in each case of clause <U>(a)</U> or <U>(b)</U>, that has had
or would reasonably be expected to have, individually or in the aggregate with other Claims, a
Company Material Adverse Effect.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.11. <U>Schedule&nbsp;14D-9, Offer Documents; Proxy Statement; Other Information</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;None of the information supplied or to be supplied in writing by or on behalf of the
Company specifically for inclusion in the Offer Documents will, at the times such documents are
filed with the SEC and are mailed to stockholders of the Company, contain any untrue statement of a
material fact or omit to state any material fact required to be stated therein or necessary to make
the statements therein, in light of the circumstances under which they are made, not misleading, or
necessary to correct any statement supplied by the Company made in any communication with respect
to the Offer previously filed with the SEC or disseminated to the stockholders of the Company. The
Schedule&nbsp;14D-9 will not, at the time the Schedule&nbsp;14D-9 is filed with the SEC or at the time such
document is first mailed to the stockholders, contain any untrue statement of a material fact or
omit to state any material fact required to be stated therein or necessary to make the statements
therein, in light of the circumstances under which they are made, not misleading, except that no
representation or warranty is made by the Company with respect to information supplied in writing
by Parent, Merger Sub or an Affiliate of Parent or Merger Sub which is contained in the Schedule
14D-9. The Schedule&nbsp;14D-9 will comply as to form in all material respects with the provisions of
the Exchange Act and the rules and regulations of the SEC thereunder.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;The proxy statement (including the letter to stockholders, notice of meeting and form of
proxy, the &#147;<U>Proxy Statement</U>&#148;) that may be filed by the Company with the SEC in connection
with seeking the adoption of this Agreement by the stockholders of the Company will not, at the
time it is filed with the SEC, or at the time it is first mailed to the stockholders of the Company
or at the time of the Company Meeting, and at the time of any amendments or supplements thereto,
contain any untrue statement of a material fact or omit to state any material fact required to be
stated therein or necessary in order to make the statements therein, in light of the circumstances
under which they are made, not misleading. The Company will cause the Proxy Statement to comply as
to form in all material respects with the requirements of the Exchange Act applicable thereto as of
the date of such filing. No representation is made by the Company with respect to statements made
in the Proxy Statement based on information supplied, or required to be supplied, by Parent, Merger
Sub or any of their affiliates specifically for inclusion or incorporation by reference therein.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.12. <U>Other Approvals</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <U>Rights Plan</U><I>. </I>The Company and the Board of Directors have taken all action
necessary to amend the Rights Agreement (without redeeming the Rights), and shall maintain in
effect all necessary action (i)&nbsp;to render the Rights Agreement inapplicable with
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->25<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">respect to the Stockholder Agreements, the Offer, the Merger, the execution and operation of
this Agreement, and any other transactions contemplated by this Agreement, and (ii)&nbsp;to ensure that
(A)&nbsp;neither Parent nor Merger Sub nor any of their &#147;Affiliates&#148; (as defined in the Rights
Agreement) or &#147;Associates&#148; (as defined in the Rights Agreement) is considered to be an &#147;Acquiring
Person&#148; (as defined in the Rights Agreement), and (B)&nbsp;the provisions of the Rights Agreement,
including the occurrence of a &#147;Distribution Date&#148; (as defined in the Rights Agreement), are not and
shall not be triggered by reason of the announcement or consummation of the Offer, the Merger, or
any of the other transactions contemplated hereby. A copy of the amendment mentioned above and the
resolutions of the Board of Directors authorizing such amendment are set forth in <U>Section
4.12</U> of the Company Disclosure Letter. The Company has delivered or made available to Parent a
true, complete and correct copy of the Rights Agreement, as amended, and the Rights Agreement has
not been further modified or amended. Neither the execution and delivery of the Stockholder
Agreements nor this Agreement nor the consummation of the Offer, the Merger and any of the
transactions contemplated hereby will result in the occurrence of a Distribution Date, as defined
in the Rights Agreement, or otherwise cause the Rights to become exercisable by the holders
thereof.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <U>Section&nbsp;203</U><I>. </I>The Board of Directors has taken all actions necessary under the
DGCL, including approving the Stockholder Agreements and approving the transactions contemplated by
this Agreement, to ensure that the restrictions on Business Combinations (as defined in Section&nbsp;203
of the DGCL) do not, and will not, apply to the transactions contemplated hereby, if any such
transactions are consummated in accordance with the terms of this Agreement. Neither the execution
and delivery of the Stockholder Agreements nor this Agreement nor the consummation of the Offer,
the Merger and any of the transactions contemplated hereby will prohibit for any period of time, or
impose any stockholder approval requirement with respect to, the Merger.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) <U>Takeover Laws</U><I>. </I>Other than as described in <U>Section&nbsp;4.12(b)</U>, no Takeover
Law or other comparable takeover provision of the Company&#146;s Certificate of Incorporation or By-Laws
applies to the Stockholder Agreements, this Agreement, the Offer or the Merger, prohibits the
consummation of the Offer or the Merger or imposes any additional stockholder approvals or
conditions with respect to the Offer or the Merger.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.13. <U>Tax Matters</U>. Except as set forth in <U>Section&nbsp;4.13</U> of the Company
Disclosure Letter:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;the Company and each of its Subsidiaries have prepared and duly and timely filed (taking
into account any extension of time within which to file) all material Tax Returns required to be
filed by any of them and all such filed Tax Returns are complete and accurate in all material
respects;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;the Company and each of its Subsidiaries have duly and timely paid all material Taxes that
are required to be paid by any of them (whether or not shown as due on such Tax Return);
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->26<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;there are not pending, outstanding or threatened in writing, any claims, audits,
examinations, investigations, actions or other proceedings in respect of Taxes of the Company or
any of its Subsidiaries;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;no deficiency with respect to Taxes has been proposed, asserted or assessed in each case,
in writing, against the Company or any of its Subsidiaries;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;there are no requests for rulings or determinations in respect of any material Taxes or
material Tax Returns pending between the Company or any of its Subsidiaries on the one hand and any
authority responsible for such Taxes or Tax Returns on the other;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;the Company and each of its Subsidiaries has timely withheld and paid all material Taxes
required to be withheld and paid in connection with amounts paid or owing to any employee,
creditor, independent contractor, shareholder or other third party and is in compliance in all
material respects with all applicable rules and regulations regarding the solicitation, collection
and maintenance of any forms, certifications and other information required in connection
therewith;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;neither the Company nor any of its Subsidiaries has any liability as a result of being a
party to any Tax sharing, Tax indemnity or other agreement or arrangement relating to Taxes (other
than an agreement or arrangement solely among members of an affiliated, consolidated or unitary
group the common parent of which is the Company or which includes only the Company and/or its
Subsidiaries);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)&nbsp;neither the Company nor any of its Subsidiaries has any liability for Taxes as a result of
having been a member of any affiliated group within the meaning of Section 1504(a) of the Code, or
any similar affiliated or consolidated group for Tax purposes under state, local or foreign Law
(other than a group the common parent of which is the Company or which includes only the Company
and/or its Subsidiaries), or has any liability for the Taxes of any Person (other than the Company
and its Subsidiaries) under Treasury Regulations Section&nbsp;1.1502-6 or any similar provision of
state, local or foreign Law, or as a transferee or successor, or otherwise;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;neither the Company nor any of its Subsidiaries has been a &#147;controlled corporation&#148; or a
&#147;distributing corporation&#148; in any distribution that was purported or intended to be governed by
Section&nbsp;355 of the Code (A)&nbsp;within the two-year period ending on the date hereof or (B)&nbsp;in a
distribution which could otherwise constitute part of a &#147;plan&#148; or &#147;series of related transactions&#148;
in conjunction with the Offer or the Merger;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j)&nbsp;neither the Company nor any of its Subsidiaries has entered into any &#147;listed transaction&#148;
within the meaning of Treasury Regulation&nbsp;Section&nbsp;1.6011-4(b)(2);
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(k)&nbsp;there are no material Liens for any Taxes upon the assets of the Company or any of its
Subsidiaries, other than Permitted Liens;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(l)&nbsp;neither the Company nor any of its Subsidiaries has (i)&nbsp;entered into any transaction that
resulted in a &#147;deferred intercompany gain&#148; (within the meaning of Treasury Regulation&nbsp;Section
1.1502-13) which gain, in whole or in part, continues to be deferred pursuant
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->27<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">to the provisions of Treasury Regulation&nbsp;Section&nbsp;1.1502-13 as of the date hereof or (ii)&nbsp;an
&#147;excess loss account,&#148; as defined in Treasury Regulation&nbsp;Section&nbsp;1.1502-9, in respect of the stock
of any Subsidiary that is a member of the United States affiliated group (as that term is defined
under Section 1504(a) of the Code and other similar provisions of state or local law) that includes
the Company as a common parent;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(m)&nbsp;no asset or liability of the Company or any of its Subsidiaries is a debt obligation that
(i)&nbsp;was issued with &#147;original issue discount,&#148; as defined in Section 1273(a) of the Code; (ii)&nbsp;is a
&#147;registration-required obligation&#148; as defined in Section&nbsp;163(f)(2) of the Code; (iii)&nbsp;is an
&#147;applicable high yield discount obligation&#148; as defined in Section&nbsp;163(i)(1) of the Code; (iv)
provides for the payment of interest that is &#147;disqualified interest,&#148; as defined under Section
163(j)(3) of the Code; (v)&nbsp;constitutes &#147;corporate acquisition indebtedness,&#148; within the meaning of
Section 279(b) of the Code; or (vi)&nbsp;is a &#147;disqualified debt instrument,&#148; as defined in Section
163(b)(2) of the Code; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(n)&nbsp;no power of attorney that is currently in force has been granted with respect to any
matter relating to Taxes that could affect the Company or any of its Subsidiaries.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As used in this Agreement, (i) &#147;<U>Taxes</U>&#148; means any and all material domestic or foreign,
federal, state, local or other taxes, charges, fees, imposts, levies or other assessments of any
kind (together with any and all interest, penalties, additions to tax and additional amounts
imposed with respect thereto) imposed by any Governmental Entity, including taxes on or with
respect to income, franchises, windfall or other profits, gross receipts, property, sales, use,
capital stock, payroll, employment, unemployment, social security, workers&#146; compensation or net
worth, and taxes in the nature of excise, withholding, ad valorem or value added or any transferee
liability in respect of any of the foregoing items payable by reason of contract, assumption
transferee liability, operation of law, Treasury Regulation&nbsp;Section&nbsp;1.1502-6(a) (or any predecessor
or successor thereof or any analogous or similar provision under Law) or otherwise, and (ii)
&#147;<U>Tax Return</U>&#148; means any material return, report or similar filing (including the attached
schedules, supplements and additional or supporting material) filed or required to be filed with
respect to Taxes, including any information return, claim for refund, amended return or declaration
of estimated Taxes (and including any amendments with respect thereto), and including, where
permitted or required, combined, consolidated, or unitary returns for any group of entities.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.14. <U>Labor Matters</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Each employee of the Company or any of its Subsidiaries (each, an &#147;<U>Employee</U>&#148;)
currently employed by the Company or one of its Subsidiaries is an &#147;at will&#148; employee (whose
employment may be terminated at any time by the Company or its Subsidiary or such employee, in each
case with or without cause or notice). All Employees are authorized to work for the Company or any
of its Subsidiaries in the country in which such person performs work according to applicable
immigration Laws.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Except as has not had and would not have, individually or in the aggregate, a Company
Material Adverse Effect, (i)&nbsp;the Company and its Subsidiaries are in compliance with all applicable
Laws or Contracts governing or concerning labor relations, employment, union and collective
bargaining, immigration, fair employment practices,
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->28<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">employment discrimination and harassment, terms and conditions of employment, workers&#146;
compensation, occupational safety and health, plant closings, and wages and hours, all other Laws
applicable to the Company or any of its Subsidiaries with respect to any of the Employees or
Independent Contractors, including ERISA, the Immigration Reform and Control Act of 1986, the
National Labor Relations Act, the Civil Rights Acts of 1866 and 1964, the Equal Pay Act, the Age
Discrimination in Employment Act, the Americans with Disabilities Act, the Family and Medical Leave
Act of 1992, the Worker Adjustment and Retraining Notification Act of 1998, the Occupational Safety
and Health Act, the Davis-Bacon Act, the Walsh-Healy Act, the Service Contract Act, Executive Order
11246, the Fair Labor Standards Act and the Rehabilitation Act of 1973 and all regulations under
such acts (collectively, the &#147;<U>Labor Laws</U>&#148;), (ii)&nbsp;neither the Company nor any of its
Subsidiaries is liable for or bound by, as the case may be, any liabilities, judgments, decrees,
orders, citations, Taxes, fines or penalties for failure to comply with any of the Labor Laws,
(iii)&nbsp;each of the Company and its Subsidiaries has withheld all amounts required by applicable Law
or by agreement to be withheld from the wages, salaries and other payments made or benefits
provided to Company Employees, and (iv)&nbsp;none of the Company or any of its Subsidiaries is liable
for any arrears of wages, salaries or other benefits or any Taxes or any penalty for failure to
comply with any of the foregoing.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Except as set forth in <U>Section&nbsp;4.14(c)</U> of the Company Disclosure Letter, there are
no pending or, to the knowledge of the Company, threatened Claims against the Company or any of its
Subsidiaries brought by or on behalf of any current or former Employee or applicant for employment
or current or former Independent Contractor (other than regular claims for benefits in accordance
with the terms of such Old Plans, New Plans, and any policies thereunder), and any pending
settlements of such Claims have been fully funded and otherwise complied with.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;To the knowledge of the Company, no Employee or Independent Contractor is in violation of
any term of any employment Contract, non-disclosure agreement, non-competition agreement, or any
restrictive covenant to a former employer relating (i)&nbsp;to the right of any such Person to be
employed or retained by the Company or any of its Subsidiaries because of the nature of the
business conducted or proposed to be conducted by the Company or its Subsidiaries, or (ii)&nbsp;to the
use by or for the benefit of any of the Company or any of its Subsidiaries of the intellectual
property of others. To the knowledge of the Company, no Employee or Independent Contractor is in
material violation of any term of any employment Contract, non-disclosure agreement,
non-competition agreement, or restrictive covenant with the Company or any of its Subsidiaries
relating to the Business.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;Neither the Company nor any of its Subsidiaries has recognized a labor union nor has any
labor union been certified as the exclusive bargaining representative of any Employees. Neither
the Company nor any of its Subsidiaries is a party to, or bound by, any collective bargaining
Contract with a labor union or labor organization, nor is any collective bargaining Contract being
negotiated. To the knowledge of the Company, there have not been any union organizing efforts
during the past three (3)&nbsp;years with respect to any Employees, including any petitions for a
certification or unionization proceeding.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;Within the past three-year period, neither the Company nor any of its Subsidiaries has
effectuated a &#147;plant closing&#148; or &#147;mass layoff&#148; as those terms are defined in
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->29<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">WARN or any similar state or local law, affecting in whole or in part any site of employment,
facility, operating unit or Employee.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;It is agreed and understood that no representation or warranty is made in respect of labor
matters in any Section of this Agreement other than <U>Sections&nbsp;4.8</U> and <U>4.14</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.15. <U>Intellectual Property</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <U>Ownership</U>. Except as has not had and would not have, individually or in the
aggregate, a Company Material Adverse Effect, either the Company or a Subsidiary of the Company
owns, or is licensed or otherwise possesses legally enforceable rights to use, all intellectual
property used in their respective businesses as currently conducted, or if not currently conducted,
as held for business to be conducted, (collectively, the &#147;<U>Company Intellectual Property</U>&#148;)
free and clear of all Liens.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <U>Trademarks</U>. <U>Section&nbsp;4.15(b)</U> of the Company Disclosure Letter contains a
complete and accurate list of all Trademarks owned by the Company or its Subsidiaries and lists any
applications, proceedings or actions before any court, tribunal (including the United States Patent
and Trademark Office) related to any of the Trademarks. All Trademarks (registered, unregistered
and including intent to use applications) set forth in <U>Section&nbsp;4.15(b)</U> of the Company
Disclosure Letter are, to the knowledge of the Company, in full force and effect, valid and
enforceable. The Company and its Subsidiaries do not own any registered intellectual property
other than the Trademarks listed in <U>Section&nbsp;4.15(b)</U> of the Company Disclosure Letter.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) <U>Non-Infringement</U>. There are no pending or, to the knowledge of the Company or any
of its Subsidiaries, threatened claims by any person alleging infringement by the Company or any of
its Subsidiaries for their use of intellectual property of the Company or any of its Subsidiaries,
and no Person has challenged the Company&#146;s or its Subsidiaries ownership, use, validity,
enforceability or registrability of any intellectual property. To the knowledge of the Company,
the conduct of the business of the Company and its Subsidiaries, as such business is currently
being conducted, has not, does not, and will not when conducted by the Surviving Corporation in
substantially the same manner following the Closing infringe or misappropriate any intellectual
property rights of any Person.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.16. <U>HIPAA.</U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Neither the Company, nor any of its Subsidiaries have collected any personally
identifiable information from any Third Parties except as described in <U>Section&nbsp;4.16(a)</U> of
the Company Disclosure Letter, and the collection of such individually identifiable health
information collected from Third Parties described in <U>Section&nbsp;4.16(a)</U> of the Company
Disclosure Letter does not violate any applicable Law, including the Health Insurance Portability
and Accountability Act except for any incidents of noncompliance that have not had and would not
have, individually or in the aggregate, a Company Material Adverse Effect. The Company and each of
its Subsidiaries has complied with all applicable Laws, including anti-spam laws and the Health
Insurance Portability and Accountability Act, and their respective internal privacy policies
relating thereto, except for any incidents of noncompliance that have not had and would not have,
individually or in the aggregate, a Company Material Adverse Effect. True and correct
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->30<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">copies of all applicable privacy policies have been made available to Parent. The Company and
each of its Subsidiaries has at all times made all disclosures to users or customers required by
applicable Laws, and none of such disclosures made or contained in any privacy policies or in any
such materials have been inaccurate, misleading or deceptive or in violation of any applicable
Laws, except for any incidents of noncompliance that have not had and would not have, individually
or in the aggregate, a Company Material Adverse Effect.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;The Company and each of its Subsidiaries has established reasonable and appropriate
safeguards to protect personally identifiable information. No unauthorized access of personally
identifiable information has occurred other than inadvertent incidents that have not had and would
not have, individually or in the aggregate, a Company Material Adverse Effect.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.17. <U>Property</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <U>Section&nbsp;4.17</U> of the Company Disclosure Letter contains a true and complete list of
all real property leases, ground leases, licenses, tenancies, subleases and all other occupancy
agreements to which the Company or any of its Subsidiaries is a party (including all amendments,
and modifications, supplements, renewals, extensions and guarantees related thereto) (the leased
and subleased space or parcel of real property thereunder being, collectively, the &#147;<U>Leased
Property</U>&#148;) (each as amended, supplemental or modified, the &#147;<U>Leases</U>&#148;) and the Company
has delivered to Parent a true, correct and complete copy of each Lease. Except as has not had and
would not have, individually or in the aggregate, a Company Material Adverse Effect: (i)&nbsp;the
Company or a Subsidiary of the Company has good and valid title to all its personal property, free
and clear of all Liens (except for Permitted Liens), and has good and valid title to the leasehold
estate in all Leased Property, free and clear of all Liens (except for Permitted Liens, and except
for title exceptions, defects, liens, charges, restrictions, encumbrances, restrictive covenants
and other matters of record which were not caused by or result from the actions or inactions of the
Company or a Subsidiary of the Company and which do not materially affect the continued use of the
property for the purposes for which the property is currently being used (assuming the timely
discharge of all obligations owing under or related to the personal property and the Leased
Property) by the Company or a Subsidiary of the Company), sufficient to conduct their respective
businesses as currently conducted; (ii)&nbsp;the Leases are valid, binding and enforceable against the
Company or a Subsidiary of the Company in accordance with their terms and are in full force and
effect; (iii)&nbsp;there is not, under any of the Leases, any existing default or violation by the
Company or any of its Subsidiaries, nor to the Company&#146;s knowledge, any existing default or
violation by any counterparty to any Lease, nor any event, fact or circumstance which, with notice
or lapse of time or both, would become a default or violation by the Company or any of its
Subsidiaries or any counterparty to any Lease or give rise to a right of termination or
cancellation under any of the Leases; (iv)&nbsp;neither the Company nor any of its Subsidiaries has
assigned, transferred, conveyed, mortgaged, or encumbered any interest in any Leased Property; and
(v)&nbsp;the Company, its Subsidiaries (and any Affiliate of the Company or its Subsidiaries, as
applicable) enjoys peaceful and undisturbed possession under the Leases.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Neither the Company nor any of its Subsidiaries owns any real property or interest in real
property, other than leasehold interests in the Leased Property.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->31<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;The Leased Property
constitutes all real property necessary to operate the Business in all
material respects as presently conducted.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.18. <U>Opinion of Financial Advisors</U>. The
Board of Directors and the Special
Committee have received the written opinion, dated as of January&nbsp;14, 2008, of RA Capital Advisors,
LLC (the &#147;<U>Financial Advisor</U>&#148;), the financial advisor to the Special Committee, to the
effect that, as of the date of such opinion, and based upon and subject to the factors and
assumptions set forth in such opinion, the Per Share Amount to be received by the holders of Shares
(other than Parent, Merger Sub and their respective affiliates) in the Offer and the Merger
Consideration to be received by the holders of Shares (other than Parent, Merger Sub and their
respective affiliates) in the Merger are fair, from a financial point of view, to such holders, and
such opinion has not been withdrawn or modified. True and complete copies of the fairness opinion
of the Financial Advisor and all agreements and understandings between the Company or any of its
Affiliates and the Financial Advisor relating to the Offer and the Merger and the other
transactions contemplated by this Agreement have been provided by the Company to Parent.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.19. <U>Required Vote of the Company Stockholders</U>. Subject to the applicability
of Section&nbsp;253 of the DGCL, the affirmative vote or written consent of the holders of a majority of
the outstanding Shares is the only vote or consent of holders of capital stock or other securities
of the Company required to adopt this Agreement (the &#147;<U>Company Stockholder Approval</U>&#148;).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.20. <U>Contracts</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <U>Section&nbsp;4.20(a)</U> of the Company Disclosure Letter sets forth all of the following
Contracts to which the Company or any of its Subsidiaries is a party to or bound by or which are
applicable to any of their assets or properties, in each case as amended through the date hereof
(each a &#147;<U>Material Contract</U>&#148;):
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;each Contract, excluding Clinical Contracts, that involves the performance of services or
the delivery of goods or materials by the Company or any of its Subsidiaries in an amount in excess
of $100,000 during any year;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;each Contract, excluding Clinical Contracts and Medical Director Contracts, that involves
the performance of services or the delivery of goods or materials to the Company or any of its
Subsidiaries in an amount in excess of $100,000 during any year;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)&nbsp;each Contract that was not entered into in the ordinary course of business consistent
with past practice and involves the payment or receipt by the Company or any of its Subsidiaries of
more than $100,000 during any year;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv)&nbsp;each Lease of Leased Property;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v)&nbsp;each Contract under which the Company or any of its Subsidiaries has incurred indebtedness
for borrowed money or granted any Lien on any of its assets in connection with any indebtedness for
borrowed money;
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->32<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vi)&nbsp;each Contract that creates a partnership, limited liability company or joint venture with
respect to which Parent will become obligated or in which Parent will hold, directly or indirectly,
an equity interest after the Closing;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vii)&nbsp;each Contract for the provision of medical direction services between a licensed
physician and a Hospice, including medical directors, program medical directors, team medical
directors and associated medical directors (each a &#147;<U>Medical Director Contract</U>&#148;);
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(viii)&nbsp;each Contract, excluding Clinical Contracts and Medical Director Contracts, with any
consultant that involves the performance of services to the Company or any of its Subsidiaries in
an amount in excess of $50,000 during any year;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ix)&nbsp;each Contract with any vendor that provides services relating to billing and
reimbursement valued in excess of $50,000 during any year;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(x)&nbsp;each Contract that contains any non-competition or non-solicitation provision applicable
to the Company or any of its Subsidiaries or that otherwise restricts the Company&#146;s or any of its
Subsidiaries&#146; business activities or limits the Company&#146;s or any of its Subsidiaries&#146; freedom to
conduct the Business or to compete with any Person;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(xi)&nbsp;other than Contracts entered into in the ordinary course of the Company&#146;s and its
Subsidiaries&#146; business for the provision of Hospice Services, each Contract that contains any
confidentiality or non-disclosure provision currently in effect and not related to any discontinued
merger, acquisition or other business combination discussed with any third party or the
transactions contemplated by this Agreement;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(xii)&nbsp;each Contract that is not terminable by the Company upon ninety (90)&nbsp;days or less notice
with expected future payments in excess of $50,000 and which are allocated by the Company to home
office or regional office administrative expenses on the Company&#146;s internal financial statements in
the ordinary course of business consistent with past practice;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(xiii)&nbsp;each Contract, including any indemnification agreement, with any (a)&nbsp;executive officer
or director of the Company or any of its Subsidiaries or any of their immediate family members
(including their spouses) or any Person known by the Company to be an affiliate of such Person, or
(b)&nbsp;Person known by the Company to be a beneficial owner of five percent (5%) or more of any class
or series of voting securities of the Company;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(xiv)&nbsp;each Contract that (A)&nbsp;grants any material exclusive rights, (B)&nbsp;grants any material
&#147;most favored nation&#148; status, rights of first refusal, rights of first negotiation or similar
rights with respect to any product or service of the Business, or (C)&nbsp;contains any provision that
requires the purchase of all or a given portion of the Company&#146;s or any of its Subsidiaries&#146;
requirements from a given Third Party, or any similar provision;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(xv)&nbsp;each Contract under which the Company or any of its Subsidiaries has any material
obligations that have not been satisfied or performed (other than confidentiality
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->33<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">obligations) relating to the acquisition or disposition of any portion of the Business
(whether by merger, sale of stock, sale of assets or otherwise); and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(xvi)&nbsp;except for the Contracts disclosed above, each Contract required to be filed by the
Company pursuant to Item&nbsp;601(b)(10) of Regulation&nbsp;S-K under the Securities Act, or that is
otherwise material to the Company and its Subsidiaries, taken as a whole, and not entered into in
the ordinary course of business consistent with past practice.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Neither the Company nor any Subsidiary of the Company is in breach or violation of, or
default under, or as of the date of this Agreement, has received notice that any other party is (or
intends to be) in breach or violation of, or default under, any Material Contract, where such
breach, violation or default has had or would reasonably be expected to have, individually or in
the aggregate, a Company Material Adverse Effect. To the knowledge of the Company, no party to any
Material Contract is in breach or violation of, or default under, the terms of any Material
Contract where such breach, violation or default has had or would reasonably be expected to have,
individually or in the aggregate, a Company Material Adverse Effect. Except as would not have a
Company Material Adverse Effect, each Material Contract is a valid and binding obligation of the
Company or the Subsidiary of the Company which is party thereto and, to the knowledge of the
Company, of each other party thereto, and is in full force and effect, subject to the
Enforceability Exceptions.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Except as set forth in <U>Section&nbsp;4.20(c)</U> of the Company Disclosure Letter, the
consummation of the Offer, the Merger, and any other transactions contemplated by this Agreement
will not cause or result in a breach or violation of, or default under, any Material Contract or
would otherwise give rise to a right of termination, cancellation, or acceleration of any material
obligation or to the loss of a material benefit under any Material Contract.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.21. <U>Finders or Brokers</U>. Except for RA Capital Advisors, LLC, neither the
Company nor any of its Subsidiaries has engaged any investment banker, broker or finder in
connection with the transactions contemplated by this Agreement who might be entitled to any fee or
any commission from the Company, any of its Subsidiaries, Parent or Merger Sub or any of their
respective Affiliates in connection with or upon consummation of the Offer, the Merger or the other
transactions contemplated by this Agreement. The Company has heretofore furnished to Parent true,
complete and correct copies of all Contracts between the Company or its Subsidiaries and RA Capital
Advisors, LLC pursuant to which such firm would be entitled to any payment relating to the Offer,
the Merger or the other transactions contemplated by this Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.22. <U>Insurance</U>. The Company and its Subsidiaries maintain, or are entitled
to the benefits of, insurance covering their material properties, operations, personnel and
businesses that are customary for businesses of their type (each, an &#147;<U>Insurance Policy</U>&#148;).
<U>Section&nbsp;4.22</U> of the Company Disclosure Letter sets forth a true and complete list of all of
the Insurance Policies and lists the amount of the last annual premium paid for all current
policies of directors&#146; and officers&#146; liability insurance maintained by the Company and its
Subsidiaries. Except as would not have a Company Material Adverse Effect, none of the Company or
its Subsidiaries has received notice from any insurer or agent of such insurer that substantial
capital improvements or other expenditures must be made in order to continue such insurance, and
all such insurance is
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->34<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">outstanding and duly in force. All premiums payable under any Insurance Policy have been paid
when due and the Company and each of its Subsidiaries are in all material respects in full
compliance with the terms of each Insurance Policy.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.23. <U>Health Care Legal Matters</U>. With respect to the Business:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;The Company and its Subsidiaries have complied, and are in compliance, with all Healthcare
Laws applicable to the Company and its Subsidiaries or the Business, except for any such
non-compliance that, individually or in the aggregate, has not had and would not have, individually
or in the aggregate, a Company Material Adverse Effect.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Without limiting the foregoing, to the knowledge of the Company, neither the Company nor
its Subsidiaries have engaged in any activities or entered into any arrangements that are
prohibited under 42 U.S.C. Sections&nbsp;1320a-7, 1320a-7a, 1320a-7b, 1395nn, and 1396b, 31 U.S.C.
Sections&nbsp;3729-3733, the federal CHAMPUS/TRICARE statute, or any other federal or state statutes
related to false or fraudulent claims, the regulations promulgated pursuant to such statutes, or
any similar or related state or local statutes or regulations.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.24. <U>Changes in Suppliers and Third-Party Payors</U>. Neither the Company nor
any of its Subsidiaries have received any notice (written or oral) from any Person supplying
products, materials or drugs to the Company or its Subsidiaries that it intends to (i)&nbsp;cease
selling such products, materials or drugs to the Company or any of its Subsidiaries, (ii)&nbsp;limit or
reduce such sales to the Company or any of its Subsidiaries, or (iii)&nbsp;increase the prices at which
such sales are made to the Company or its Subsidiaries. Neither the Company nor its Subsidiaries
have received any notice (written or oral) from any third-party payor that it intends to terminate,
limit or reduce its business relations with the Company or any of its Subsidiaries in the event of
a sale of the Business or otherwise.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.25. <U>Certain Relationships</U>. Except as set forth in <U>Section&nbsp;4.25</U> of
the Company Disclosure Letter, in connection with the Business, neither the Company nor any of its
Subsidiaries nor any of its or their directors or officers has entered into any joint venture,
partnership, co-ownership or other arrangement involving any ownership or investment interest by
any Person, including a hospital, long-term care facility, physician or physician group, that is or
was in a position to make or influence referrals, furnish items or services to, or otherwise
generate business for, the Company or any of its Subsidiaries.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.26. <U>Rates and Reimbursement Policies</U>. Neither the Company nor any of its
Subsidiaries has any reimbursement or payment rate appeals, disputes or contested positions pending
before any Governmental Entity with respect to the Business, other than those that, if unsuccessful
have not had and would not have, individually or in the aggregate, a Company Material Adverse
Effect.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;4.27. <U>No Additional Representations</U>. Except for the representations and
warranties of the Company set forth in this Agreement (including the Company Disclosure Letter and
the Designated SEC Reports), neither the Company nor any other Person on behalf of the Company
makes any express or implied representation or warranty with respect to the Company or with respect
to any other information provided to Parent in connection with the transactions
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->35<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">contemplated hereby. Without limiting the foregoing, and without limiting or modifying the
representations and warranties contained in the Agreement, the Company makes no representation or
warranty to Parent with respect to (a)&nbsp;the information set forth in the Information Memorandum or
(b)&nbsp;except as provided in <U>Article&nbsp;IV</U>, the Company Disclosure Letter and the Designated SEC
Reports, any financial projection or forecast relating to the Company or any of its Subsidiaries,
whether or not included in the Information Memorandum or any management presentation.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ARTICLE V</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB</B>

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Parent and Merger Sub jointly and severally represent and warrant to the Company as follows:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;5.1. <U>Qualification, Organization, Subsidiaries, etc</U>. Each of Parent and
Merger Sub is a legal entity duly organized, validly existing and in good standing under the Laws
of its respective jurisdiction of organization and has all requisite corporate or similar power and
authority to own, lease and operate its properties and assets and to carry on its business as
presently conducted and is qualified to do business and is in good standing as a foreign
corporation in each jurisdiction where the ownership, leasing or operation of its assets or
properties or conduct of its business requires such qualification, except where the failure to be
so organized, validly existing, qualified or in good standing, or to have such power or authority,
would not, individually or in the aggregate, prevent or materially delay the consummation of the
Offer or the Closing or prevent or materially delay or materially impair the ability of Parent or
Merger Sub to satisfy the Tender Offer Conditions or the conditions precedent to the Merger, to
obtain financing for the Offer or the Merger or to consummate the Merger, the Offer and the other
transactions contemplated by this Agreement (a &#147;<U>Parent Material Adverse Effect</U>&#148;). Parent
has made available to the Company prior to the date of this Agreement true and complete copies of
the certificates of incorporation and by-laws or other equivalent organizational documents of
Parent and Merger Sub, each as amended through the date hereof.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;5.2. <U>Corporate Authority Relative to This Agreement; No Violation</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Each of Parent and Merger Sub has all requisite corporate power and authority to enter
into this Agreement and to consummate the transactions contemplated hereby. The execution and
delivery of this Agreement and the consummation of the transactions contemplated hereby have been
duly and validly authorized by the board of directors of each of Parent and Merger Sub and by
Parent, as the sole stockholder of Merger Sub, and no other corporate proceedings on the part of
Parent or Merger Sub are necessary to authorize the consummation of the transactions contemplated
hereby. This Agreement has been duly and validly executed and delivered by Parent and Merger Sub
and, assuming this Agreement constitutes the valid and binding agreement of the Company, this
Agreement constitutes the valid and binding agreement of Parent and Merger Sub, enforceable against
each of Parent and Merger Sub in accordance with its terms, subject to the Enforceability
Exceptions.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->36<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;The execution, delivery and performance by Parent and Merger Sub of this Agreement and the
consummation of the Offer and the Merger by Parent and Merger Sub do not and will not require any
consent, approval, authorization or permit of, action by, filing with or notification to any
Governmental Entity, other than (i)&nbsp;the filing of the Certificate of Merger with the Secretary of
State of the State of Delaware in accordance with the DGCL, (ii)&nbsp;compliance with the applicable
requirements of the Exchange Act, (iii)&nbsp;compliance with the rules and regulations of NASDAQ, (iv)
compliance with the HSR Act, and (v)&nbsp;compliance with any applicable state securities or blue sky
laws (collectively, clauses (i)&nbsp;through (v), the &#147;<U>Parent Approvals</U>&#148;), and other than any
consent, approval, authorization, permit, action, filing or notification the failure of which to
make or obtain would not, individually or in the aggregate, have a Parent Material Adverse Effect.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;The execution, delivery and performance by Parent and Merger Sub of this Agreement and the
consummation by Parent and Merger Sub of the Merger and the other transactions contemplated hereby
do not and will not (i)&nbsp;contravene or conflict with the organizational or governing documents of
Parent or any of its Subsidiaries, (ii)&nbsp;assuming compliance with the matters referenced in
<U>Section&nbsp;5.2(b)</U> and receipt of the Parent Approvals, contravene or conflict with or
constitute a material violation of any provision of any Law binding upon or applicable to Parent or
any of its Subsidiaries or any of their respective properties or assets, or (iii)&nbsp;result in any
violation of, or default (with or without notice or lapse of time, or both) under, or give rise to
a right of termination, cancellation or acceleration of any material obligation or to the loss of a
material benefit under any loan, guarantee of indebtedness or credit agreement, note, bond,
mortgage, indenture, lease, agreement, contract, instrument, permit, concession, franchise, right
or license binding upon Parent or any of its Subsidiaries or result in the creation of any Lien
(other than Permitted Liens) upon any of the properties or assets of Parent or any of its
Subsidiaries, other than, in the case of clauses (ii)&nbsp;and (iii), any such violation, conflict,
default, termination, cancellation, acceleration, right, loss or Lien that would not have,
individually or in the aggregate, a Parent Material Adverse Effect.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;5.3. <U>Investigations; Litigation</U>. There is no investigation or review pending
(or, to the knowledge of Parent, threatened) by any Governmental Entity with respect to Parent or
any of its Subsidiaries which would have, individually or in the aggregate, a Parent Material
Adverse Effect, and there are no actions, suits, inquiries, investigations or proceedings pending
(or, to Parent&#146;s knowledge, threatened) against or affecting Parent or its Subsidiaries, or any of
their respective properties at law or in equity before any Governmental Entity, in each case which
would have, individually or in the aggregate, a Parent Material Adverse Effect.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;5.4. <U>Proxy Statement; Schedule&nbsp;14D-9; Other Information</U>. None of the
information provided by Parent or its Subsidiaries to be included in the Schedule&nbsp;14D-9 or the
Proxy Statement will, at the time such documents are filed with the SEC, or at the time such
documents are first mailed to the stockholders of the Company (or in the case of the Proxy
Statement, at the time of the Company Meeting, if any), contain any untrue statement of a material
fact or omit to state any material fact required to be stated therein or necessary in order to make
the statements therein, in light of the circumstances under which they were made, not misleading.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->37<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;5.5. <U>Aggregate Cash Consideration</U>. Parent will have available cash resources
and financing in an amount sufficient to enable Merger Sub to purchase the Shares pursuant to the
Offer and to consummate the Merger and perform its other obligations under this Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;5.6. <U>Parent Business</U>. Parent is the direct or indirect owner of all of the
outstanding capital stock of the Subsidiaries (other than Parent) of Odyssey HealthCare, Inc.
(&#147;<U>Odyssey</U>&#148;) that conduct Odyssey&#146;s business of providing Hospice Services or own, lease or
license substantially all of the assets of Odyssey.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;5.7. <U>Capitalization of Merger Sub</U>. The authorized capital stock of Merger Sub
consists of 1,000 shares of common stock, par value $0.01 per share, all of which are validly
issued and outstanding. All of the issued and outstanding capital stock of Merger Sub is, and at
the Effective Time will be, owned by Parent or a direct or indirect subsidiary of Parent. Merger
Sub has outstanding no option, warrant, right, or any other agreement pursuant to which any Person
other than Parent may acquire any equity security of Merger Sub. Merger Sub has not conducted any
business prior to the date hereof and has, and prior to the Effective Time will have, no assets,
liabilities or obligations of any nature other than those incident to its formation, pursuant to
this Agreement and the Merger and the other transactions contemplated by this Agreement, and
related to its guarantee of the Odyssey Credit Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;5.8. <U>No Vote of Parent Stockholders</U>. No vote of the stockholders of Parent or
the holders of any other securities of Parent (equity or otherwise) is required by any applicable
Law, the certificate of incorporation or by-laws or other equivalent organizational documents of
Parent or the applicable rules of any exchange on which securities of Parent are traded, in order
for Parent to consummate the transactions contemplated hereby.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;5.9. <U>Finders or Brokers</U>. Except for Odyssey&#146;s engagement of Goldman, Sachs &#038;
Co. to act as its financial advisor in connection with the transactions contemplated hereby,
neither Parent nor any of its Subsidiaries has employed any investment banker, broker or finder in
connection with the transactions contemplated by this Agreement who might be entitled to any fee or
any commission in connection with or upon consummation of the Offer and/or the Merger.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;5.10. <U>Certain Arrangements</U>. As of the date of this Agreement, there are no
contracts, undertakings, commitments, agreements, obligations or understandings, whether written or
oral, between Parent or Merger Sub or any of their affiliates, on the one hand, and any member of
the Company&#146;s management or the Board of Directors, on the other hand, relating in any way to the
Company, the transactions contemplated by this Agreement or to the operations of the Company after
the Effective Time.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;5.11. <U>No Additional Representations</U>. Except for the representations and
warranties of Parent and Merger Sub set forth in this Agreement, none of Parent, Merger Sub or any
other Person on behalf of Parent or Merger Sub makes any express or implied representation or
warranty with respect to Parent or Merger Sub or with respect to any other information provided to
the Company in connection with the transactions contemplated by this Agreement.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->38<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ARTICLE VI</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>COVENANTS AND AGREEMENTS</B>

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.1. <U>Conduct of Business by the Company and Parent</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;From and after the date hereof and prior to the earlier of the date on which a majority of
the Company&#146;s directors are designees of Parent or Merger Sub or the date, if any, on which this
Agreement is earlier terminated pursuant to <U>Section&nbsp;8.1</U> (the &#147;<U>Termination Date</U>&#148;),
and except (i)&nbsp;as may be required by applicable Law, (ii)&nbsp;as may be agreed in writing by Parent,
with the prior written consent of Parent, or (iii)&nbsp;as expressly contemplated, required or permitted
by this Agreement, the Company shall and shall cause each of its Subsidiaries to (x)&nbsp;conduct its
business in the ordinary course consistent with past practice and (y)&nbsp;use commercially reasonable
efforts to maintain and preserve intact its business organization and advantageous business
relationships and to retain the services of its key officers and key employees.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;From and after the date hereof and prior to the earlier of the date on which a majority of
the Company&#146;s directors are designees of Parent or Merger Sub or the Termination Date, except as
set forth in <U>Section&nbsp;6.1</U> of the Company Disclosure Letter, or as expressly contemplated,
required or expressly permitted by this Agreement, without the prior written consent of Parent, the
Company:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;shall not, and shall not permit any of its Subsidiaries to, (x)&nbsp;make, declare or pay any
dividends on or make other distributions in respect of any of its capital stock, or set aside funds
therefor, (y)&nbsp;split, combine or reclassify any of its capital stock, or issue, authorize or propose
the issuance of any other securities in respect of, in lieu of or in substitution for, shares of
its capital stock, or (z)&nbsp;redeem, repurchase or otherwise acquire or encumber any shares of its
capital stock, or any rights, warrants or options to acquire any such shares, except as required by
the terms of its securities outstanding or any Company Benefit Plan in effect on the date hereof,
or set aside funds therefor;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;shall not, and shall not permit any of its Subsidiaries to, (x)&nbsp;grant any options,
warrants or other rights to purchase shares of capital stock, or (y)&nbsp;amend the terms of or reprice
any Option outstanding on the date of this Agreement or amend the terms of the Company Stock Plans;
<U>provided</U>, <U>however</U>, that, notwithstanding the foregoing, from and after the date of
this Agreement the Company shall be entitled to grant Restricted Shares under the VistaCare, Inc.
1998 Stock Option Plan, solely utilizing the form of Restricted Stock Award Agreement attached to
Section&nbsp;6.1(b)(ii) of the Company Disclosure Letter, to employees (other than any executive
officers or directors of the Company) of the Company or any of its Subsidiaries hired after the
date hereof in the ordinary course of business consistent with past practice, subject to the
following limitations: (x)&nbsp;no such newly hired employee shall be granted more than 400 Restricted
Shares after the date hereof, (y)&nbsp;the aggregate number of Restricted Shares granted to newly hired
employees pursuant to this proviso shall not exceed 3000 Restricted Shares and (z)&nbsp;no such
Restricted Stock Award Agreement shall be amended or modified by the Company without the prior
written consent of Parent;
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->39<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)&nbsp;except for transactions among the Company and its wholly owned Subsidiaries or among the
Company&#146;s wholly owned Subsidiaries, shall not, and shall not permit any of its Subsidiaries to,
issue, sell, pledge, dispose of or encumber, or authorize the issuance, sale, pledge, disposition
or encumbrance of, any shares of its capital stock or other ownership interest in the Company or
any of its Subsidiaries or any securities convertible into or exchangeable for any such shares or
ownership interest, or any rights, warrants or options to acquire or with respect to any such
shares of capital stock, ownership interest or convertible or exchangeable securities or take any
action to cause to be exercisable any otherwise unexercisable Company Stock Option under any
existing Company Stock Plan (except as otherwise provided by the terms of this Agreement or the
express terms of any unexercisable options outstanding on the date hereof), other than (A)
issuances of shares of capital stock in respect of any exercise of Company Stock Options
outstanding on the date hereof or as may be granted after the date hereof as permitted under this
<U>Section&nbsp;6.1(b)</U>, (B)&nbsp;the acquisition of Shares from a holder of a Company Stock Option or
Restricted Shares in satisfaction of withholding obligations or in payment of the exercise price,
and (C)&nbsp;the issuance of Restricted Shares solely in accordance with, and subject to the limitations
set forth in, the proviso to <U>Section&nbsp;6.1(b)(ii)</U>;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv)&nbsp;shall not, and shall not permit any of its Subsidiaries to, amend or waive, or propose to
amend or waive, any provision of its certificate of incorporation or by-laws or similar
organizational documents;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v)&nbsp;shall not, and shall not permit any of its Subsidiaries to, (w)&nbsp;merge or consolidate with,
or acquire any equity interest in (including, without limitation, through the creation of any
Subsidiary of the Company), any Person, or enter into an agreement with respect thereto, (x)
acquire or agree to acquire any material assets, except for capital expenditures otherwise
permitted by <U>Section&nbsp;6.1(b)(xv)</U>, (y)&nbsp;make any loan or advance to, or otherwise make any
investment in, any Person, or (z)&nbsp;enter into any joint venture, partnership or other similar
arrangement;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vi)&nbsp;except for the planned Hospice divestitures disclosed in Section&nbsp;6.1 of the Company
Disclosure Letter which are consummated in accordance with the terms set forth for such
divestitures in <U>Section&nbsp;6.1</U> of the Company Disclosure Letter, shall not, and shall not
permit any of its Subsidiaries to, sell, lease, license, transfer, exchange, swap, mortgage,
encumber or otherwise dispose of, or agree to sell, lease (whether such lease is an operating or
capital lease), license, transfer, exchange, swap, mortgage, encumber or otherwise dispose of, any
of its material assets;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vii)&nbsp;shall not authorize, recommend, propose or announce an intention to adopt a plan of
complete or partial liquidation, dissolution, merger consolidation, restructuring, recapitalization
or other reorganization;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(viii)&nbsp;shall not, and shall not permit any of its Subsidiaries to, except as may be required
by Law or pursuant to any of the Company Benefit Plans existing on the date of this Agreement, (A)
grant any increases in the compensation (including, without limitation, salary, bonus and other
benefits) of any of its directors, officers or key employees; (B)&nbsp;pay or agree to pay any pension,
retirement allowance or other employee benefit to any director, officer or employee, whether past
or present; (C)&nbsp;enter into any new, or materially amend any existing,
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->40<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">employment, change of control, severance or termination agreement or arrangement with any
Person; (D)&nbsp;become obligated under any new Company Benefit Plan, which was not in existence on the
date hereof, or amend any such plan or agreement in existence on the date hereof if such amendment
would have the effect of materially enhancing any benefits thereunder; (E)&nbsp;establish, adopt or
enter into any collective bargaining agreement; (F)&nbsp;grant any general increase in compensation
(including, without limitation, salary, bonus and other benefits) to employees, except for
increases occurring in the ordinary course of business consistent with past practice; or (G)&nbsp;enter
into, make or extend any loans or advances to any of its directors, officers, employees, agents or
consultants, except for ordinary course of business advances for business related expenses;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ix)&nbsp;shall not, and shall not permit any of its Subsidiaries to, (A)&nbsp;assume, incur or become
liable for or prepay any indebtedness for borrowed money (directly, contingently or otherwise), (B)
guarantee any such indebtedness, (C)&nbsp;issue or sell any debt securities or warrants or rights to
acquire any debt securities, (D)&nbsp;guarantee any debt obligations of any other Person, (E)&nbsp;enter into
any lease (whether such lease is an operating or capital lease), (F)&nbsp;create any Lien (other than
Permitted Liens) on the property of the Company, or (G)&nbsp;enter into any &#147;keep well&#148; or other
agreement or arrangement to maintain the financial condition of any other Person;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(x)&nbsp;shall not, and shall not permit any of its Subsidiaries to, (A)&nbsp;except as permitted by
clause (B), modify, rescind, terminate, waive, release or otherwise amend in any material respect
any of the terms or provisions of any Material Contract, (B)&nbsp;fail to renew any Material Contract on
terms that are no less favorable to the Company than under the existing contract, or (C)&nbsp;except for
contracts described under <U>Section&nbsp;4.20(a)(xi)</U> and entered into in the ordinary course of
the Company&#146;s business and in accordance with past practice, enter into any Contract that would
have been required to be disclosed pursuant to <U>Section&nbsp;4.20</U> of the Company Disclosure
Letter if it had been entered into on or prior to the date of this Agreement;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(xi)&nbsp;shall not, and shall not permit any of its Subsidiaries to, except for the transactions
set forth in <U>Section&nbsp;6.1(b)(xi)</U> of the Company Disclosure Letter, all of which have been
previously approved by the Board of Directors, enter into any real property lease, sublease or
other agreement concerning real property or modify, renew or terminate any existing Lease;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(xii)&nbsp;shall not, and shall not permit any of its Subsidiaries to, except for the opening of
any new Hospice Services locations which are currently planned or in process, all of which are
listed in <U>Section&nbsp;6.1(b)(xii)</U> of the Company Disclosure Letter, open any new office
location;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(xiii)&nbsp;shall not, and shall not permit any of its Subsidiaries to, other than as required by
the SEC, Law or GAAP, make any changes with respect to accounting policies, procedures or practices
or any of its methods of reporting revenue, deductions, income or other material items for
financial accounting purposes;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(xiv)&nbsp;shall not, and shall not permit any of its Subsidiaries to, make any material change (or
file any such change) in any method of Tax accounting or make any material
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->41<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">change in any Tax election; settle or compromise any material Tax liability for an amount
materially in excess of the amount reserved therefor on the financial statements included in the
Designated SEC Reports; or enter into any closing agreement relating to Taxes for an amount
materially in excess of the amount reserved therefor on the financial statements included in the
Designated SEC Reports;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(xv)&nbsp;shall not, and shall not permit any of its Subsidiaries to, incur capital expenditures in
excess of (i) $75,000 individually and (ii) $300,000 in the aggregate;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(xvi)&nbsp;shall not, and shall not permit any of its Subsidiaries to, deposit or otherwise invest
any cash on hand into accounts, securities or other instruments having a maturity of more than 30
days or that will impose payment or penalty upon liquidation within 120&nbsp;days of such deposit or
investment;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(xvii)&nbsp;shall not, and shall not permit any of its Subsidiaries to, transfer or license to any
Person or entity or otherwise extend, amend or modify in any material respect any rights to any
material Company Intellectual Property, other than non-exclusive licenses in the ordinary course of
business and consistent with past practice;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(xviii)&nbsp;shall not, and shall not permit any of its Subsidiaries to, fail to use its reasonable
best efforts to maintain in effect existing insurance policies or comparable replacement policies
to the extent available for a reasonable cost;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(xix)&nbsp;shall not, and shall not permit any of its Subsidiaries to, enter into, amend or modify
any agreement or arrangement with affiliates, directors or officers of the Company or any of its
Subsidiaries or any of their family members (including spouses);
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(xx)&nbsp;shall not waive, release, assign, settle, compromise or dispose of any Claim, except for
the waiver, release, assignment, settlement, compromise or disposition of Claims in the ordinary
course of business consistent with past practice and which do not involve (A)&nbsp;any restriction or
limitation on the Company&#146;s or any of its Subsidiaries&#146; ability to conduct their business as it is
currently being conducted or (B)&nbsp;any settlement payment by, or liability of, the Company, its
Subsidiaries or any of their Affiliates in an amount in excess of $50,000 for an individual Claim,
or $400,000 in the aggregate for all Claims;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(xxi)&nbsp;shall not, and shall not permit any of its Subsidiaries to, take any action or fail to
take any action which would, or would be reasonably likely to, individually or in the aggregate,
prevent, materially delay or materially impede the ability of Parent or Merger Sub to consummate
the Offer or of the Company to consummate the Merger or the other transactions contemplated by this
Agreement;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(xxii)&nbsp;shall not, and shall not permit any of its Subsidiaries to, agree to or make any
commitment to, whether orally or in writing, take any actions prohibited by this Agreement; and
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->42<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(xxiii)&nbsp;shall not agree to take, make any commitment to take, or adopt any resolutions of its
Board of Directors in support of, any of the actions prohibited by this <U>Section&nbsp;6.1(b)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Parent agrees with the Company, on behalf of itself and its Subsidiaries and affiliates,
that, between the date hereof and the Effective Time, Parent shall not, and shall not permit any of
its Subsidiaries or affiliates to, take or agree to take any action (including entering into
agreements with respect to any acquisitions, mergers, consolidations or business combinations)
which would reasonably be expected to result in, individually or in the aggregate, a Parent
Material Adverse Effect.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.2. <U>Access</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Subject to compliance with applicable Laws, the Company shall (i)&nbsp;provide to Parent and to
its employees, accountants, consultants, legal counsel, financial advisors and agents, lenders and
other representatives (collectively, &#147;<U>Parent Representatives</U>&#148;) reasonable access during
normal business hours upon prior notice, throughout the period prior to the earlier of the
Effective Time and the Termination Date, to the Company&#146;s and its Subsidiaries&#146; properties,
contracts, commitments, books and records, (ii)&nbsp;furnish to Parent and the Parent Representatives
such financial and operating data and other information as the Parent Representatives may
reasonably request (including, but not limited to, furnishing to Parent the financial results of
the Company in advance of any filing by the Company with the SEC containing such financial results)
and (iii)&nbsp;instruct the employees, counsel, financial advisors, auditors and other authorized
representatives (other than directors who are not employees) of the Company and its Subsidiaries to
cooperate reasonably with Parent and the Parent Representatives in their investigation of the
Company and its Subsidiaries. The foregoing notwithstanding, the Company shall not be required to
afford such access if it would cause a violation of any agreement to which the Company or any of
its Subsidiaries is a party, would cause a loss of attorney/client privilege or trade secret
protection to the Company or any of its Subsidiaries or would constitute a violation of any
applicable Law. Notwithstanding the foregoing, any such investigation or consultation shall be
conducted in such a manner as not to interfere unreasonably with the business or operations of the
Company or its Subsidiaries or otherwise result in any significant interference with the prompt and
timely discharge by such employees of their normal duties. No investigations pursuant to this
<U>Section&nbsp;6.2(a)</U> shall affect any representations or warranties of the parties herein or the
conditions to the obligations of the parties hereto.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Subject to prior consultation with the Company, the Company shall provide Parent and its
representatives reasonable access during normal business hours upon prior notice, throughout the
period prior to the earlier of the Effective Time and the Termination Date, to the employees of the
Company and its Subsidiaries and to information for the purpose of transition planning and to
enable Parent to make presentations to, and discuss with, employees of the Company and its
Subsidiaries, on both a group and individual basis, Parent&#146;s plans and strategies for post-Closing
operations subject to necessary antitrust safeguards. The Company shall have the right to have a
representative present at all meetings between Parent and its representatives and any employees of
the Company and its Subsidiaries. Any such meetings will be conducted in such a manner as not to
interfere unreasonably with the business or operations of
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->43<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">the Company or its Subsidiaries or otherwise interfere, other than in any immaterial respect,
with the prompt and timely discharge by such employees of the Company and its Subsidiaries of their
normal duties.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;During the period prior to the Effective Time, the Company shall promptly furnish to
Parent and Merger Sub (i)&nbsp;a copy of each report, schedule, registration statement and other
document in advance of filing it with the SEC, and shall provide Parent and Merger Sub a reasonable
opportunity to review and comment upon such document, during such period, (ii)&nbsp;a copy of each
document received by it from the SEC, during such period, and (iii)&nbsp;all other information
concerning its business, properties and personnel as Parent and Merger Sub may reasonably request.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;Parent hereby agrees that all information provided to it or its Parent Representatives in
connection with this Agreement and the consummation of the transactions contemplated hereby shall
be deemed to be Evaluation Material, as such term is used in, and shall be treated in accordance
with, the confidentiality agreement, dated as of July&nbsp;25, 2007, as amended, between Odyssey and the
Company, (the &#147;<U>Confidentiality Agreement</U>.&#148;).
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;Notwithstanding any provision of this Agreement, no information or knowledge obtained in
any investigation conducted by Parent or Merger Sub or provided to Parent or Merger Sub shall
affect or be deemed to modify any representation or warranty of the Company contained herein.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.3. <U>Solicitation</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Subject to <U>Section&nbsp;6.3(b)</U>, the Company agrees that, following the date of this
Agreement and prior to the Effective Time or, if earlier, the termination of this Agreement in
accordance with <U>Article&nbsp;VIII</U>, none of the Company, the Company&#146;s Subsidiaries or any of
their respective Representatives shall, directly or indirectly, (i)&nbsp;initiate, solicit, encourage
(including by way of providing information), facilitate or induce the submission of any inquiries,
proposals or offers that constitute or may reasonably be expected to lead to, any Company
Acquisition Proposal, (ii)&nbsp;engage or participate in any discussions or negotiations regarding, or
provide or cause to be provided any non-public information relating to the Company or any of its
Subsidiaries in connection with, or have any discussions with any Person relating to, an actual or
proposed Company Acquisition Proposal, or otherwise encourage or facilitate any effort or attempt
to make or implement a Company Acquisition Proposal, (iii)&nbsp;approve, endorse or recommend, or
propose publicly to approve, endorse or recommend, any Company Acquisition Proposal, (iv)&nbsp;approve,
endorse or recommend, or publicly announce an intention to approve, endorse or recommend, or,
except for the waivers and releases permitted by the following clause (vi), enter into, any letter
of intent, agreement in principle, merger agreement, acquisition agreement, option agreement or
other similar agreement relating to any Company Acquisition Proposal, (v) (A)&nbsp;approve any
transaction or any Third Party becoming an &#147;interested stockholder&#148; under Section&nbsp;203 of the DGCL
or otherwise exempting any Person from any applicable Takeover Statute or (B)&nbsp;amend the Rights
Agreement or grant any waiver or release or approve any transaction or redeem any Rights under the
Rights Agreement, except in connection with the transactions contemplated by this Agreement, or
(vi)&nbsp;amend, terminate, waive, release or fail to enforce, or grant any consent under, any
confidentiality, standstill or
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->44<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">similar agreement (<U>provided</U>, that the Company shall be permitted to grant waivers or
releases under any such agreement solely to permit the counterparty thereto to make a non-public
offer or proposal to the Board of Directors (or any duly constituted committee of the Board of
Directors) with respect to a Company Acquisition Proposal). The Company shall advise Parent
(promptly after the execution and delivery of this Agreement) of the identity of each Person who
makes an actual or proposed Company Acquisition Proposal or requests a waiver or release from any
confidentiality, standstill or similar agreement and the material terms of any such Company
Acquisition Proposal. The Company shall promptly inform its Representatives, and shall cause its
Subsidiaries promptly to inform their respective Representatives, of the obligations under this
<U>Section&nbsp;6.3</U>. The Company shall immediately cease and cause to be terminated any
solicitation, encouragement, discussion or negotiation with any Persons conducted heretofore by the
Company, its Subsidiaries or any of their respective Representatives with respect to any Company
Acquisition Proposal and shall use its (and will cause the Representatives of the Company and its
Subsidiaries to use their) commercially reasonable efforts to require the other parties thereto to
promptly return or destroy in accordance with the terms of such agreement any confidential
information previously furnished by the Company, the Company&#146;s Subsidiaries or any of their
respective Representatives thereunder. The Company shall ensure that its Representatives are aware
of the provisions of this <U>Section&nbsp;6.3(a)</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Notwithstanding anything to the contrary contained in <U>Section&nbsp;6.3(a)</U>, if at any
time following the date of this Agreement and prior to the Acceptance Date, (i)&nbsp;the Company
receives an unsolicited written Company Acquisition Proposal from a Third Party that did not result
from or arise in connection with a breach of <U>Section&nbsp;6.3(a)</U> and that the Board of Directors
(or any duly constituted committee of the Board of Directors) believes in good faith to be bona
fide and (ii)&nbsp;the Board of Directors (or any duly constituted committee of the Board of Directors)
determines in good faith, after consultation with its independent financial advisors and based on
the advice of outside legal counsel, that such Company Acquisition Proposal constitutes or could
reasonably be expected to result in a Superior Proposal from that Third Party, then the Company
may, prior to the Acceptance Date and subject to compliance with the provisions of this <U>Section
6.3</U>, (A)&nbsp;furnish information with respect to the Company and its Subsidiaries to the Person
making such Company Acquisition Proposal and (B)&nbsp;participate in discussions or negotiations with
the Person making such Company Acquisition Proposal regarding such Company Acquisition Proposal
(&#147;<U>Permitted Actions</U>&#148;) if the Board of Directors (or any duly constituted committee of the
Board of Directors) concludes in good faith, after consultation with its outside financial advisors
and based on the advice of outside legal counsel, that, as a result of such Company Acquisition
Proposal, the failure to take such Permitted Action would be inconsistent with its fiduciary duties
under applicable Law; <U>provided</U>, that the Company will not, and will not allow
Representatives to, disclose any non-public information to such Person without entering into an
Acceptable Confidentiality Agreement with such Person prior to such disclosure and promptly
providing Parent with a copy of such fully executed Acceptable Confidentiality Agreement; and
<U>provided</U> <U>further</U> that the Company shall have delivered written notice to Parent
prior to or concurrently with taking any action permitted pursuant to this <U>Section&nbsp;6.3(b)</U>.
The Company shall promptly (and in no event later than 24 hours following receipt) notify Parent
and Merger Sub orally and in writing (which notice shall include the material terms and conditions
of the Company Acquisition Proposal and the identity of the Person submitting the same) in the
event it receives a Company Acquisition Proposal from a Person or group of related Persons and
shall keep Parent and Merger Sub reasonably informed orally and in writing as to the status and
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->45<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">any material developments concerning the same, including prompt written notice to Parent of
any determination by the Board of Directors (or any duly constituted committee of the Board of
Directors) that a Superior Proposal has been made. Without limiting the generality of the
foregoing, (1)&nbsp;the Company shall promptly notify Parent and Merger Sub orally and in writing if it
determines in accordance with this <U>Section&nbsp;6.3(b)</U> to begin providing information or to
engage in discussions or negotiations concerning a Company Acquisition Proposal received from a
Person or group of related Persons, (2)&nbsp;prior to providing any non-public information to such
Person or entering into discussions or negotiations with such Person, the Company shall promptly
notify Parent orally and in writing of any such Company Acquisition Proposal received by, and such
information requested from, and any such discussions or negotiations sought to be initiated or
continued with, the Company, any Subsidiary of the Company or any of their respective
Representatives indicating, in connection with such notice, the material terms and conditions of
the Company Acquisition Proposal and the identity of the Person making such Company Acquisition
Proposal, and (3)&nbsp;the Company shall promptly provide Parent with copies of any material non-public
information concerning the Company or any of its Subsidiaries that is provided to the Person making
the Company Acquisition Proposal or its Representatives that was not previously provided or made
available to Parent and copies of all documents and written communications relating to such Company
Acquisition Proposal exchanged between the Company, any of its Subsidiaries or any of its or their
Representatives, on the one hand, and the Third Party making such Company Acquisition Proposal, on
the other.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Except as permitted by <U>Section&nbsp;6.3(d)</U>, neither the Board of Directors nor any
committee thereof shall directly or indirectly (i)&nbsp;amend, withdraw, modify, change, condition or
qualify in any manner adverse to Parent or Merger Sub, or publicly propose to withdraw or modify in
any manner adverse to Parent or Merger Sub, the Recommendation, (ii)&nbsp;approve or recommend or
publicly propose to approve or recommend, any Company Acquisition Proposal, or (iii)&nbsp;take any other
action or make any other public statement inconsistent with the Recommendation. None of the Board
of Directors, any committee thereof or the Company itself, shall agree with any Person to limit or
not to give prior notice to Parent and Merger Sub of its intention to effect a Recommendation
Withdrawal or to terminate this Agreement in light of a Superior Proposal.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;Notwithstanding <U>Sections&nbsp;6.3(a)(iii)</U> and <U>6.3(a)(iv)</U> and <U>Section
6.3(c)</U>, if, at any time prior to the Acceptance Date, the Company receives a Superior Proposal
that did not result from a breach of this <U>Section&nbsp;6.3</U>, the Board of Directors (or any duly
constituted committee of the Board of Directors) may withdraw, modify, change, condition or qualify
the Recommendation in a manner adverse to Parent and Merger Sub (&#147;<U>Recommendation
Withdrawal</U>&#148;); <U>provided</U>, <U>however</U>, that the Board of Directors (or any duly
constituted committee of the Board of Directors) may not effect a Recommendation Withdrawal
pursuant to this <U>Section&nbsp;6.3(d)</U> (i)&nbsp;unless the Company has complied with this <U>Section
6.3</U>, (ii)&nbsp;until after the third Business Day following actual receipt by Parent by the Company
of a Notice of Superior Proposal, (iii)&nbsp;unless either (A)&nbsp;on or before the expiration of the three
(3)&nbsp;Business Day period following the actual receipt by Parent of the Notice of Superior Proposal
referred to in the foregoing clause (ii), Parent does not make a Matching Bid in response to such
Superior Proposal or (B)&nbsp;following receipt of a Matching Bid within the three (3)&nbsp;Business Day
period, the Board of Directors (or any duly constituted committee of the Board of Directors)
concludes in good faith, after consultation with its financial advisors and based on the advice of
outside legal
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->46<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">counsel and after taking into consideration the Matching Bid, that the Superior Proposal to
which the Notice of Superior Proposal relates continues to be a Superior Proposal and (iv)&nbsp;unless
the Board of Directors (or any duly constituted committee of the Board of Directors) determines in
good faith, after consultation with its financial advisors and based on the advice of outside legal
counsel, that the failure to effect a Recommendation Withdrawal in response to such Superior
Proposal would be inconsistent with its fiduciary duties under applicable Law. Unless the Board of
Directors has previously effected a Recommendation Withdrawal, or is concurrently therewith
withdrawing, the Recommendation in accordance with this <U>Section&nbsp;6.3</U> and otherwise complies
with <U>Section&nbsp;6.3(e)</U>, neither the Board of Directors nor any committee thereof shall
recommend any Company Acquisition Proposal to the stockholders of the Company or, except as
otherwise permitted by this <U>Section&nbsp;6.3</U>, enter into any letter of intent, agreement in
principle, merger, acquisition or similar agreement with respect to any Company Acquisition
Proposal.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;Notwithstanding anything in this <U>Section&nbsp;6.3</U> to the contrary, at any time prior to
the Acceptance Date, the Board of Directors (or any duly constituted committee of the Board of
Directors) may, in response to a Superior Proposal that did not result from a breach of this
<U>Section&nbsp;6.3</U>, cause the Company to terminate this Agreement pursuant to <U>Section
8.1(g)</U> and concurrently with such termination enter into a definitive agreement providing for
the transactions contemplated by such Superior Proposal; <U>provided</U>, <U>however</U>, that
the Company shall not terminate this Agreement pursuant to <U>Section&nbsp;8.1(g)</U>, and any
purported termination pursuant to <U>Section&nbsp;8.1(g)</U> shall be void and of no force or effect,
unless the Company shall have complied with all the provisions of this <U>Section&nbsp;6.3</U>,
including the notification provisions in this <U>Section&nbsp;6.3(e)</U>, and with all applicable
requirements of <U>Section&nbsp;8.3(a)(ii)</U> (including the payment of the Termination Fee prior to
or concurrently with such termination) in connection with such Superior Proposal; and
<U>provided</U> <U>further</U>, <U>however</U>, that the Company shall not exercise its right to
terminate this Agreement pursuant to <U>Section&nbsp;8.1(g)</U>: (A)&nbsp;until after the third Business Day
following actual receipt by Parent of written notice from the Company advising Parent that the
Company has received a Superior Proposal, specifying the material terms and conditions of the
Superior Proposal and attaching the most current versions of the definitive agreement, all exhibits
and other attachments thereto and agreements (such as stockholder agreements) ancillary thereto to
effect such Superior Proposal, and identifying the Person making such Superior Proposal (a
&#147;<U>Notice of Superior Proposal</U>&#148;) and stating that the Board of Directors intends to cause the
Company to exercise its right to terminate this Agreement pursuant to <U>Section&nbsp;8.1(g)</U> (it
being understood and agreed that, prior to any termination pursuant to <U>Section&nbsp;8.1(g)</U>
taking effect, any amendment to the price or any other material term of a Superior Proposal (such
amended Superior Proposal, a &#147;<U>Modified Superior Proposal</U>&#148;) shall require a new Notice of
Superior Proposal and a new three (3)&nbsp;Business Day period with respect to such Modified Superior
Proposal) and (B)&nbsp;unless either (x)&nbsp;on or before the expiration of the three (3)&nbsp;Business Day
period following the actual receipt by Parent of any Notice of Superior Proposal, Parent does not
make a good faith written proposal (a &#147;<U>Matching Bid</U>&#148;) in response to such Superior Proposal
or (y)&nbsp;following receipt of a Matching Bid within the three (3)&nbsp;Business Day period, the Board of
Directors (or any duly constituted committee of the Board of Directors) concludes in good faith,
after consultation with its financial advisors and based on the advice of outside legal counsel and
after taking into consideration the Matching Bid, that the Superior Proposal to which the Notice of
Superior Proposal relates continues to be a Superior Proposal.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->47<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;Nothing contained in this <U>Section&nbsp;6.3</U> or elsewhere in this Agreement shall
prohibit the Company from taking and disclosing to its stockholders a position contemplated by Rule
14d-9 and 14e-2(a) promulgated under the Exchange Act if, in the good faith judgment of the Board
of Directors (or any duly constituted committee of the Board of Directors), after receipt of advice
from its outside legal counsel, failure so to disclose would be inconsistent with its disclosure
obligations under applicable Law.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;As used in this Agreement, the term:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;&#147;<U>Acceptable Confidentiality Agreement</U>&#148; means a confidentiality and standstill
agreement that contains provisions that, in the aggregate, are no less restrictive of and no more
favorable to the Person (other than the Company) subject to such agreement than those contained in
the Confidentiality Agreement (and which contains additional provisions that expressly and solely
permit the Company to comply with its obligations under this <U>Section&nbsp;6.3</U> <U>provided</U>
that the duration of the standstill agreement shall not be less than the duration of the standstill
agreement contained in the Confidentiality Agreement). Notwithstanding the foregoing, a party who
has previously entered into a confidentiality agreement with the Company relating to a purchase of,
or business combination with, the Company shall not be required to enter into a new or revised
confidentiality agreement if such existing confidentiality agreement contains provisions that
satisfy the requirements for an Acceptable Confidentiality Agreement contained in the immediately
preceding sentence;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;&#147;<U>Company Acquisition Proposal</U>&#148; means any inquiry, proposal or offer from any
Person or group of Persons other than Parent, Merger Sub or their respective Affiliates regarding
any of the following: (a)&nbsp;the acquisition by a Third Party of beneficial ownership (as defined in
Rule&nbsp;13d-3 under the Exchange Act) of more than fifteen percent (15%) of the total outstanding
voting securities of the Company, whether from the Company or pursuant to a tender offer or
exchange offer or otherwise, in any one transaction or series of related transactions, (b)&nbsp;a
merger, consolidation, business combination, reorganization, share exchange, recapitalization or
similar transaction or series of related transactions involving the Company or any of its
Subsidiaries, (c)&nbsp;a liquidation or dissolution of the Company or any Subsidiary of the Company, or
(d)&nbsp;any sale, lease, exchange or other disposition of assets (including the sale, lease, exchange
or other disposition of the equity interests of one or more of the Company&#146;s Subsidiaries) that
would result in a Third Party acquiring more than fifteen percent (15%) of the fair market value on
a consolidated basis of the total consolidated assets of the Company and its Subsidiaries, taken as
a whole, or to which more than fifteen percent (15%) of the consolidated revenues and earnings of
the Company and its Subsidiaries, taken as a whole, are attributable, in any one transaction or in
a series of transactions;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)&nbsp;&#147;<U>Superior Proposal</U>&#148; means a Company Acquisition Proposal, (except that solely
for purposes of the definition of &#147;Superior Proposal&#148; all references in the definition of &#147;Company
Acquisition Proposal&#148; to &#147;fifteen percent (15%)&#148; shall be deemed to be references to &#147;fifty percent
(50%)&#148; and all references to &#147;the Company or any of its Subsidiaries&#148; in clauses (b)&nbsp;and (c)&nbsp;of the
definition of &#147;Company Acquisition Proposal&#148; shall be deemed references to &#147;the Company and its
Subsidiaries, taken as a whole&#148;) that (a)&nbsp;the Board of Directors of the Company (or any duly
constituted committee of the Board of Directors) concludes in good faith, after consultation with
its financial advisors and based on the advice of
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->48<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">outside legal counsel, is on terms that are more favorable, from a financial point of view, to
the stockholders of the Company than the terms of the Offer, the Merger and the other transactions
contemplated hereby (including any written proposal by Parent and Merger Sub received by the
Company to amend the terms of this Agreement); and (b)&nbsp;is reasonably capable of being consummated,
taking into account the availability and terms of any required financing for, and conditions to,
the proposal.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.4. <U>Filings; Other Actions</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;If the Company Stockholder Approval is required under the DGCL, as promptly as reasonably
practicable following the consummation or expiration of the Offer, the Company shall prepare and
file with the SEC the Proxy Statement, which shall, subject to <U>Section&nbsp;6.3</U>, include the
Recommendation and shall use its reasonable best efforts to respond to any comments by the SEC
staff in respect of the Proxy Statement. Subject to applicable Laws, the Company and Parent (with
respect to itself and Merger Sub) each shall, upon request by the other, furnish the other with all
information concerning itself, its Subsidiaries, directors, officers and stockholders and such
other matters as may be reasonably necessary or advisable in connection with the Proxy Statement or
any other statement, filing, notice or application made by or on behalf of Parent, the Company or
any of their respective Subsidiaries to any Third Party in connection with the Offer, the Merger
and the transactions contemplated by this Agreement. The Company shall use its reasonable best
efforts to cause the Proxy Statement to be mailed to the Company&#146;s stockholders as promptly as
practicable after the Proxy Statement is cleared by the SEC. The Company shall promptly notify
Parent of the receipt of any oral or written comments from the SEC relating to the Proxy Statement.
The Company shall cooperate and provide Parent with a reasonable opportunity to review and comment
on the draft of the Proxy Statement (including each amendment or supplement thereto). The Company
shall provide Parent with copies of all filings made and correspondence with the SEC with respect
to the Proxy Statement. If at any time prior to the Effective Time, any information should be
discovered by any party hereto which should be set forth in an amendment or supplement to the Proxy
Statement so that the Proxy Statement would not include any misstatement of a material fact or omit
to state any material fact required to be stated therein or necessary to make the statements
therein, in the light of the circumstances under which they were made, not misleading, the party
which discovers such information shall promptly notify the other parties hereto and, to the extent
required by applicable Law, an appropriate amendment or supplement describing such information
shall be filed promptly by the Company with the SEC and disseminated by the Company to the
stockholders of the Company as soon as practicable.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Subject to the other provisions of this Agreement, the Company shall (i)&nbsp;take all action
necessary in accordance with the DGCL and its certificate of incorporation and by-laws to promptly
and duly call, give notice of, convene and hold a meeting of its stockholders as promptly as
reasonably practicable following the mailing of the Proxy Statement for the purpose of obtaining
the Company Stockholder Approval (such meeting or any adjournment or postponement thereof, the
&#147;<U>Company Meeting</U>&#148;), (ii)&nbsp;cause the Proxy Statement to include the Recommendation and a copy
of the opinion referred to in <U>Section&nbsp;4.18</U>, and (iii)&nbsp;subject to <U>Section&nbsp;6.3</U>, use
its reasonable best efforts to solicit from its stockholders proxies in favor of the approval and
adoption of this Agreement, the Merger and the other transactions contemplated hereby.
Notwithstanding anything in this Agreement to the contrary, unless this Agreement is
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->49<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">terminated in accordance with <U>Section&nbsp;8.1</U> and subject to compliance with <U>Section
8.3</U>, the Company, regardless of whether the Board of Directors (whether or not acting through
the Special Committee, if such committee still exists or otherwise by resolution of a majority of
its disinterested directors) has approved, endorsed or recommended a Company Acquisition Proposal,
or has withdrawn, modified, changed, conditioned or qualified the Recommendation, will submit this
Agreement to the stockholders of the Company at the Company Meeting for the purpose of adopting
this Agreement. Notwithstanding the foregoing, if a Short Form&nbsp;Merger may be effected in
accordance with <U>Section&nbsp;2.8</U> and Section&nbsp;253 of the DGCL, the parties hereto agree to take
all necessary and appropriate action to cause the Merger to become effective on the dates specified
in <U>Section&nbsp;2.2</U> without a Company Meeting, in accordance with Section&nbsp;253 of the DGCL.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.5. <U>Employee Matters</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Prior to the Closing Date, the Company shall (i)&nbsp;cause the sponsor of any Company Benefit
Plan intended to be qualified pursuant to Section 401(a) of the Code to take all legal steps to
effectuate its termination through proper resolutions, a consent, or as otherwise applicable; (ii)
cause the sponsor of any Company Benefit Plan that provides for the deferral of compensation
(within the meaning of Section&nbsp;409A of the Code and applicable guidance issued thereunder) pursuant
to an &#147;account balance plan&#148; (as defined in Treasury Regulation&nbsp;1.409A-1(c)(2)(i)(A)) or a
&#147;nonaccount balance plan&#148; (as defined in Treasury Regulation&nbsp;1.409A-1(c)(2)(i)(C)) and any trust
agreement entered into to secure benefits under any such arrangement (the &#147;<U>Parent Deferred
Compensation Plans</U>&#148;), to take all legal steps to effectuate the termination of the Parent
Deferred Compensation Plans through proper resolutions, a consent, or as otherwise applicable, and
to take all necessary steps to cause a distribution of amounts due and owing to participants under
the Parent Deferred Compensation Plans; and (iii)&nbsp;terminate any Company payroll deductions with
respect to an arrangement described in Department of Labor Regulation&nbsp;Section&nbsp;2510.3-(1)(j) through
proper resolutions, a consent, or as otherwise applicable.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;Upon and after the Closing Date, Parent shall continue to sponsor the Company Benefit
Plans set forth on <U>Section&nbsp;6.5(b)</U> of the Company Disclosure Letter (the &#147;<U>Continued
Plans</U>&#148;) for the benefit of each current and former employee of the Company and its
Subsidiaries, other than such employees covered by collective bargaining agreements (the
&#147;<U>Company Employees</U>&#148;), in accordance with the terms of such Continued Plans. The Company
Employees shall be entitled to participate in the Continued Plans from and after the Closing Date
until such time that Parent suspends participation in or terminates such Continued Plans (the
&#147;<U>Transition Period</U>&#148;). Notwithstanding the foregoing, upon and after the Closing Date until
May&nbsp;1, 2008, Parent shall continue to sponsor, for the benefit of the Company Employees, those
Continued Plans that solely provide for medical and dental benefits. Upon the expiration of the
Transition Period, the Company Employees shall then be entitled to participate in the benefit plans
and arrangements sponsored or maintained by Parent to the extent such plans or arrangements are
made available to similarly situated employees of Parent (the &#147;<U>New Plans</U>&#148;), subject to the
terms and conditions of the New Plans. For purposes of eligibility to participate in the New
Plans, each Company Employee shall be credited with his or her years of service with the Company
and its Subsidiaries before the Effective Time. Parent shall cause all pre-existing condition
exclusions of any New Plan to be waived for each Company Employee and his or her
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->50<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">covered dependents unless such Company Employee, or dependent, as applicable, would not be
entitled to coverage for the condition if the covered employee were employed by the Parent during
the period for which credited service is applied.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;For all purposes (including purposes of vesting, eligibility to participate and level of
benefits) under the employee benefit plan of Parent and its Subsidiaries maintained pursuant to
Section 401(k) of the Code, each Company Employee shall be credited with his or her years of
service with the Company and its Subsidiaries and their respective predecessors before the
Effective Time, to the same extent as such Company Employee was entitled, before the Effective
Time, to credit for such service under the Company&#146;s plan maintained pursuant to Section 401(k) of
the Code in which such Company Employee participated or was eligible to participate immediately
prior to the Effective Time.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;Nothing herein shall be deemed to be a guarantee of employment for any Employee, or to
restrict the right of the Surviving Corporation, or any affiliate thereof, to terminate any
Employee. Notwithstanding the foregoing provisions of this <U>Section&nbsp;6.5</U>, nothing contained
herein, whether express or implied, (i)&nbsp;shall be treated as an amendment or other modification of
any Company Benefit Plan, or (ii)&nbsp;shall limit the right of the Surviving Corporation or any of its
affiliates to amend, terminate or otherwise modify any Company Benefit Plan following the Closing
Date. Parent, Merger Sub and the Company acknowledge and agree that all provisions contained in
this <U>Section&nbsp;6.5</U> with respect to Employees are included for the sole benefit of Parent,
Merger Sub and the Company, and that nothing herein, whether express or implied, shall create any
third party beneficiary or other rights (i)&nbsp;in any other Person, including, without limitation, any
Employees, former Employees, any participant in any Company Benefit Plan, or any dependent or
beneficiary thereof, or (ii)&nbsp;to continued employment with Parent, the Surviving Corporation, or any
of their respective affiliates or continued participation in any Company Benefit Plan.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.6. <U>Efforts</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Subject to the terms and conditions set forth in this Agreement, each of the parties
hereto will use its reasonable best efforts promptly to take, or cause to be taken, all actions, to
file, or cause to be filed, all documents and do, or cause to be done, and to assist and cooperate
with the other parties in doing, all things necessary, proper or advisable under applicable Laws to
consummate the Offer and to consummate and make effective the Merger and the other transactions
contemplated by this Agreement, including (i)&nbsp;the obtaining of all necessary actions or nonactions,
waivers, consents, clearances, approvals, and expirations or terminations of waiting periods,
including the Specified Approvals and the Parent Approvals, from Governmental Entities and the
making of all necessary registrations and filings and the taking of all steps as may be necessary
to obtain an approval, clearance or waiver from, or to avoid an action or proceeding by, any
Governmental Entity, (ii)&nbsp;the obtaining of all necessary consents, approvals or waivers from Third
Parties, (iii)&nbsp;the defending of any lawsuits or other legal proceedings, whether judicial or
administrative, challenging this Agreement or the consummation of the Offer, the Merger or any
other transaction contemplated by this Agreement and (iv)&nbsp;the execution and delivery of any
additional instruments reasonably necessary to consummate the transactions contemplated by this
Agreement; <U>provided</U>, <U>however</U>, that in no event shall the Company or any of its
Subsidiaries be required to pay prior to the Effective Time
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->51<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">any fee, penalty or other consideration to any Third Party, other than a Governmental Entity,
for any consent or approval required for the consummation of the transactions contemplated by this
Agreement under any contract or agreement (other than de minimis amounts or if Parent and Merger
Sub have provided adequate assurance of repayment). No party shall take any action that is
intended or would reasonably be expected to, individually or in the aggregate, result in any of the
Tender Offer Conditions or the conditions to the Merger set forth in <U>Article&nbsp;VII</U> not being
satisfied or the satisfaction of those conditions being materially delayed.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;On or before January&nbsp;18, 2008, each party hereto shall file, or cause to be filed by their
respective &#147;ultimate parent entities&#148;, with the Federal Trade Commission and the Antitrust Division
of the Department of Justice, any Notification and Report Forms and related material required to be
filed by it under the HSR Act and the rules and regulations promulgated thereunder with respect to
the transactions contemplated by this Agreement and thereafter shall promptly make any further
filings pursuant thereto that may be necessary, proper or advisable and to respond on a timely
basis to any requests for additional information made by either of such agencies. Parent shall pay
the filing fees in connection with any such required filings. Upon and subject to the terms of
this <U>Section&nbsp;6.6</U>, Parent and the Company shall, and shall cause their respective
Subsidiaries to use their respective reasonable efforts to obtain prompt termination of any waiting
period under the HSR Act and prompt termination of any other requisite waiting period under any
applicable Law.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;From the date of this Agreement through the date of termination of the required waiting
period under the HSR Act, the Company, Parent and Merger Sub and their respective Subsidiaries
shall not take any action that would reasonably be expected to hinder or delay the obtaining of
clearance or the expiration of the applicable waiting period under the HSR Act or any other
applicable antitrust Law.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;Subject to the terms and conditions herein provided and without limiting the foregoing,
until the Agreement is terminated in accordance with its terms the Company and Parent shall (i)
cooperate with each other in (x)&nbsp;determining whether any filings are required to be made with, or
consents, permits, authorizations, waivers, clearances, approvals, and expirations or terminations
of waiting periods are required to be obtained from, any Third Parties in connection with the
execution and delivery of this Agreement and the consummation and effectiveness of, the Offer, the
Merger and the other transactions contemplated hereby and (y)&nbsp;timely making all such filings and
timely seeking all such consents, permits, authorizations or approvals, (ii)&nbsp;supply to any
Governmental Entity as promptly as practicable any additional information or documents that may be
requested pursuant to any Law or by such Governmental Entity and (iii)&nbsp;take, or cause to be taken,
all other actions and do, or cause to be done, all other things necessary, proper or advisable to
consummate the Offer and to consummate and make effective the Merger and the other transactions
contemplated hereby, including taking all such further action as may be necessary to resolve such
objections, if any, as state antitrust enforcement authorities or competition authorities of any
other nation or other jurisdiction or any other Person may assert under any Law with respect to the
Offer, the Merger and the other transactions contemplated hereby, and to avoid or eliminate each
and every impediment under any Law that may be asserted by any Governmental Entity with respect to
the Offer, the Merger and the other transactions contemplated hereby so as to enable the Expiration
Date and the Closing to occur as soon as reasonably possible (and in any event no later than the
End Date).
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->52<!-- /Folio -->
</DIV>



<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;Notwithstanding any terms contained in this Agreement to the contrary, Merger Sub, Parent
and its other Subsidiaries shall have no obligation to agree to (x)&nbsp;the sale, divestiture or
disposition of any material assets or businesses of Parent or its Subsidiaries or controlled
affiliates or of the Company or its Subsidiaries or (y)&nbsp;otherwise take or commit to take any
actions that after the Closing Date would limit the freedom of Parent or its Subsidiaries&#146;
(including the Surviving Corporation&#146;s) or controlled affiliates&#146; freedom of action with respect
to, or its ability to retain, one or more of its or its Subsidiaries (including the Surviving
Corporation&#146;s) businesses, product lines, services or assets; nor shall the Company or any of its
Subsidiaries be required to consent or agree to or otherwise take any action with respect to, any
requirement, condition, understanding, agreement or order of a Governmental Entity to sell, to hold
separate or otherwise dispose of, or to conduct, restrict, operate, invest or otherwise change the
assets or business of the Company or any of its affiliates, unless (but only if Parent grants its
written consent in Parent&#146;s sole and absolute discretion) such requirement, condition,
understanding, agreement or order is binding on the Company only in the event that the Closing
occurs.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;Subject to applicable legal limitations and the instructions of any Governmental Entity,
the Company and Parent shall keep each other apprised of the status of matters relating to the
completion of the transactions contemplated hereby, including to the extent permitted by Law and
with the exception of the HSR filings and competitively sensitive documents promptly furnishing the
other with copies of notices or other communications sent or received by the Company or Parent, as
the case may be, or any of their respective Subsidiaries, to or from any Third Party with respect
to such transactions. Subject to applicable Law and to the extent not prohibited by such
Governmental Entity, the Company and Parent shall permit the other party to review in advance any
proposed communication to any supervisory or Governmental Entity with the exception of HSR filings
and competitively sensitive documents. To the extent practicable, each of the Company and Parent
agrees not to participate in any substantive meeting or discussion, either in Person or by
telephone, with any Governmental Entity in connection with such transactions unless it consults
with the other party in advance and, to the extent not prohibited by such Governmental Entity,
gives the other party the opportunity to attend and participate.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;In furtherance and not in limitation of the covenants of the parties contained in this
<U>Section&nbsp;6.6</U>, if any administrative or judicial action or proceeding, including any
proceeding by a private party, is instituted (or threatened to be instituted) challenging any
transaction contemplated by this Agreement, each of the Company and Parent shall cooperate in all
respects with each other and shall use their respective reasonable best efforts to contest and
resist any such action or proceeding and to have vacated, lifted, reversed or overturned any
decree, judgment, injunction or other order, whether temporary, preliminary or permanent, that is
in effect and that prohibits, prevents or restricts consummation of the Offer, the Merger and the
other transactions contemplated by this Agreement. Notwithstanding the foregoing or any other
provision of this Agreement, nothing in this <U>Section&nbsp;6.6</U> shall limit a party&#146;s right to
terminate this Agreement pursuant to <U>Article&nbsp;VIII</U> so long as such party has, prior to such
termination, complied with its obligations under this <U>Section&nbsp;6.6</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.7. <U>Takeover Statute</U>. If any &#147;fair price,&#148; &#147;moratorium,&#148; &#147;control share
acquisition&#148; or other form of antitakeover statute or regulation shall become applicable to the
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->53<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Offer, the Merger or the other transactions contemplated hereby, each of the Company and
Parent and the members of their respective boards of directors shall grant such approvals and take
such actions as are reasonably necessary so that the transactions contemplated hereby may be
consummated as promptly as practicable on the terms contemplated hereby and otherwise act to
eliminate or minimize the effects of such statute or regulation on the Offer, the Merger and the
other transactions contemplated hereby.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.8. <U>Public Announcements</U>. The parties will consult with each other and will
mutually agree upon any press release or public announcement pertaining to the Offer or the Merger
and shall not issue any such press release or make any such public announcement prior to such
consultation and agreement, except as may be required by applicable Law (or stock exchange rules),
in which case the party proposing to issue such press release or make such public announcement
shall use reasonable efforts to consult in good faith with the other party before issuing any such
press release or making any such public announcement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.9. <U>Indemnification and Insurance</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Parent and Merger Sub agree that all rights to exculpation, indemnification and
advancement of expenses existing as of the date of this Agreement in favor of the current or former
directors, officers or employees, as the case may be, of the Company or its Subsidiaries as
provided in their respective certificates of incorporation or by-laws or other organization
documents or in any agreement in effect on the date hereof with the Company shall survive the
Merger and shall continue in full force and effect in accordance with their respective terms as of
the date hereof. For a period of six (6)&nbsp;years from the Closing Date, the Company (and following
the Effective Time, the Surviving Corporation) shall maintain in effect the exculpation,
indemnification and advancement of expenses provisions of the Company&#146;s and any Company
Subsidiary&#146;s certificates of incorporation and by-laws or similar organization documents as in
effect on the date of this Agreement, or in any indemnification agreements of the Company or its
Subsidiaries with any of their respective directors, officers or employees listed in <U>Section
6.9</U> of the Company Disclosure Letter, and shall not amend, repeal or otherwise modify any such
provisions in any manner that would materially and adversely affect the rights thereunder of any
individuals who at the Closing Date were current or former directors, officers or employees of the
Company or any of its Subsidiaries; <U>provided</U>, <U>however</U>, that all rights to
indemnification in respect of any Action pending or asserted or any claim made within such period
shall continue until the disposition of such Action or resolution of such claim. From and after
the Closing Date, Parent shall cause the Company (and following the Effective Time, the Surviving
Corporation) and its Subsidiaries to honor, in accordance with their respective terms, each of the
covenants contained in this <U>Section&nbsp;6.9</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;The Company (and following the Effective Time, the Surviving Corporation) shall, to the
fullest extent permitted under applicable Law, indemnify and hold harmless (and advance funds in
respect of each of the foregoing) each current and former director or officer of the Company or any
of its Subsidiaries (each, together with such Person&#146;s heirs, executors or administrators, an
&#147;<U>Indemnified Party</U>&#148;) against any costs or expenses (including advancing reasonable
attorneys&#146; fees and expenses in advance of the final disposition of any claim, suit, proceeding or
investigation to each Indemnified Party to the fullest extent permitted by Law), judgments, fines,
losses, claims, damages, liabilities and amounts paid in
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->54<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">settlement in connection with any actual or threatened claim, action, suit, proceeding or
investigation, whether civil, criminal, administrative or investigative (an &#147;<U>Action</U>&#148;),
arising out of, relating to or in connection with any action or omission occurring or alleged to
have occurred before the Closing Date (including acts or omissions in connection with such persons
serving as an officer, director or other fiduciary in any entity if such service was at the request
or for the benefit of the Company); <U>provided</U>, <U>however</U>, that the Company (and
following the Effective Time, the Surviving Corporation) shall not be liable for any settlement
effected without either Parent&#146;s or the Company&#146;s (and following the Effective Time, the Surviving
Corporation&#146;s) prior written consent (which shall not be unreasonably withheld or delayed) and the
Company (and following the Effective Time, the Surviving Corporation) shall not be obligated to pay
the fees and expenses of more than one counsel (selected by a plurality of the applicable
Indemnified Parties) for all Indemnified Parties in any jurisdiction with respect to any single
such Action, unless the use of one counsel for such Indemnified Parties would present such counsel
with a conflict of interest that would make such joint representation inappropriate. It shall be a
condition to the advancement of any amounts to be paid in respect of legal and other fees and
expenses that the Company (and following the Effective Time, the Surviving Corporation) receive an
undertaking by the Indemnified Party to repay such legal and other fees and expenses paid in
advance if it is ultimately determined that such Indemnified Party is not entitled to be
indemnified under applicable Law. In the event of any such Action, the Company (and following the
Effective Time, the Surviving Corporation) shall reasonably cooperate with the Indemnified Party in
the defense of any such Action.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;For a period of six (6)&nbsp;years from the Closing Date, the Company (and following the
Effective Time, the Surviving Corporation) shall either cause to be maintained in effect the
current policies of directors&#146; and officers&#146; liability insurance maintained by the Company and its
Subsidiaries or provide substitute policies or purchase a &#147;tail policy,&#148; in either case of
substantially the same coverage and amounts and containing terms and conditions that are not
materially less advantageous in the aggregate than the directors&#146; and officers&#146; liability insurance
coverage maintained by the Company on the date of this Agreement with respect to matters arising on
or before the Closing Date; <U>provided</U>, <U>however</U>, that after the Acceptance Date, the
Company (and following the Effective time, the Surviving Corporation) shall not be required (and,
prior to the Effective Time, shall not be permitted) to pay with respect to such current or
substitute insurance policies in respect of any one policy year annual premiums in excess of 300%
of the last annual premium paid by the Company prior to the date hereof in respect of the coverage
required to be obtained pursuant hereto, but in such case shall purchase as much coverage as
reasonably practicable for such amount; and <U>further</U> <U>provided</U>, <U>however</U>, that
after the Effective Time if the Surviving Corporation purchases a six-year &#147;tail policy&#148; and the
same coverage costs more than 300% of such last annual premium, the Surviving Corporation shall
purchase the maximum amount of &#147;tail&#148; coverage that can be obtained for 300% of such last annual
premium. At the Company&#146;s option, the Company may purchase prior to the Effective Time, a six-year
prepaid &#147;tail policy&#148; on terms and conditions providing substantially equivalent benefits as the
current policies of directors&#146; and officers&#146; liability insurance maintained by the Company and its
Subsidiaries on the date of this Agreement with respect to matters arising on or before the Closing
Date; <U>provided</U> that the cost of such tail policy shall not exceed 300% of the last annual
premium paid by the Company prior to the date hereof in respect of the coverage required to be
obtained pursuant hereto. If such tail prepaid policy has been obtained by the
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->55<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Company prior to the Effective Time, Parent shall cause the Surviving Corporation to maintain
such policy in full force and effect, for its full term.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;The rights of each Indemnified Party hereunder shall be in addition to, and not in
limitation of, any other rights such Indemnified Party may have under the certificates of
incorporation or by-laws or other organization documents of the Company or any of its Subsidiaries
or the Surviving Corporation, any other indemnification arrangement, the DGCL or otherwise.
Subsequent amendment of the Certificates of Incorporation, bylaws or other organizational documents
of the Company or any of its Subsidiaries or of the Surviving Corporation shall not diminish or
impair the rights of any Indemnified Party. The provisions of this <U>Section&nbsp;6.9</U> shall
survive the consummation of the Merger and expressly are intended to benefit, and are enforceable
by, each of the Indemnified Parties.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;In the event Parent, the Surviving Corporation or any of their respective successors or
assigns (i)&nbsp;consolidates with or merges into any other Person and shall not be the continuing or
surviving corporation or entity in such consolidation or merger or (ii)&nbsp;transfers all or
substantially all of its properties and assets to any Person, then, and in either such case, proper
provision shall be made so that the successors and assigns of Parent or the Surviving Corporation,
as the case may be, shall assume the obligations set forth in this <U>Section&nbsp;6.9</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.10. <U>Control of Operations</U>. Without in any way limiting any party&#146;s rights
or obligations under this Agreement, the parties understand and agree that nothing contained in
this Agreement shall give Parent, directly or indirectly, the right to control or direct the
Company&#146;s operations prior to the earlier of the Acceptance Date and the Effective Time. Subject
to the rights and obligations of the parties hereunder, prior to the earlier of the Acceptance Date
and the Effective Time, the Company shall exercise, consistent with the terms and conditions of
this Agreement, complete control and supervision over its operations.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.11. <U>Disposition of Litigation</U>. The Company and Parent will consult with
respect to any action by any Third Party to restrain or prohibit or otherwise oppose the Offer, the
Merger or the other transactions contemplated by this Agreement or any Stockholder Agreement and,
subject to <U>Section&nbsp;6.3</U>, shall use their reasonable best efforts to resist any such effort
to restrain or prohibit or otherwise oppose the Offer, the Merger or the other transactions
contemplated by this Agreement or any Stockholder Agreement. Parent may participate in (but not
control) the defense of any stockholder litigation against the Company and its directors or
officers relating to the transactions contemplated by this Agreement or any Stockholder Agreement
at Parent&#146;s sole cost and expense; <U>provided</U>, <U>however</U>, that without Parent&#146;s prior
written consent, not to be unreasonably withheld, the Company shall not enter into or agree to any
settlement, compromise, admission or acknowledgment of the validity of any such stockholder
litigation matter if such settlement, compromise, admission or acknowledgement would impose
injunctive or other non-monetary relief or other duties or obligations on the Company and its
Subsidiaries that would have a Company Material Adverse Effect or would continue following the
Closing Date and; <U>provided</U> <U>further</U>, that without Parent&#146;s prior written consent,
not to be unreasonably withheld, the Company shall not enter into or agree to any settlement,
compromise, admission or acknowledgment of the validity of any such stockholder litigation matter
if such settlement, compromise, admission or acknowledgement would result in a payment obligation
by or on behalf of the Company or any of its Subsidiaries of more than
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->56<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">$500,000. In addition, subject to <U>Section&nbsp;6.3</U>, the Company shall not voluntarily
cooperate with any Third Party which has sought or may hereafter seek to restrain or prohibit or
otherwise oppose the Offer, the Merger or the other transactions contemplated by this Agreement or
any Stockholder Agreement and shall cooperate with Parent to resist any such effort to restrain or
prohibit or otherwise oppose the Offer, the Merger or the other transactions contemplated by this
Agreement or any Stockholder Agreement. The Company may participate in (but not control) decisions
relating to any antitrust agency investigation or litigation relating to the Offer, the Merger or
the other transactions contemplated by this Agreement. Subject to the other provisions of this
Agreement, Parent will have sole power to negotiate and settle any antitrust agency challenge.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.12. <U>Notification of Certain Matters</U>. The Company shall give prompt notice
to Parent, and Parent shall give prompt notice to the Company, of (i)&nbsp;any notice or other
communication received by such party from any Governmental Entity in connection with the Offer, the
Merger or the other transactions contemplated hereby or from any Person alleging that the consent
of such Person is or may be required in connection with the Offer, the Merger or the other
transactions contemplated hereby, if the subject matter of such communication or the failure of
such party to obtain such consent could be material to the Company, the Surviving Corporation or
Parent, (ii)&nbsp;any actions, suits, claims, investigations or proceedings commenced or, to such
party&#146;s knowledge, threatened against, relating to or involving or otherwise affecting such party
or any of its Subsidiaries which relate to the Offer, the Merger or the other transactions
contemplated hereby, (iii)&nbsp;the discovery of any fact or circumstance that, or the occurrence or
non-occurrence of any event the occurrence or non-occurrence of which, would cause or result in any
of the Tender Offer Conditions or any of the conditions set forth in <U>Article&nbsp;VII</U> not being
satisfied or satisfaction of those conditions being materially delayed in violation of any
provision of this Agreement, (iv)&nbsp;the occurrence, or failure to occur, of any event of which it
becomes aware that has caused or that would be likely to cause any representation or warranty of
such party contained in this Agreement to be untrue or inaccurate at any time from the date hereof
to the Closing Date, and (v)&nbsp;the failure of such party to comply with or satisfy in any material
respect any covenant, condition or agreement to be complied with or satisfied by it hereunder;
<U>provided</U>, <U>however</U>, that the delivery of any notice pursuant to this <U>Section
6.12</U> shall not (x)&nbsp;cure any breach of, or non-compliance with, any other provision of this
Agreement or (y)&nbsp;limit the remedies available to the party receiving such notice.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.13. <U>Termination of Credit Agreement and Funded Indebtedness</U>. On or prior to
the second Business Day prior to the Acceptance Date, the Company shall deliver to Parent copies of
payoff letters, in reasonable form, from the holders of any Funded Indebtedness of the Company or
its Subsidiaries, including, without limitation, the administrative agent under the Credit
Agreement. On the Acceptance Date, the Company shall repay all such Funded Indebtedness, terminate
the Credit Agreement and the Loan Agreement, and obtain the release of all mortgages, liens and
other security over the Company&#146;s and its Subsidiaries&#146; properties and assets securing such
obligations (other than the filing of Form UCC-3s).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.14. <U>Company Rights Agreement</U>. The Board of Directors shall take all further
actions reasonably requested by Parent in order to render the Rights inapplicable to the
Stockholder Agreements, this Agreement and the transactions contemplated hereby and thereby,
including the Offer and the Merger.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->57<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.15. <U>Stock Exchange De-listing</U>. After the date hereof and prior to the
Acceptance Date, the Company shall use reasonable best efforts to take, or cause to be taken, all
actions, and do or cause to be done all things, reasonably necessary, proper or advisable on its
part under applicable Laws and rules and policies of the NASDAQ and the other exchanges on which
the Common Stock is listed to maintain the Company&#146;s listing thereon. Prior to the Closing Date,
the Company shall cooperate with Parent and use reasonable best efforts to take, or cause to be
taken, all actions, and do or cause to be done all things, reasonably necessary, proper or
advisable on its part under applicable Laws and rules and policies of the NASDAQ and the other
exchanges on which the Common Stock is listed to enable the delisting by the Surviving Corporation
of the Shares from the NASDAQ and the other exchanges on which the Common Stock is listed and the
deregistration of the Shares under the Exchange Act as promptly as practicable after the Effective
Time.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.16. <U>Transfer Taxes</U>. The parties shall cooperate in the preparation,
execution and filing of all returns, questionnaires, applications or other documents regarding all
state, local and foreign real property transfer or gains, sales, use, transfer, value added, stock
transfer and stamp taxes, any transfer, recording, registration and other fees or similar Taxes
which become payable in connection with the transactions contemplated by this Agreement that are
required to be filed on or before the Effective Time.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.17. <U>Rule&nbsp;14d-10(d)</U>. Prior to the Acceptance Date, the Company (acting
through the compensation committee of the Board of Directors) shall use reasonable efforts to (i)
take all such steps as may be required to cause each agreement, arrangement or understanding
entered into by the Company or its Subsidiaries since January&nbsp;1, 2007 with any of its officers,
directors or employees pursuant to which consideration is paid to such officer, director or
employee to be approved as an &#147;employment compensation, severance or other employee benefit
arrangement&#148; within the meaning as set forth in Rule&nbsp;14d-10(d) of the Exchange Act, and (ii)&nbsp;take
all such steps necessary as may be required or advisable to satisfy the requirements of the
non-exclusive safe harbor with respect to such employment, compensation, severance or other
employee benefit arrangement or payment in accordance with Rule&nbsp;14d-10(d) under the Exchange Act.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;6.18. <U>Financing</U>. The Company shall and shall cause its Subsidiaries to and
shall use commercially reasonable efforts to cause each of its and their respective
Representatives, including legal and accounting, to provide all commercially reasonable cooperation
that is reasonably requested by Parent in obtaining the financing necessary to consummate the
Offer, the Merger and the other transactions contemplated by this Agreement (provided that such
requested cooperation does not materially interfere with the ongoing operations of the Company and
its Subsidiaries).
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ARTICLE VII</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>CONDITIONS TO THE MERGER</B>

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;7.1. <U>Conditions to Each Party&#146;s Obligation to Effect the Merger</U>. The
respective obligations of each party to effect the Merger shall be subject to the fulfillment (or
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->58<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">waiver by Parent and the Company) at or prior to the Effective Time of only the following
conditions:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;Unless the Merger is consummated pursuant to Section&nbsp;253 of the DGCL, the Company
Stockholder Approval shall have been obtained, <U>provided</U> that this condition shall be deemed
to have been satisfied if a failure to obtain the Company Stockholder Approval is attributable to
Parent failing to vote all of its respective Shares in favor of the Merger.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;The waiting period (and any extension thereof) applicable to the Merger under the HSR Act
shall have been terminated or shall have expired, and no restrictive order or other requirements
shall have been placed on the Company, Parent, Merger Sub or the Surviving Corporation in
connection therewith.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;No Governmental Entity of competent jurisdiction shall have enacted, promulgated, issued
or entered any Law which remains in effect and that enjoins or otherwise prohibits consummation of
the Merger; <U>provided</U>, <U>however</U>, that prior to invoking this condition, each party
shall use its reasonable best efforts to have any such Law vacated, including by satisfaction of
such party&#146;s obligations pursuant to <U>Section&nbsp;6.6</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;Merger Sub shall have accepted for purchase the Shares validly tendered and not properly
withdrawn pursuant to the Offer in accordance with the terms hereof and thereof.
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ARTICLE VIII</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>TERMINATION</B>

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;8.1. <U>Termination or Abandonment</U>. Anything contained in this Agreement to the
contrary notwithstanding, this Agreement may be terminated and the Offer or the Merger may be
abandoned at any time prior to the Effective Time, whether before or after any adoption by the
stockholders of the Company of this Agreement:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;by the mutual written consent of the Company and Parent;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;by either the Company or Parent, at any time prior to the Acceptance Date (and in no event
after the Acceptance Date) and after the End Date, if the Acceptance Date shall not have occurred
on or before July&nbsp;13, 2008 (such date, as extended pursuant to the terms hereof, the &#147;<U>End
Date</U>&#148;); the End Date shall be extended automatically to the close of business on the first
Business Day immediately following the Expiration Date if the Expiration Date is extended beyond
July&nbsp;13, 2008, pursuant to <U>Section&nbsp;1.1(d))</U>; <U>provided</U>, <U>however</U>, that the
right to terminate this Agreement pursuant to this <U>Section&nbsp;8.1(b)</U> shall not be available to
any party where the failure of such party (or any Affiliate of such party) to fulfill any of its
obligations under this Agreement or any Stockholder Agreement has primarily resulted in, or been
the principal cause of, the failure of the Acceptance Date to have occurred on or before the End
Date;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;by either the Company or Parent if there shall be any Law in effect that permanently
enjoins or otherwise prohibits the consummation of the Offer or that permanently enjoins or
otherwise prohibits the Merger and such Law shall have become final and non-
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->59<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">appealable; <U>provided</U>, that, in the case of any judgment, ruling, order, writ,
injunction, decree or agency requirement, the party seeking to terminate this Agreement pursuant to
this <U>Section&nbsp;8.1(c)</U> shall have used its reasonable best efforts to have such Law lifted
prior to such Law having become final and non-appealable to the extent required by <U>Section
6.6</U>;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;by either the Company or Parent, at any time after April&nbsp;14, 2008, if, as of the then most
recent Expiration Date occurring on or after April&nbsp;14, 2008, all of the Tender Offer Conditions
(other than the Minimum Condition) were satisfied (or capable of being satisfied in the case of any
Tender Offer Conditions that by their nature are to be satisfied on the Expiration Date or
immediately prior to the Acceptance Date) for at least two consecutive Business Days prior to such
Expiration Date, and as of the expiration time on such Expiration Date, the Minimum Condition is
not satisfied; <U>provided</U>, <U>however</U>, that the right to terminate this Agreement
pursuant to this <U>Section&nbsp;8.1(d)</U> shall not be available to any party where the failure of
such party (or any affiliate of such party) to fulfill any of its obligations under this Agreement
or any Stockholder Agreement has primarily resulted in, or been the principal cause of, the failure
of the Minimum Condition to be satisfied;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;by the Company if Parent or Merger Sub shall have breached or failed to perform any of its
representations, warranties, covenants or other agreements contained in this Agreement, which
breach or failure to perform (x)&nbsp;would give rise to a Parent Material Adverse Effect or would
result in a failure of a Tender Offer Condition or a condition set forth in <U>Section&nbsp;7.1</U> to
be satisfied or the failure of the Acceptance Date or the Closing to occur and (y)&nbsp;is either
incurable or, if curable, is not cured by Parent or Merger Sub by the earlier to occur of (A)&nbsp;the
tenth (10<SUP style="font-size: 85%; vertical-align: text-top">th</SUP>) day following receipt by Parent of written notice of such breach or failure
to perform delivered by the Company or (B)&nbsp;the End Date; <U>provided</U>, <U>however</U>, that
the Company shall not have the right to terminate this Agreement pursuant to this <U>Section
8.1(e)</U> if, at the time of delivery of such written notice, the Company is then in material
breach of its obligations under this Agreement;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;by Parent if the Company shall have breached or failed to perform (i)&nbsp;any of its covenants
or other agreements in <U>Section&nbsp;6.3</U> other than an immaterial, technical breach of any
covenant or other agreement in <U>Section&nbsp;6.3</U> that would not hinder or delay the Offer or the
Merger or any other transactions contemplated hereby or (ii)&nbsp;any of its representations,
warranties, other covenants or other agreements contained in this Agreement, which breach or
failure to perform with respect to this clause (ii) (A)&nbsp;would result in a failure of a Tender Offer
Condition or a condition set forth in <U>Section&nbsp;7.1</U> to be satisfied or failure of the
Acceptance Date or the Closing to occur and (B)&nbsp;is either incurable or, if curable, is not cured by
the Company by the earlier to occur of (x)&nbsp;the tenth (10<SUP style="font-size: 85%; vertical-align: text-top">th</SUP>) day following receipt by the
Company of written notice of such breach or failure to perform delivered by Parent or (y)&nbsp;the End
Date; <U>provided</U>, <U>however</U>, that Parent shall not have the right to terminate this
Agreement pursuant to this <U>Section&nbsp;8.1(f)</U> if, at the time of delivery of such written
notice, Parent or Merger Sub is then in material breach of its obligations under this Agreement;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;by the Company, at any time prior to the Acceptance Date (and in no event after the
Acceptance Date), in order to enter into a transaction, pursuant to and in accordance with the
terms and conditions of <U>Section&nbsp;6.3(e)</U>, that constitutes a Superior Proposal;
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->60<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><U>provided</U>, <U>however</U>, that termination of this Agreement pursuant to this
<U>Section&nbsp;8.1(g)</U> shall not be effective until the Termination Fee has been paid to Parent in
accordance with <U>Section&nbsp;8.3</U>;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)&nbsp;by the Company, at any time prior to the Acceptance Date (and in no event after the
Acceptance Date), if (i)&nbsp;Merger Sub shall have terminated the Offer in material violation of the
terms of this Agreement or failed to extend the Offer to the extent required by <U>Section&nbsp;1.1</U>
(in either case, other than in connection with a valid termination of this Agreement in accordance
with <U>Section&nbsp;8.1</U>); or (ii)&nbsp;at any Expiration Date, Merger Sub shall fail to accept for
payment and pay for Shares validly tendered and not properly withdrawn in the Offer in material
violation of the terms of the Offer specified in <U>Section&nbsp;1.1</U>;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;by Parent, if the Board of Directors or any committee thereof (i)&nbsp;fails to make the
Recommendation in the Offer Documents, the Schedule&nbsp;14D-9 or the Proxy Statement in accordance with
<U>Section&nbsp;1.2</U> and <U>Section&nbsp;6.4</U> or resolves to do any of the foregoing, (ii)&nbsp;effects a
Recommendation Withdrawal, or resolves or publicly proposes to effect a Recommendation Withdrawal,
(iii)&nbsp;approves, endorses or recommends, or resolves or publicly proposes to approve, endorse or
recommend, any Company Acquisition Proposal (including approval of a definitive agreement or
agreement in principle with respect thereto), (iv)&nbsp;fails to reaffirm the Recommendation on or
before the tenth Business Day following the date on which a Company Acquisition Proposal has been
publicly announced (it being understood that taking a neutral position or no position with respect
to any Company Acquisition Proposal shall be considered a failure to reaffirm the Recommendation),
or (v)&nbsp;does not reaffirm the Recommendation within three Business Days following the date on which
Parent requests such reaffirmation in writing;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j)&nbsp;by Parent, if since the date of this Agreement and prior to the purchase of Shares in the
Offer there shall have been a Company Material Adverse Effect that has not been or cannot be cured
by the End Date; or
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(k)&nbsp;by Parent if there has been any breach of any representation or warranty (when made on or
at the time of termination as if made on such date of termination, except to the extent that it
relates to a particular date) contained in <U>Section&nbsp;4.2</U> unless the value of such breaches of
Section&nbsp;4.2 does not individually or in the aggregate exceed $500,000 as determined utilizing the
Per Share Amount.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">A terminating party shall provide written notice of termination to the other party specifying the
reason(s) for such termination.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;8.2. <U>Effect of Termination</U>. In the event of termination of this Agreement
pursuant to <U>Section&nbsp;8.1</U>, this Agreement shall forthwith become null and void and there
shall be no liability or obligation on the part of the Company, Parent, Merger Sub or their
respective Subsidiaries or affiliates, except that the Confidentiality Agreement, this <U>Section
8.2</U>, <U>Section&nbsp;8.3</U> and <U>Article&nbsp;IX</U> will survive the termination hereof;
<U>provided</U>, <U>however</U>, that no such termination shall relieve any party from any
liability or damages for willful or intentional breach of this Agreement or fraud, in which case
the aggrieved party shall be entitled to all rights and remedies available at law or in equity,
including those set forth in <U>Section&nbsp;8.3</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;8.3. <U>Termination Fees and Expense Reimbursement</U>.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->61<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;In the event that:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;(A)&nbsp;after the date of this Agreement, any Company Acquisition Proposal (substituting
&#147;thirty percent (30%)&#148; for the &#147;fifteen percent (15%)&#148; threshold set forth in the definition of
&#147;Company Acquisition Proposal&#148;) (a &#147;<U>Qualifying Transaction</U>&#148;) (1)&nbsp;is publicly announced,
publicly proposed, publicly disclosed or consummated, or (2)&nbsp;shall have been communicated to senior
officers of the Company or the Board of Directors and the Company shall have breached any of its
covenants or other agreements under <U>Section&nbsp;1.2</U>, <U>6.4</U> or <U>6.6</U> and/or the
senior officers of the Company or the Board of Directors (or any committee thereof) shall have
failed to keep such Qualifying Transaction (including the fact that such Company Acquisition
Proposal was made, the terms thereof and the identity of the Person making such Company Acquisition
Proposal) confidential, in each case of the immediately foregoing clauses (1)&nbsp;and (2), prior to the
date of termination of this Agreement, (B)&nbsp;this Agreement is terminated by Parent pursuant to
<U>Section&nbsp;8.1(f)</U> or by Parent or the Company pursuant to <U>Section&nbsp;8.1(b)</U> or
<U>Section&nbsp;8.1(d)</U>, and (C)&nbsp;the Company enters into a definitive agreement with respect to, or
consummates, a transaction contemplated by any proposal regarding a Qualifying Transaction on or
before the 275<SUP style="font-size: 85%; vertical-align: text-top">th</SUP> day after (and not including) the date of termination of this
Agreement;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;this Agreement is terminated by the Company pursuant to <U>Section&nbsp;8.1(g)</U>; or
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)&nbsp;this Agreement is terminated by Parent pursuant to <U>Section&nbsp;8.1(i)</U>;
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">then in any such event under clause (i), (ii)&nbsp;or (iii)&nbsp;of this <U>Section&nbsp;8.3(a)</U>, the Company
shall pay to Parent, by wire transfer of immediately available funds,
$4,413,500 in cash (the &#147;<U>Termination Fee</U>&#148;), net of any Parent Expenses previously
actually paid to or at the direction of Parent by the Company pursuant to <U>Section&nbsp;8.3(b)</U>,
it being understood that in no event shall the Company be required to pay the Termination Fee on
more than one occasion. Any Termination Fee payable pursuant to this <U>Section&nbsp;8.3(a)</U> shall
be payable as follows:
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A) any Termination Fee payable pursuant to the foregoing clause (i)&nbsp;shall be payable
on the next Business Day following the earlier of the consummation of the transaction
contemplated by the Qualifying Transaction or the date on which the Company enters into a
definitive agreement contemplating such Qualifying Transaction;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B) any Termination Fee payable pursuant to the foregoing clause (ii)&nbsp;shall be payable
concurrently with, and as a condition precedent to, the termination of this Agreement
pursuant to <U>Section&nbsp;8.1(g)</U>; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(C) any Termination Fee payable pursuant to the foregoing clause (iii)&nbsp;shall be payable
on the next Business Day following the termination of this Agreement pursuant to <U>Section
8.1(i)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;In the event that this Agreement is terminated (i)&nbsp;by Parent pursuant to <U>Section
8.1(b)</U> (and at the time of such termination by Parent, the Company did not have the right
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->62<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">to terminate this Agreement pursuant to such section primarily due to the Company&#146;s willful or
intentional breach of any of the Company&#146;s representations or warranties contained in this
Agreement and/or the Company&#146;s failure to perform any of the Company&#146;s covenants or other
agreements contained in this Agreement), (ii)&nbsp;by Parent pursuant to clause (ii)&nbsp;of <U>Section
8.1(f)</U> and such right of termination by Parent is due primarily to the Company&#146;s willful or
intentional breach of any of the Company&#146;s representations or warranties contained in this
Agreement and/or the Company&#146;s failure to perform any of the Company&#146;s covenants or other
agreements contained in this Agreement or (iii)&nbsp;by Parent pursuant to <U>Section&nbsp;8.1(k)</U>, then
the Company shall pay to Parent by wire transfer of immediately available funds, as promptly as
possible (but in any event within two Business Days) following receipt of reasonable documentation
thereof, all of Parent&#146;s and Merger Sub&#146;s out-of-pocket fees and expenses (including all fees and
expenses of counsel, accountants, consultants, financial advisors and investment bankers of Parent
and its affiliates and fees paid to any Governmental Entity) actually incurred by Parent or Merger
Sub or on their behalf on or prior to the termination of this Agreement in connection with or
related to the authorization, preparation, negotiation, execution and performance of the
transactions contemplated by this Agreement, which amount shall not be greater than $1,471,000 in the aggregate (such aggregate expenses as limited by the
applicable dollar limitation, &#147;<U>Parent Expenses</U>&#148;); <U>provided</U> that the existence of
circumstances that could require the Termination Fee subsequently to become payable pursuant to
<U>Section&nbsp;8.3(a)(i)</U> shall not relieve the Company of its obligations to pay the Parent
Expenses pursuant to this <U>Section&nbsp;8.3(b)</U>; and <U>provided</U>, <U>further</U> that the
payment by the Company of Parent Expenses pursuant to this <U>Section&nbsp;8.3(b)</U> shall not relieve
the Company of any obligation to pay the Termination Fee pursuant to <U>Section&nbsp;8.3(a)(i)</U>
except to the extent indicated in <U>Section&nbsp;8.3(a)</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;In the event that this Agreement is terminated (i)&nbsp;by the Company pursuant to <U>Section
8.1(b)</U> (and at the time of such termination by the Company, Parent did not have the right to
terminate this Agreement pursuant to such section primarily due to Parent&#146;s or Merger Sub&#146;s willful
or intentional breach of any of Parent&#146;s or Merger Sub&#146;s representations or warranties contained in
this Agreement and/or Parent&#146;s or Merger Sub&#146;s failure to perform any of Parent&#146;s or Merger Sub&#146;s
covenants or other agreements contained in this Agreement) or (ii)&nbsp;by the Company pursuant to
<U>Section&nbsp;8.1(e)</U> and such right of termination by the Company is due primarily to Parent&#146;s or
Merger Sub&#146;s willful or intentional breach of any of Parent&#146;s or Merger Sub&#146;s representations or
warranties contained in this Agreement and/or Parent&#146;s or Merger Sub&#146;s failure to perform any of
Parent&#146;s or Merger Sub&#146;s covenants or other agreements contained in this Agreement, then Parent and
Merger Sub shall pay to the Company by wire transfer of immediately available funds, as promptly as
possible (but in any event within two Business Days) following receipt of reasonable documentation
thereof, the Company Expenses.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;In the event that the Company, on the one hand, or Parent and Merger Sub, on the other
hand, shall fail to pay the Termination Fee, Parent Expenses and/or Company Expenses required to be
paid pursuant to this <U>Section&nbsp;8.3</U> when due, such fee and/or expenses shall accrue interest
for the period commencing on the date such fee and/or expenses became past due, at a rate equal to
the rate of interest publicly announced by Citibank, in the City of New York from time to time
during such period, at such bank&#146;s Prime Lending Rate. In addition, if the Company, on the one
hand, or Parent and Merger Sub, on the other hand, shall fail to pay such fee and/or expenses, as
the case may be, when due, then, as applicable, the Company, on the one hand, or Parent and Merger
Sub, on the other hand, shall also pay to the other party all of
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->63<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">the other party&#146;s costs and expenses (including attorneys&#146; fees and expenses) in connection
with efforts to collect such fee and/or expenses.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;Parent and the Company acknowledge that the Termination Fee, the Parent Expenses, the
Company Expenses and this <U>Section&nbsp;8.3</U> are an integral part of the Offer and the Merger and
the other transactions contemplated by this Agreement and that, without these agreements, Parent
and the Company would not enter into this Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;If more than one provision contained in <U>Section&nbsp;8.1</U> is an applicable basis for
termination of this Agreement by the Company or Parent, as applicable, then the Company or Parent,
as applicable, shall be entitled to assert more than one provision contained in <U>Section&nbsp;8.1</U>
as the basis for its termination of this Agreement and the Company or Parent, as applicable, shall
be entitled to receive payment of the highest fee or expense reimbursement available pursuant to
this <U>Section&nbsp;8.3</U> arising out of such reasons for termination of this Agreement,
<U>provided</U> that Parent shall not be entitled to more than one recovery of the Termination Fee
or Parent Expenses, as applicable, and the Company shall not be entitled to more than one recovery
of the Company Expenses; provided, that no such payments of fees and/or expenses shall relieve any
party from any liability or damages for willful or intentional breach of this Agreement or fraud,
in which case the aggrieved party shall be entitled to all rights and remedies available at law or
in equity as provided in <U>Section&nbsp;8.2</U>.
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>ARTICLE IX</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>MISCELLANEOUS</B>

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.1. <U>No Survival of Representations and Warranties</U>. None of the
representations and warranties contained in this Agreement or in any instrument delivered pursuant
to this Agreement shall survive the Effective Time.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.2. <U>Expenses</U>. Except as set forth in this Agreement, including <U>Section
8.3</U>, whether or not the Merger is consummated, all costs and expenses incurred in connection
with the Merger, this Agreement and the transactions contemplated hereby shall be paid by the party
incurring or required to incur such expenses, except that expenses incurred in connection with the
printing, filing and mailing of the Proxy Statement (including applicable SEC filing fees) and all
fees paid in respect of any regulatory filings shall be borne one-half by Parent and one-half by
the Company.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.3. <U>Counterparts; Effectiveness</U>. This Agreement may be executed in two or
more consecutive counterparts (including by facsimile or pdf), each of which shall be an original,
with the same effect as if the signatures thereto and hereto were upon the same instrument, and
shall become effective when one or more counterparts have been signed by each of the parties and
delivered (by facsimile, pdf or otherwise) to the other parties. This Agreement shall not become
effective until such time as this Agreement and the Stockholder Agreements (or counterparts
thereof) have been executed and delivered by each of the parties thereto; <U>provided</U>,
<U>however</U>, that Parent, in its sole discretion, may waive the condition that it receive
executed Stockholder Agreements from individual Stockholders.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->64<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.4. <U>Governing Law</U>. This Agreement shall be governed by and construed in
accordance with the laws of the State of Delaware, without giving effect to any choice or conflict
of law provision or rule (whether of the State of Delaware or any other jurisdiction) that would
cause the application of the laws of any jurisdiction other than the State of Delaware.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.5. <U>Jurisdiction; Enforcement</U>. The parties agree that irreparable damage
would occur in the event that any of the provisions of this Agreement were not performed in
accordance with their specific terms or were otherwise breached. The parties recognize that in the
event that any of the parties hereto should refuse to perform their respective obligations under
the provisions of this Agreement, monetary damages alone may not be adequate. It is accordingly
agreed that, prior to the valid and effective termination of this Agreement in accordance with
<U>Article&nbsp;VIII</U>, the parties shall be entitled to an injunction or injunctions to prevent
breaches of this Agreement and to enforce specifically the terms and provisions of this Agreement
(including (i)&nbsp;the obligation of Merger Sub to pay for any Shares accepted for payment in the Offer
in accordance with the terms of this Agreement or (ii)&nbsp;the obligation of the Company, Parent or
Merger Sub to consummate the Offer and the Merger in accordance with the terms of this Agreement)
exclusively in the Delaware Court of Chancery and any state appellate court therefrom within the
State of Delaware (or, if the Delaware Court of Chancery declines to accept jurisdiction over a
particular matter, any state or federal court within the State of Delaware). In addition, each of
the parties hereto irrevocably agrees that any legal action or proceeding with respect to this
Agreement and the rights and obligations arising hereunder, or for recognition and enforcement of
any judgment in respect of this Agreement and the rights and obligations arising hereunder brought
by the other party hereto or its successors or assigns, shall be brought and determined exclusively
in the Delaware Court of Chancery and any state appellate court therefrom within the State of
Delaware (or, if the Delaware Court of Chancery declines to accept jurisdiction over a particular
matter, any state or federal court within the State of Delaware). Each of the parties hereto
hereby irrevocably submits with regard to any such action or proceeding for itself and in respect
of its property, generally and unconditionally, to the personal jurisdiction of the aforesaid
courts and agrees that it will not bring any action relating to this Agreement or any of the
transactions contemplated by this Agreement in any court other than the aforesaid courts. Each of
the parties hereto hereby irrevocably waives, and agrees not to assert as a defense, counterclaim
or otherwise, in any action or proceeding with respect to this Agreement, (a)&nbsp;any claim that it is
not personally subject to the jurisdiction of the above named courts for any reason other than the
failure to serve in accordance with this <U>Section&nbsp;9.5</U>, (b)&nbsp;any claim that it or its property
is exempt or immune from jurisdiction of any such court or from any legal process commenced in such
courts (whether through service of notice, attachment prior to judgment, attachment in aid of
execution of judgment, execution of judgment or otherwise) and (c)&nbsp;to the fullest extent permitted
by the applicable Law, any claim that (i)&nbsp;the suit, action or proceeding in such court is brought
in an inconvenient forum, (ii)&nbsp;the venue of such suit, action or proceeding is improper or (iii)
this Agreement, or the subject matter hereof, may not be enforced in or by such courts.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.6. <U>WAIVER OF JURY TRIAL</U>. EACH OF THE PARTIES HERETO IRREVOCABLY WAIVES ANY
AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT
OR THE TRANSACTIONS CONTEMPLATED HEREBY.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->65<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.7. <U>Notices</U>. Any notice required to be given hereunder shall be sufficient
if in writing, and sent by facsimile transmission (<U>provided</U> that any notice received by
facsimile transmission or otherwise at the addressee&#146;s location on any Business Day after 5:00 p.m.
(addressee&#146;s local time) shall be deemed to have been received at 9:00 a.m. (addressee&#146;s local
time) on the next Business Day), by reliable overnight delivery service (with proof of service),
hand delivery or certified or registered mail (return receipt requested and first-class postage
prepaid), addressed as follows:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">To Parent or Merger Sub:

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Odyssey HealthCare Holding Company<BR>
717 North Harwood Street, Suite&nbsp;1500<BR>
Dallas, Texas 75201<BR>
Facsimile: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (214)&nbsp;245-3336<BR>
Attention: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; W. Bradley Bickham

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">with a copy to (which shall not constitute notice hereunder):

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Vinson &#038; Elkins L.L.P.<BR>
Trammell Crow Center<BR>
2001 Ross Avenue, Suite&nbsp;3700<BR>
Dallas, TX 75201<BR>
Facsimile: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (214)&nbsp;999-7959<BR>
Attention: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; P. Gregory Hidalgo

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">To the Company:

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">VistaCare, Inc.<BR>
4800 North Scottsdale Road<BR>
Suite&nbsp;5000<BR>
Scottsdale, Arizona 85251<BR>
Facsimile: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (480)&nbsp;648-4555<BR>
Attention: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Stephen Lewis

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">with a copy to (which shall not constitute notice hereunder):

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Squire, Sanders &#038; Dempsey L.L.P.<BR>
40 North Central Avenue, Suite&nbsp;2700<BR>
Phoenix, Arizona 85004<BR>
Facsimile: (602)&nbsp;253-8129<BR>
Attention: &nbsp;&nbsp;Frank Placenti, Esq.<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Joseph P. Richardson, Esq.

</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">or to such other address as any party shall specify by written notice so given, and such notice
shall be deemed to have been delivered as of the date so telecommunicated, personally delivered or
received. Any party to this Agreement may notify any other party of any changes to the address or
any of the other details specified in this paragraph; <U>provided</U>, <U>however</U>, that such
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->66<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">notification shall only be effective on the date specified in such notice or two (2)&nbsp;Business Days
after the notice is given, whichever is later. Rejection or other refusal to accept or the
inability to deliver because of changed address of which no notice was given shall be deemed to be
receipt of the notice as of the date of such rejection, refusal or inability to deliver.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.8. <U>Assignment; Binding Effect</U>. Neither this Agreement nor any of the
rights, interests or obligations hereunder shall be assigned by any of the parties hereto (whether
by operation of law or otherwise) without the prior written consent of the other parties, except
that Merger Sub may assign, in its sole discretion, any of or all of its rights, interest and
obligations under this Agreement (i)&nbsp;to Parent or to any direct or indirect wholly-owned Subsidiary
of Parent or (ii)&nbsp;in the form of a collateral assignment to any institutional lender who provides
funds to Parent or its affiliates for the consummation of the transactions contemplated hereby, but
no such assignment shall relieve Merger Sub of its obligations hereunder. Subject to the preceding
sentence, this Agreement shall be binding upon and shall inure to the benefit of the parties hereto
and their respective successors and permitted assigns. Parent shall cause Merger Sub, and any
assignee thereof, to perform its obligations under this Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.9. <U>Severability</U>. Any term or provision of this Agreement which is invalid
or unenforceable in any jurisdiction shall, as to that jurisdiction, be ineffective to the sole
extent of such invalidity or unenforceability without rendering invalid or unenforceable the
remainder of such term or provision or the remaining terms and provisions of this Agreement in any
jurisdiction. If any provision of this Agreement is so broad as to be unenforceable, such
provision shall be interpreted to be only so broad as is enforceable.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.10. <U>Entire Agreement; No Third-Party Beneficiaries</U>. This Agreement
(including the <U>Annexes</U>, exhibits and schedules hereto), the Confidentiality Agreement, the
Stockholder Agreements and the amendment to the Rights Agreement and the resolutions of the Board
of Directors authorizing such amendment set forth in <U>Section&nbsp;4.12</U> of the Company Disclosure
Letter constitute the entire agreement, and supersede all other prior agreements and
understandings, both written and oral, between the parties, or any of them, with respect to the
subject matter hereof and thereof. Except for the provisions of <U>Section&nbsp;6.9</U> (which shall
be for the benefit of the Indemnified Parties as stated therein), this Agreement is not intended to
and shall not confer upon any Person other than the parties hereto any rights or remedies
hereunder.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.11. <U>Amendments; Waivers</U>. At any time prior to the Effective Time, any
provision of this Agreement may be amended, modified, supplemented or waived if, and only if, such
amendment, modification, supplement or waiver is in writing and signed, in the case of an
amendment, modification or supplement, by the Company, Parent and Merger Sub, or in the case of a
waiver, by the party against whom the waiver is to be effective; <U>provided</U>, <U>however</U>,
that after receipt of the Company Stockholder Approval, if applicable, if any such amendment or
waiver shall by applicable Law or in accordance with the rules and regulations of NASDAQ require
further approval of the stockholders of the Company, the effectiveness of such amendment or waiver
shall be subject to the approval of the stockholders of the Company. Notwithstanding the
foregoing, no failure or delay by the Company or Parent in exercising any right hereunder shall
operate as a waiver thereof nor shall any single or partial exercise thereof preclude any other or
further exercise of any other right hereunder.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->67<!-- /Folio -->
</DIV>




<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.12. <U>Headings</U>. Headings of the Articles and Sections of this Agreement are
for convenience of the parties only and shall be given no substantive or interpretive effect
whatsoever. The table of contents to this Agreement is for reference purposes only and shall not
affect in any way the meaning or interpretation of this Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.13. <U>Interpretation</U>. When a reference is made in this Agreement to an
Article or Section, such reference shall be to an Article or Section of this Agreement unless
otherwise indicated. Whenever the words &#147;include,&#148; &#147;includes&#148; or &#147;including&#148; are used in this
Agreement, they shall be deemed to be followed by the words &#147;without limitation.&#148; The words
&#147;hereof,&#148; &#147;herein&#148; and &#147;hereunder&#148; and words of similar import when used in this Agreement shall
refer to this Agreement as a whole and not to any particular provision of this Agreement. All
terms defined in this Agreement shall have the defined meanings when used in any certificate or
other document made or delivered pursuant to this Agreement unless otherwise defined therein. The
definitions contained in this Agreement are applicable to the singular as well as the plural forms
of such terms and to the masculine as well as to the feminine and neuter genders of such term. Any
agreement, instrument or statute defined or referred to herein or in any agreement or instrument
that is referred to herein means such agreement, instrument or statute as from time to time
amended, modified or supplemented, including (in the case of agreements or instruments) by waiver
or consent and (in the case of statutes) by succession of comparable successor statutes and
references to all attachments thereto and instruments incorporated therein. Each of the parties
has participated in the drafting and negotiation of this Agreement. If an ambiguity or question of
intent or interpretation arises, this Agreement shall be construed as if it is drafted by all the
parties, and no presumption or burden of proof shall arise favoring or disfavoring any party by
virtue of authorship of any of the provisions of this Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.14. <U>No Recourse</U>. This Agreement may only be enforced against, and any
claims or causes of action that may be based upon, arise out of or relate to this Agreement, or the
negotiation, execution or performance of this Agreement may only be made against the entities that
are expressly identified as parties hereto and no past, present or future affiliate, director,
officer, employee, incorporator, member, manager, partner, stockholder, agent, attorney or
representative of any party hereto shall have any liability (i)&nbsp;for any obligations or liabilities
of the parties to this Agreement, (ii)&nbsp;for any claim based on, in respect of, or by reason of, the
transactions contemplated hereby or (iii)&nbsp;resulting from the Company or its Representatives making
available to Parent any information regarding the Company, or Parent&#146;s use of such information,
including the Information Memorandum, and the other due diligence materials made available to
Parent, including in the data room, other management presentations (formal or informal) or in any
other form in connection with the transactions contemplated by this Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;9.15. <U>Definitions</U>. References in this Agreement to specific Laws or to
specific provisions of Laws shall include all rules and regulations promulgated thereunder. Any
statute defined or referred to herein or in any agreement or instrument referred to herein shall
mean such statute as from time to time amended, modified or
supplemented, including by succession of comparable successor statutes. For purposes of this
Agreement, the following terms will have the following meanings when used herein:
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->68<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>1998 Stock Option Plan</U>&#148; means the Company&#146;s 1998 Stock Option Plan, as amended,
restated and adopted by the Board of Directors on April&nbsp;12, 2004 and subsequently approved by the
stockholders at the 2004 annual meeting of stockholders.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>2002 Non-Employee Director Stock Option Plan</U>&#148; means the 2002 Non-Employee Director
Stock Option Plan, as amended and restated November&nbsp;11, 2002.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Acceptable Confidentiality Agreement</U>&#148; has the meaning set forth in <U>Section
6.3(g)(i)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Acceptance Date</U>&#148; has the meaning set forth in <U>Section&nbsp;1.1(f)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Action</U>&#148; has the meaning set forth in <U>Section&nbsp;6.9(b)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>affiliates</U>&#148; means, with respect to any Person, any other Person which, directly or
indirectly, controls, or is controlled by, or is under common control with, such Person. As used
in this definition, &#147;control&#148; (including with its correlative meanings, &#147;controlled by&#148; and &#147;under
common control with&#148;) shall mean the possession, directly or indirectly, of the power to direct or
cause the direction of management or policies of a Person, whether through the ownership of
securities or partnership or other ownership interests, by contract or otherwise.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Agreement</U>&#148; has the meaning set forth in the Preamble.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Board Actions</U>&#148; has the meaning set forth in <U>Section&nbsp;1.2(a)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Board of Directors</U>&#148; has the meaning set forth in the Recitals.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Board Percentage</U>&#148; has the meaning set forth in <U>Section&nbsp;1.4(a)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Book-Entry Shares</U>&#148; has the meaning set forth in <U>Section&nbsp;3.2(a)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Business</U>&#148; means the business of the Company and its Subsidiaries of providing Hospice
Services to patients and their families at home or in facilities.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Business Day</U>&#148; has the meaning set forth in <U>Section&nbsp;1.1(d)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Cancelled Shares</U>&#148; has the meaning set forth in <U>Section&nbsp;3.1(b)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Certificate of Merger</U>&#148; has the meaning set forth in <U>Section&nbsp;2.3</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Certificates</U>&#148; has the meaning set forth in <U>Section&nbsp;3.2(a)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Claim</U>&#148; has the meaning set forth in <U>Section&nbsp;4.10</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Class&nbsp;A Common Stock</U>&#148; means the Class&nbsp;A Common Stock, $0.01 par value per share, of
the Company.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Class&nbsp;B Common Stock</U>&#148; has the meaning set forth in <U>Section&nbsp;4.2(a)</U>.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->69<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Clinical Contracts</U>&#148; means any contract (other than a Lease of Leased Property or
Medical Director Contract) entered into in the ordinary course of business with a hospital, nursing
home, assisted living facility, consulting physician, therapist, staffing company or hospice
provider for the provision of Hospice Services.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Closing</U>&#148; has the meaning set forth in <U>Section&nbsp;2.2</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Closing Date</U>&#148; has the meaning set forth in <U>Section&nbsp;2.2</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Code</U>&#148; has the meaning set forth in <U>Section&nbsp;3.2(b)(iv)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Common Stock</U>&#148; has the meaning set forth in <U>Section&nbsp;3.1(a)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Company</U>&#148; has the meaning set forth in the Preamble.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Company Acquisition Proposal</U>&#148; has the meaning set forth in <U>Section
6.3(g)(ii)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Company Balance Sheet</U>&#148; means the Company&#146;s consolidated balance sheet included in the
Company&#146;s Annual Report on Form 10-K for the fiscal year ended September&nbsp;30, 2007, as amended.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Company Benefit Plans</U>&#148; has the meaning set forth in <U>Section&nbsp;4.8(a)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Company Disclosure Letter</U>&#148; has the meaning set forth in <U>Article&nbsp;IV</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Company Employees</U>&#148; has the meaning set forth in <U>Section&nbsp;6.5(b)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Company Expenses</U>&#148; means , subject to the dollar limitations set forth in this
definition, the aggregate amount of all of the Company&#146;s reasonably documented out-of-pocket fees
and expenses (including all fees and expenses of counsel, accountants, consultants, financial
advisors and investment bankers of the Company and fees paid to any Governmental Entity, but
excluding any Termination Fee or Parent Expenses) actually incurred by or on behalf of the Company
(i)&nbsp;on or prior to December&nbsp;3, 2007, solely in connection with or related to the authorization,
preparation, and negotiation of this Agreement and the Exclusivity Agreement (including drafts),
the establishment of the data room or otherwise having direct applicability to the transactions
between the parties contemplated hereby, which amount shall not be greater than $150,000, and (ii)
after December&nbsp;3, 2007 and on or prior to the termination of this Agreement, solely in connection
with or related to the authorization, preparation, negotiation, execution and performance of the
transactions contemplated by this Agreement; provided that &#147;Company Expenses&#148; (which means the
aggregate sum of the fees and expenses described by the foregoing clauses (i)&nbsp;and (ii)) shall not
be greater than
$1,471,000 in the aggregate.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Company Intellectual Property</U>&#148; has the meaning set forth in <U>Section&nbsp;4.15(a)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Company Material Adverse Effect</U>&#148; has the meaning set forth in <U>Section&nbsp;4.1(c)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Company Meeting</U>&#148; has the meaning set forth in <U>Section&nbsp;6.4(b)</U>.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->70<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Company Permits</U>&#148; has the meaning set forth in <U>Section&nbsp;4.6(b)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Company SEC Documents</U>&#148; has the meaning set forth in <U>Section&nbsp;4.5(a)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Company Stock Options</U>&#148; has the meaning set forth in <U>Section&nbsp;3.3(a)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Company Stock Plans</U>&#148; has the meaning set forth in <U>Section&nbsp;3.3(a)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Company Stockholder Approval</U>&#148; has the meaning set forth in <U>Section&nbsp;4.19</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Confidentiality Agreement</U>&#148; has the meaning set forth in <U>Section&nbsp;6.2(d)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Contract</U>&#148; means any contract, agreement, arrangement, commitment, letter of intent,
memorandum of understanding, license, lease, promise, instrument, or other similar understanding,
whether written or oral, in each case that is legally binding as of the date in question.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Credit Agreement</U>&#148; means the Second Amended and Restated Loan and Security Agreement,
dated as of December&nbsp;23, 2004, by and among the Company and its Subsidiaries and Healthcare
Business Credit Corporation.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Designated SEC Reports</U>&#148; means the Annual Report on Form 10-K filed by the Company for
the fiscal year ended September&nbsp;30, 2007, and each Current Report on Form 8-K filed by the Company
after the filing date of such Annual Report on Form 10-K and prior to the date hereof, but
excluding therefrom any disclosures set forth in any section of the foregoing SEC reports relating
to forward looking statements and any other disclosures included therein to the extent that they
are cautionary, predictive or forward looking in nature.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>DGCL</U>&#148; means the Delaware General Corporation Law.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Dissenting Shares</U>&#148; has the meaning set forth in <U>Section&nbsp;3.1(d)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Effective Time</U>&#148; has the meaning set forth in <U>Section&nbsp;2.3</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Employees</U>&#148; has the meaning set forth in <U>Section&nbsp;4.14(a)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>End Date</U>&#148; has the meaning set forth in <U>Section&nbsp;8.1(b)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Enforceability Exceptions</U>&#148; has the meaning set forth in <U>Section&nbsp;4.4(a)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Environmental Law</U>&#148; has the meaning set forth in <U>Section&nbsp;4.7(a)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>ERISA</U>&#148; has the meaning set forth in <U>Section&nbsp;4.8(a)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>ERISA Affiliate</U>&#148; has the meaning set forth in <U>Section&nbsp;4.8(a)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>ESPP</U>&#148; has the meaning set forth in <U>Section&nbsp;3.3(a)</U>.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->71<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Exchange Act</U>&#148; means the Securities Exchange Act of 1934, as amended, and the rules
and regulations promulgated thereunder.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Exchange Fund</U>&#148; has the meaning set forth in <U>Section&nbsp;3.2(a)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Expiration Date</U>&#148; has the meaning set forth in <U>Section&nbsp;1.1(d)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Financial Advisor</U>&#148; has the meaning set forth in <U>Section&nbsp;4.18</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Funded Indebtedness</U>&#148; means all indebtedness for borrowed money.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>GAAP</U>&#148; means United States generally accepted accounting principles.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Governmental Entity</U>&#148; has the meaning set forth in <U>Section&nbsp;4.4(b)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Governmental Programs</U>&#148; has the meaning set forth in <U>Section&nbsp;4.6(d)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Hazardous Substance</U>&#148; has the meaning set forth in <U>Section&nbsp;4.7(b)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Healthcare Law</U>&#148; means any Law relating to healthcare regulatory matters, including
(A)&nbsp;42 U.S.C. Sections&nbsp;1320a-7, 7a and 7b, which are commonly referred to as the &#147;Federal
Anti-Kickback Statute&#148;; (B)&nbsp;42 U.S.C. Section&nbsp;1395nn, which is commonly referred to as the &#147;Stark
Statute&#148;; (C)&nbsp;31 U.S.C. Sections&nbsp;3729-3733, which is commonly referred to as the &#147;Federal False
Claims Act&#148;; (D)&nbsp;42 U.S.C. Sections&nbsp;1320d through 1320d-8 and 42 C.F.R. Sections&nbsp;160, 162 and 164,
which is commonly referred to as the &#147;Health Insurance Portability and Accountability Act of 1996;&#148;
and (E)&nbsp;any state Law addressing the same or similar purposes as the foregoing Laws.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Hospice</U>&#148; means any licensed entity owned and/or operated by the Company or any of its
Subsidiaries that is primarily engaged in providing Hospice Services.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Hospice Services</U>&#148; means those palliative care services furnished to terminally ill
individuals that are covered under the Medicare and Medicaid programs, including nursing care,
medical social services, services of physicians or mid-level practitioners, counseling services,
short term inpatient care, medical appliances and supplies (including drugs and biologicals), home
health aid and homemaker services, physical therapy, occupational therapy and speech-language
pathology services, and any other services specified in a patient&#146;s plan of care as reasonable and
necessary for the palliation and management of the patient&#146;s terminal illness and related
conditions and for which payment may otherwise be made under the Medicare or Medicaid program.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>HSR Act</U>&#148; means the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended,
and the rules and regulations promulgated thereunder.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Indemnified Party</U>&#148; has the meaning set forth in <U>Section&nbsp;6.9(b)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Independent Contractors</U>&#148; has the meaning set forth in <U>Section&nbsp;4.14(a)</U>.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->72<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Independent Directors</U>&#148; has the meaning set forth in <U>Section&nbsp;1.4(a)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Information Memorandum</U>&#148; means the Confidential Information Memorandum made available
to Parent by the Company, as subsequently updated, supplemented or amended.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Insurance Policy</U>&#148; has the meaning set forth in <U>Section&nbsp;4.22</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>knowledge</U>&#148; means (a)&nbsp;with respect to Parent, the knowledge of each of Robert Lefton,
Chief Executive Officer; R. Dirk Allison, Chief Financial Officer; Craig P. Goguen, Chief Operating
Officer; and W. Bradley Bickham, General Counsel and (b)&nbsp;with respect to the Company, the knowledge
of each of Rick Slager, Chief Executive Officer; Henry Hirvela, Chief Financial Officer; Roseanne
Berry, Chief Compliance Officer; Charlene Ross, Vice President Patient Care Services; Mark Cheek,
Vice President Information Technology with respect to Section&nbsp;4.15 only; John Crisci, Chief People
Officer; Jessica Hood, Senior Vice President Operations; and Steve Lewis, General Counsel.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Labor Laws</U>&#148; has the meaning set forth in <U>Section&nbsp;4.14(b)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Law</U>&#148; or &#147;<U>Laws</U>&#148; means any federal, state, local or foreign law, statute,
ordinance, rule, regulation, manual instruction, treaty, obligation, duty, judgment, ruling, order,
writ, injunction, decree or agency requirement of, or adopted, promulgated or imposed by, any
Governmental Entity.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Leased Property</U>&#148; has the meaning set forth in <U>Section&nbsp;4.17(a)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Leases</U>&#148; has the meaning set forth in <U>Section&nbsp;4.17(a)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Liability</U>&#148; means with respect to any Person, any liability or obligation of such
Person of any kind, character or description, whether direct or indirect, known or unknown,
asserted or unasserted, choate or inchoate, absolute or contingent, accrued or unaccrued, disputed
or undisputed, liquidated or unliquidated, secured or unsecured, joint or several, due or to become
due, vested or unvested, executory, determined, determinable or otherwise, and regardless of
whether the same is required to be accrued on the financial statements of such Person.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Lien</U>&#148; means a right of termination, cancellation or acceleration of any material
obligation or to the loss of a material benefit under any loan, guarantee of indebtedness or credit
agreement, note, bond, mortgage, indenture, lease, agreement, contract, instrument, permit,
concession, franchise, right or license binding upon the Company or any of the
Company&#146;s Subsidiaries or result in the creation of any liens, claims, mortgages,
encumbrances, pledges, security interests, equities or charges of any kind.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Loan Agreement</U>&#148; means the Loan Agreement, dated March&nbsp;1, 2006 between the Company and
De Lage Landen Financial Services, Inc. together with the related Promissory Note.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Matching Bid</U>&#148; has the meaning set forth in <U>Section&nbsp;6.3(e)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Material Contract</U>&#148; has the meaning set forth in <U>Section&nbsp;4.20(a)</U>.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->73<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Medical Director Contracts</U>&#148; has the meaning set forth in <U>Section
4.20(a)(vii)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Medicare and Medicaid Programs</U>&#148; has the meaning set forth in <U>Section&nbsp;4.6(d)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Merger</U>&#148; has the meaning set forth in the Recitals.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Merger Consideration</U>&#148; has the meaning set forth in <U>Section&nbsp;3.1(a)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Merger Sub</U>&#148; has the meaning set forth in the Preamble.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Minimum Condition</U>&#148; has the meaning set forth in <U>Annex A</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Minority Investments</U>&#148; means, with respect to any Person, any corporation or other
entity (including a division or line of business of such corporation or other entity) (A)&nbsp;of which
such Person and/or any of its Subsidiaries beneficially owns a portion of the equity interests that
is insufficient to make such corporation or other entity a Subsidiary of such Person, and (B)&nbsp;over
which such Person and/or any of its Subsidiaries does not exercise control.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Modified Superior Proposal</U>&#148; has the meaning set forth in <U>Section&nbsp;6.3(e)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Multiemployer Plan</U>&#148; has the meaning set forth in <U>Section&nbsp;4.8(a)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>NASDAQ</U>&#148; means The NASDAQ Stock Market LLC.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>New Plans</U>&#148; has the meaning set forth in <U>Section&nbsp;6.5(b)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Notice of Superior Proposal</U>&#148; has the meaning set forth in <U>Section&nbsp;6.3(e)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Odyssey</U>&#148; has the meaning set forth in <U>Section&nbsp;5.6</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Odyssey Credit Agreement</U>&#148; means the Amended and Restated Credit Agreement, dated as
of May&nbsp;24, 2007, by and among Odyssey Healthcare Operating A, LP, Odyssey Healthcare Operating B,
LP, Hospice of the Palm Coast, Inc., the other credit parties signatory thereto, and General
Electric Capital Corporation, as agent and lender, as such agreement may be amended or restated
from time to time.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Offer</U>&#148; has the meaning set forth in the Recitals.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Offer Documents</U>&#148; has the meaning set forth in <U>Section&nbsp;1.1(a)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Old Plans</U>&#148; has the meaning set forth in <U>Section&nbsp;6.5(b)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Option Consideration</U>&#148; has the meaning set forth in <U>Section&nbsp;3.3(a)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Options Reserved Shares</U>&#148; has the meaning set forth in <U>Section&nbsp;4.2(a)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Order</U>&#148; means any binding and enforceable decree, injunction, judgment, order, ruling,
assessment or writ issued by a Governmental Entity.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->74<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Parent</U>&#148; has the meaning set forth in the Preamble.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Parent Approvals</U>&#148; has the meaning set forth in <U>Section&nbsp;5.2(b)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Parent Deferred Compensation Plans</U>&#148; has the meaning set forth in <U>Section
6.5(a)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Parent Expenses</U>&#148; has the meaning set forth in <U>Section&nbsp;8.3(b)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Parent Material Adverse Effect</U>&#148; has the meaning set forth in <U>Section&nbsp;5.1</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Parent Representatives</U>&#148; has the meaning set forth in <U>Section&nbsp;6.2(a)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Paying Agent</U>&#148; has the meaning set forth in <U>Section&nbsp;3.2(a)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Per Common Share Price</U>&#148; has the meaning set forth in <U>Section&nbsp;1.3(a)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Per Share Amount</U>&#148; has the meaning set forth in <U>Section&nbsp;1.1(a)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Permitted Actions</U>&#148; has the meaning set forth in <U>Section&nbsp;6.3(b)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Permitted Lien</U>&#148; means a Lien (A)&nbsp;for Taxes or governmental assessments, charges or
claims of payment not yet due or being contested in good faith and, in each case, for which
adequate accruals or reserves have been established in accordance with GAAP, (B)&nbsp;which is a
carriers&#146;, warehousemen&#146;s, mechanics&#146;, materialmen&#146;s, repairmen&#146;s or other similar lien arising in
the ordinary course of business and securing obligations not past due or payable without penalty,
or (C)&nbsp;which is a zoning, entitlement or other land use or environmental regulation by any
Governmental Entity.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Person</U>&#148; means an individual, a corporation, a partnership, a limited liability
company, an association, a trust or any other entity, group (as such term is used in Section&nbsp;13 of
the Exchange Act) or organization, including a Governmental Entity, and any permitted successors
and assigns of such Person.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Preferred Stock</U>&#148; has the meaning set forth in <U>Section&nbsp;4.2(a)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Provider Agreements</U>&#148; has the meaning set forth in <U>Section&nbsp;4.6(d)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Proxy Statement</U>&#148; has the meaning set forth in <U>Section&nbsp;4.11(b)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Qualifying Transaction</U>&#148; has the meaning set forth in <U>Section&nbsp;8.3(a)(i)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Recommendation</U>&#148; has the meaning set forth in <U>Section&nbsp;4.4(a)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Recommendation Withdrawal</U>&#148; has the meaning set forth in <U>Section&nbsp;6.3(d)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Representatives</U>&#148; means, with respect to the applicable Person, such Person&#146;s
officers, directors, employees, investment bankers, attorneys, accountants, consultants, agents,
advisors, affiliates and other representatives.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->75<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Restricted Shares</U>&#148; has the meaning set forth in <U>Section&nbsp;3.3(b)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Rights</U>&#148; has the meaning given to such term in the Rights Agreement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Rights Agreement</U>&#148; has the meaning set forth in <U>Section&nbsp;4.2(b)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Sarbanes-Oxley Act</U>&#148; means the Sarbanes-Oxley Act of 2002 and any related rules and
regulations promulgated thereunder or under the Exchange Act.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Schedule&nbsp;14D-9</U>&#148; has the meaning set forth in <U>Section&nbsp;1.2(b)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Schedule&nbsp;TO</U>&#148; has the meaning set forth in <U>Section&nbsp;1.1(a)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>SEC</U>&#148; means the Securities and Exchange Commission.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Securities Act</U>&#148; means the Securities Act of 1933, as amended, and the rules and
regulations promulgated thereunder.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Share</U>&#148; has the meaning set forth in <U>Section&nbsp;3.1(a)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Short Form&nbsp;Merger</U>&#148; has the meaning set forth in <U>Section&nbsp;2.8</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Special Committee</U>&#148; has the meaning set forth in the Recitals.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Specified Approvals</U>&#148; has the meaning set forth in <U>Section&nbsp;4.4(b)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Stock Option Cash Out Consideration</U>&#148; has the meaning set forth in <U>Section
3.3(a)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Stockholder Agreements</U>&#148; has the meaning set forth in the Recitals.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Subsidiaries</U>&#148; means, with respect to any Person, any corporation, partnership,
limited liability company, association, trust or other form of legal entity of which (i)&nbsp;at least
50% of the outstanding voting securities or other equity interests are directly or indirectly owned
by such Person and any one or more of its Subsidiaries, (ii)&nbsp;such Person or any Subsidiary of such
Person is a general partner, or (iii)&nbsp;voting power to elect a majority of the board of directors or
others performing similar functions with respect to
such corporation, partnership, limited liability company, association, trust or other
organization is held by such Person or by any one or more of its Subsidiaries, or by such Person
and any one or more of its Subsidiaries.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Superior Proposal</U>&#148; has the meaning set forth in <U>Section&nbsp;6.3(g)(iii)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Surviving Corporation</U>&#148; has the meaning set forth in <U>Section&nbsp;2.1</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Takeover Laws</U>&#148; has the meaning set forth in <U>Section&nbsp;1.2(a)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Tax Return</U>&#148; has the meaning set forth in <U>Section&nbsp;4.13</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Taxes</U>&#148; has the meaning set forth in <U>Section&nbsp;4.13</U>.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->76<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Tender Offer Conditions</U>&#148; has the meaning set forth in <U>Section&nbsp;1.1(a)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Termination Date</U>&#148; has the meaning set forth in <U>Section&nbsp;6.1(a)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Termination Fee</U>&#148; has the meaning set forth in <U>Section&nbsp;8.3(a)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Third Party</U>&#148; means a Person (or group of Persons) other than Parent, Merger Sub or
any of their respective affiliates.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Top-Up Option</U>&#148; has the meaning set forth in <U>Section&nbsp;1.3(a)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Top-Up Option Shares</U>&#148; has the meaning set forth in <U>Section&nbsp;1.3(a)</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Trademarks</U>&#148; means all trademarks, service marks, trade names, logos, common law
trademarks and service marks, trademark and service mark registrations and applications therefore
and domain names.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#147;<U>Transition Period</U>&#148; has the meaning set forth in <U>Section&nbsp;6.5(b)</U>.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">&#091;Signature Page Follows&#093;
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->77<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed and delivered
as of the date first above written.
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="57%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="32%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left"><B>ODYSSEY HEALTHCARE HOLDING COMPANY</B></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Robert A. Lefton
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Robert A. Lefton</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">President and Chief Executive Officer</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left"><B>OHC INVESTMENT, INC.</B></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Robert A. Lefton
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Robert A. Lefton</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">President and Chief Executive Officer</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left"><B>VISTACARE, INC.</B></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Richard R. Slager</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Richard R. Slager</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Chief Executive Officer</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt">&#091;Signature Page to Agreement and Plan of Merger&#093;

</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><U>Annex A</U>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><U>Conditions to the Offer</U>.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding any other provision of the Offer, Merger Sub shall not be required to, and
Parent shall not be required to cause Merger Sub to, accept for payment or, subject to any
applicable rules and regulations of the SEC, including Rule&nbsp;14e-1(c) promulgated under the Exchange
Act (relating to Merger Sub&#146;s obligation to pay for or return tendered Shares promptly after
termination or withdrawal of the Offer), pay, and (subject to any such rules or regulations) may,
to the extent expressly permitted by this Agreement, delay the acceptance for payment for, or the
payment for, any Shares validly tendered and not properly withdrawn, and, to the extent permitted
by the Agreement, may amend or terminate the Offer if (i)&nbsp;there shall not have been validly
tendered and not properly withdrawn on or prior to the Expiration Date a number of Shares which,
when taken together with the Shares, if any, beneficially owned by Parent, Merger Sub or any of
their affiliates, represents at least a majority of the total number of Shares outstanding on a
&#147;fully diluted basis&#148; (which assumes conversion or exercise of all Company Stock Options and other
securities convertible into or exercisable or exchangeable for Shares, regardless of the conversion
or exercise price, the vesting schedule or other terms thereof and assumes that such awards shall
be earned at the maximum target level set forth in the applicable Company Stock Plan and applicable
award agreement assuming that the Offer is completed, in each case, other than potential dilution
attributable to the Rights) on the Expiration Date (the &#147;<U>Minimum Condition</U>&#148;), (ii)&nbsp;any
applicable waiting periods under the HSR Act shall not have expired or been terminated prior to the
Expiration Date or any restrictive order or other requirements shall have been placed on the
Company, Parent, Merger Sub or the Surviving Corporation in connection therewith; or (iii)&nbsp;at any
time after the date of this Agreement and prior to the Acceptance Date, any of the following
events shall occur and be continuing:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;there shall be pending any Law, proceeding, action, suit or litigation by any Governmental
Entity that seeks to (i)&nbsp;challenge the acquisition by
Parent, Merger Sub or any of their respective affiliates of Shares pursuant to the Offer, (ii)
restrain, prohibit or delay the making or consummation of the Offer or the Merger, (iii)&nbsp;make the
purchase of or payment for some or all of the Shares pursuant to the Offer or the Merger illegal,
(iv)&nbsp;impose material limitations on the ability of Parent, Merger Sub, the Company or any of their
respective affiliates to acquire or hold, or to require Parent, Merger Sub, the Company or any of
their respective affiliates to dispose of or hold separate, any material portion of their assets or
business, (v)&nbsp;impose material limitations on the ability of Parent, Merger Sub, the Company or any
of their respective affiliates to continue to conduct, own or operate, as heretofore conducted,
owned or operated, all or any material portion of their businesses or assets, (vi)&nbsp;impose or result
in material limitations on the ability of Parent, Merger Sub or any of their respective affiliates
to exercise full rights of ownership of the Shares purchased by them, including the right to vote
the Shares purchased by them on any or all matters properly presented to the stockholders of the
Company, or (vii)&nbsp;prohibit or restrict in a material manner the financing of any of the
transactions contemplated by the Agreement;
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->Annex A-1<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;this Agreement shall have been terminated by the Company, Merger Sub or Parent in
accordance with its terms;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) (i)&nbsp;any of the representations and warranties of the Company set forth in Sections&nbsp;4.2(a),
4.2(b), 4.12(a), 4.12(b) or 4.19 shall not be true and correct in all respects (except, in the case
of Sections&nbsp;4.2(a) and (b), to the extent that the value of any inaccuracies thereof do not
individually or in the aggregate exceed $500,000 as determined utilizing the Per Share Amount), in
each case at and as of the date of this Agreement and at and as of the Expiration Date as though
made at and as of the Expiration Date (except to the extent expressly made as of an earlier date,
in which case as of such date), or (ii)&nbsp;any of the other representations and warranties of the
Company set forth herein shall not be true and correct in each case at and as of the date of this
Agreement and at and as of the Expiration Date as though made at and as of the Expiration Date
(except to the extent expressly made as of an earlier date, in which case as of such date), except,
in the case of this clause (ii), where the failure of such representations and warranties to be so
true and correct has not had and would not have, individually or in the aggregate, a Company
Material Adverse Effect;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;the Company shall have failed to perform in all material respects (provided that any
obligation the performance of which is subject to materiality, Company Material Adverse Effect or
similar qualification shall not be so qualified for purposes of determining the existence of any
nonperformance thereof) any obligation or shall have failed to comply in all material respects with
any covenant or agreement required by this Agreement to be performed or complied with by it prior
to the Expiration Date and such failure to perform shall not have been cured prior to the
Expiration Date;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)&nbsp;there shall have occurred any fact, condition, circumstance, event, change, effect or
occurrence which has had or would reasonably be expected to have, either individually or in the
aggregate, a Company Material Adverse Effect;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)&nbsp;the Company shall have failed to deliver to Parent immediately prior to the Acceptance
Date a certificate, dated as of such time and signed by its Chief Executive Officer or Chief
Financial Officer, each certifying, solely in his or her capacity as an officer of the Company
without personal liability, to the effect that the conditions set forth in clauses (c)&nbsp;and (d)&nbsp;of
this <U>Annex A</U> have been satisfied and also that the condition set forth in clause (e)&nbsp;of
this <U>Annex A</U> has not occurred; or
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)&nbsp;the Company shall have failed to comply with its obligations under <U>Section&nbsp;1.3</U> of
the Agreement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subject to the terms of this Agreement, the foregoing conditions are for the sole benefit of
Parent and Merger Sub and may be asserted by Parent or Merger Sub regardless of the circumstances
(other than any such circumstances caused by any action or inaction by Parent or Merger Sub in
breach of this Agreement) giving rise to any such conditions and may be waived by Parent or Merger
Sub in whole or in part at any time and from time to time, in each case except for the Minimum
Condition, in the sole discretion of Parent or Merger Sub, in each case, subject to the terms and
conditions of this Agreement, including <U>Section&nbsp;1.1(b)</U>. The failure by Parent or Merger
Sub at any time to exercise any of the foregoing rights shall not be deemed a
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->Annex A-2<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">waiver of any such
right and each such right shall be deemed an ongoing right which may be asserted at any time and
from time to time.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->Annex A-3<!-- /Folio -->
</DIV>




</BODY>
</HTML>
</TEXT>
</DOCUMENT>
